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Section 1. The trouble with fatigue 
 
 
 
 
 
 
“Fatigue has always been an elusive creature” 
 
Simon Wessely (1956 - ) 
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Chapter 1. General Introduction 
 
 
 
 
 
 
 
 
 
 
 
“We are continually faced with a series of great opportunities, brilliantly 
disguised as insoluble problems” 
 
John W. Gardner (1912-2002) 
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Introduction 
 Stroke is a common and devastating neurological disease with far reaching 
consequences. It is one of the leading causes of death in developed countries 
and survivors of stroke often face lasting physical, cognitive, psychological and 
social disabilities as a result of their illness.
1-4
 In the Netherlands each year about 
41.000 people suffer a stroke, of which 20% do not survive the first year after 
the attack.
5
 Due to the ageing of the population and improved healthcare 
facilities for patients in the acute phase of stroke,
4
 the amount of patients 
surviving a stroke is increasing, as is the number of patients who have to cope 
with the chronic consequences of stroke. It is estimated that from 2000 to 2020 
the number of stroke survivors in the Netherlands will increase from about 
118.000 to 152.000.
6
 For these patients the consequences of stroke will have to 
be managed as a chronic disease.  
 A stroke may be accompanied by a large series of consequences and co-
morbidities. Frequently encountered co-morbidities include hypertension, 
diabetes, pulmonary and heart disease.
7
 Complications that arise as a 
consequence of the brain injury itself exhibit a wide diversity of clinical signs and 
symptoms. These can be broadly classified into: (1) sensorimotor, (2) cognitive, 
and (3) emotional and behavioral symptoms. Sensorimotor sequelae of stroke 
may include: muscle weakness (paresis), increased muscle tone (spasticity), loss 
of sensibility, tinnitus, (central) pain, loss of smell, and visual field deficits. 
Cognitive problems often encountered after stroke are: mental slowness, 
attention deficits, memory deficits, language disorders, visuospatial neglect, and 
impaired executive functions.
8
 The emotional and behavioral consequences can 
include: depressive symptoms, anxiety, irritability, emotional instability, apathy 
and, as a result, changes in personality.
4, 8
 Furthermore emotional and behavioral 
problems can arise in response to the consequences of the stroke, the ensuing 
impaired functioning and altered social roles in everyday life.
9
  
 A frequently voiced complaint by stroke patients is fatigue. Unfortunately, 
fatigue was not considered a core symptom of stroke until rather recently, in the 
1990’s. Current research has established that it is indeed a distinct symptom 
after stroke requiring medical attention.
10
 Two main causes for this long lasting 
neglect of fatigue have been suggested. First, fatigue is a subjective feeling which 
is difficult to define.
11-13
 The second cause is its non-pathognomic nature, as 
fatigue is a non-specific complaint accompanying many (neurological) diseases.
11
 
As this has had long reaching effects on the general view of fatigue after stroke, 
these causes will be discussed in more detail in section 1 of this chapter. 
Furthermore, in the above-mentioned classification of consequences after 
stroke, fatigue seems to comprise all three elements: the sensorimotor, the 
cognitive as well as the behavioral and emotional. It is sometimes seen as a 
diminished ability to concentrate or a diminished activity level, whereas on the 
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other hand, it can negatively influence mood and vice versa. After stroke, fatigue 
is a frequently mentioned symptom with about 29 to 77% of patients even 
experiencing severe levels of post-stroke fatigue (PSF). Furthermore, the impact 
of PSF on daily life is vast with 29 to 50% of the patients rating fatigue as one of 
their worst symptoms.
10, 14, 15
 Moreover, PSF has been found to have a negative 
effect on quality of life,
16-18
 rehabilitation outcome,
19
 functional independence in 
daily life
18, 19
 and even mortality.
20, 21
 It is thus of great importance to not only 
recognize PSF in patients, but also to treat this symptom in order to improve 
overall rehabilitation outcome and the general wellbeing of patients with stroke.  
 Investigations of PSF and especially of treatment options for PSF are still in 
their infancy. Recent reviews stress that, although PSF is a common and 
debilitating symptom after stroke, many of its aspects still need to be studied
20
 
and no guidelines for clinicians have been established until now
21-23
. Moreover, 
several researchers have stressed that PSF is disregarded in scientific research as 
well as in clinical practice. Articles entitled “Fatigue after stroke: a major but 
neglected issue” by Staub and Bogousslavsky (2001)
22
; “Post-stroke fatigue: an 
important yet neglected symptom” by Morley et al (2005)
23
; and “Post stroke 
fatigue-where is the evidence to guide practice?” by Barker-Collo et al (2007)
24
 
exemplify this idea. Thus, extensive research into the field of PSF is still greatly 
needed.  
 Unfortunately, research into PSF is subject to several complicating issues. 
Fatigue is by nature a subjective feeling and, therefore, difficult to define and 
measure.
13, 25
 To complicate matters, the existing research into PSF (as discussed 
in further detail in paragraph 1.1) has largely focused on either the cognitive or 
the emotional aspect, with or without interest in the physical component. Thus, 
the multi-dimensional nature of fatigue has been disregarded.
10
 Not surprisingly, 
there is a lack of a generally accepted unambiguous definition of PSF, let alone 
an unambiguous assessment procedure to measure it. Consequently, a wide 
variety of assessment tools to measure PSF are in use, often ill-defined and only 
moderately correlating with each other. Studies using different PSF-assessment 
tools often find conflicting evidence with regard to associated variables, as 
discussed in more detail in paragraph 1.3. This impedes the comparison of 
studies and the generalization of findings.  
 In conclusion, the neglected status of PSF, the division of focus of the 
tripartite consequences of stroke (e.g. physical, cognitive or emotional) and the 
use of a wide variety of assessment tools have not only hampered the 
development of a comprehensive theory of the etiology of PSF, but also 
hindered the development of clear guidelines for health care professionals in the 
recognition and treatment of patients with PSF. Hence, the central objective of 
this dissertation is to provide first directions for researchers and clinicians faced 
with patients that suffer from PSF. Herein, the three perspectives on PSF will be 
incorporated. In addressing these issues, and in order to gain understanding of 
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the current standing and knowledge of PSF, the latter part of this introduction 
and the core of this thesis are divided into two main sections. The focus of the 
first section is on the symptoms of fatigue, its ambiguous definition, its 
neglected status, its diverse assessment tools and its many equivocal 
associations. The second section is then dedicated to the treatment of PSF. 
References of all chapters are provided on page 149. 
 
Section 1. The trouble with fatigue 
Fatigue in general is a well-known feeling. Normal fatigue can often be 
related to increased mental or physical activity. It does not systematically 
impede activities and it is alleviated after sufficient rest. On the other hand, 
severe and pathological fatigue is a familiar symptom accompanying many 
diseases, such as cancer, heart disease, pulmonary disease and the flu. Here 
fatigue is ’too normal a symptom’ to aid in the differential diagnosis of the 
primary disease itself and is almost never a primary treatment target. On the 
other hand, fatigue is one of the diagnostic criteria of clinical depression as 
stated in the DSM-IV-TR.
26
 Therefore, it is not surprising that fatigue has often 
been assessed in the framework of depression
10
 and, consequently, has been 
referred to as “pseudo-depressive symptom” by Bogousslavsky in his W. 
Feinberg Lecture.
27
  
The prevalence rates of fatigue amongst all neurological afflictions are 
high, but hardly any effective treatment is available.
11, 21
 Fatigue is a highly 
subjective experience and its unambiguous assessment poses great challenges 
for the clinician. It is not surprising that, when faced with fatigued patients, 
researchers and clinicians have seen fatigue as one of many symptoms of a 
disease or a common non-specific disease symptom
13
 that does not need further 
attention or is untreatable. Thus, fatigue has often been neglected in research 
and in medical practice.
28
  
Several qualitative studies undertaken in developed countries have 
emphasized that fatigue is neglected in general health care.
29-31
 Flinn & Stube 
(2009)
30
 formed three focus groups of stroke survivors in the United States in 
order to gather experiences of fatigue and its subsequent impact on daily life. 
Common themes among these groups were the lack of information that patients 
and their families had received, as well as the continuous search for the cause of 
fatigue and its social validation.
30
 In interviews held with 15 patients in Sweden, 
Bendz (2003)
29
 reported that while the patients’ experience of fatigue and loss of 
control influenced their rehabilitation process, the health care professionals 
ignored these aspects in their recordings.
29
 Furthermore, in a longitudinal study 
in Australia, White et al (2012)
31
 did not only show that PSF led to role loss, but 
also that the lack of information on PSF caused confusion and distress, 
elongating the time needed to adjust to fatigue.
31
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In summary, patients have an urgent need to understand their 
experience of fatigue, aspire to have it properly assessed and explained, so that 
they feel less overwhelmed and know what to do about it.
30
 However, in order to 
inform and treat patients, health care professionals first need to know what PSF 
is, how to diagnose it, and what treatment strategies are available. A first 
prerequisite then is a uniform definition of PSF.  
 
1.1. The definition and experience of fatigue  
  As mentioned before, defining the subjective feeling of fatigue proves to 
be difficult.
9, 30-33
 This is probably the reason that many different definitions of 
fatigue in neurological disorders, and specifically for PSF, are in operation as 
summarized in table 1. It is striking that these definitions can be broadly 
classified into descriptions of ‘subjective emotional’ fatigue or ‘more objective’ 
measures focusing on limitations in mental or physical work-output. Research 
following these different views of PSF will evidently have different foci and use 
different operationalisations and assessments. In the subjective approach 
researchers will rely on self-report assessments of ‘experienced fatigue’, 
whereas studies applying the ‘objective fatigue’ line will use behavioral tasks in 
which attention or work output is measured.  
  The problem with these different approaches is that the ‘subjective 
experience’ of fatigue seems to be a different construct than the constructs 
involving either mental and/or physical activity. Studies investigating both views 
have shown that feelings of PSF as assessed with self-report measures are not 
directly associated with physical fitness
34
 and correlate only moderately at best 
with the ‘objective measurements’ such as attentional tasks.
35-38
 More 
pressingly, valid biological markers of fatigue have still to be found
33, 39
 and 
assessment tools to be developed and validated.
36, 37, 40
 
  However, there are common features to the ‘subjective’ and ‘objective’ 
definitions of PSF. These involve a distinction between ‘normal’ and 
‘pathological’ fatigue after stroke: several studies have shown that patients 
describe PSF to be qualitatively different from fatigue before stroke.
30, 31, 41, 42
 
While normal fatigue and exertion occur after energy expenditure, have a short 
duration and improve with rest,
30, 43, 44
 PSF is characterized by early exhaustion, 
more severe fatigue, and an aversion to effort. PSF is not directly related to 
visible effort, may elicit difficulties in sustaining actions, and is not typically 
ameliorated by rest.
20, 43
 In addition to this description, as mentioned previously, 
PSF seems to be a multi-factorial concept [e.g. Lerdal et al, 2009
20
]. The 
subjective feeling of fatigue, the physical and mental activity could be different 
components. This is exemplified by the findings that patients differ greatly in 
their experience of fatigue including a more emotional, cognitive or physical 
feeling
31, 41
 as well as in the fluctuation
41
  and impact of their experienced fatigue 
on daily life.
31, 42
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Various studies have also shown that PSF is a persistent complaint,  
starting directly post onset for most patients.
16, 41
 Although some prospective 
studies have reported declining prevalence rates of PSF over time,
35, 45
 others 
have not found any difference over a time course of several years.
46, 47
 
Furthermore, relatively consistent prevalence rates (between 29% and 77%) of 
PSF have been found from admission up to 6 years after stroke as shown in 
figure 1. Since the long-term duration seems to be such an intrinsic feature of 
PSF, this warrants the incorporation of persistence into the definition of PSF. 
  In summary, as so-called biological markers of fatigue are still lacking, a 
‘subjective’ definition of PSF is adopted in this thesis, incorporating both physical 
and mental fatigue as well as the persistence of fatigue: “a subjective experience 
of extreme and persistent tiredness, weakness or exhaustion after stroke, which 
can present itself mentally, physically or both, and is unrelated to visible 
previous exertion levels”. Herein, the impact of fatigue on activities or daily life is 
not addressed, since this may vary considerably,
31, 42
 and is possibly even more 
sensitive to the effects of personal disposition towards experienced fatigue.  
 
Figure 1. Prevalence rates of post-stroke fatigue (fatigue severity and fatigue impact) 
observed at different times post stroke onset. 
 
 
1.2. General assessment procedures  
  As mentioned above, a uniform definition of PSF is lacking and no 
derived and well-validated assessment instruments have been specifically 
developed for this population. As objective markers are still lacking, assessment 
of PSF is hitherto mainly restrained to the use of questionnaires. It is has been 
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reported that more than 250 self-report devices, of which 150 have been only 
used once, exist in the general literature on fatigue.
48
 Also for PSF, many 
different questionnaires have been proposed, as can be seen in table 2. To name 
a few, there are linear analogue scales (visual analogue scale, VAS)
44,49
; single 
questions requiring a yes/no answer and questionnaires: vitality domain in the 
Short-Form 36 (VIT SF-36)
50
; Brief Fatigue Inventory (BFI)
28
; Fatigue Assessment 
Scale (FAS)
50, 51
; Checklist Individual Strength-20R (CIS-20R)
52, 53
; Fatigue Severity 
Scale (FSS)
54
; Multidimensional Fatigue Inventory (MFI-20)
28
; and the 
Multidimensional Fatigue Symptom Inventory (MFSI)
28
. These scales differ from 
each other in several regards. First, the construct that is assessed varies 
considerably, as there is no guiding definition of PSF. Whereas some scales focus 
on energy levels (SF-36), others take physical and/or mental fatigue into account 
(CIS-20R; MFI-20) and again other questionnaires seem to focus mainly on the 
experienced impact of fatigue on daily life (FSS). Furthermore, some 
questionnaires assess multiple domains of fatigue (e.g. CIS-20R; MFSI), whereas 
others regard fatigue as a uniform construct (e.g. SF-36 and FSS).   
  The wide variety of scales used has led to major problems in comparing 
studies and standardizing data,
33, 39
 since no scale measures the exact same 
construct as the other.
28, 51
 This is probably one of the main reasons for the 
substantial differences found in the prevalence rates of PSF (29 to 77%), but also 
for the variability in associations found with other variables. Furthermore, 
studies that used identical tools have used different cut-off scores to determine 
PSF (see table 2), compromising the comparability of data even more.  
  
1.3. PSF and its associations 
In an effort to disentangle its content and etiology the majority of 
studies have focused on the associations of PSF with pre-clinical, demographical 
and psychosocial variables (see table 2). The findings of these studies are 
summarized in what follows, starting with pre-stroke, stroke, clinical and socio- 
demographical variables. Thereafter, the main findings will be summarized of 
previous studies regarding depression and other psychological variables. Finally, 
an overview of the relationship between cognitive performance and PSF will be 
given.  
  
1.3.1. Pre-stroke variables  
Few studies have systematically taken pre-stroke variables into account, 
such as pre-existing morbidities, pre-stroke depression or pre-stroke fatigue. To 
our knowledge six studies have investigated whether hypertension, cardiac 
disease, diabetes mellitus or handicap prior to stroke had a relation with PSF. Of 
these, one study reported prior myocardial infarction to be more prevalent in 
patients with  than in patients without PSF.
55
 The other studies did not report 
associations with pre-stroke variables.
14, 49, 56-58
 Two studies took pre-stroke 
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fatigue into consideration and found that it increased the risk of PSF. Controlling 
for pre-stroke fatigue decreased the association between PSF and post-stroke 
depressive symptoms.
16, 49
 The reported prevalence rates of pre-stroke fatigue 
were 61%
49
 and 30%.
16
 Two other studies questioned patients about pre-stroke 
depression. One reported an association with PSF,
55
 whereas the other did not.
47
 
 Thus, so far, the only pre-stroke variable found to be consistently 
related to PSF is pre-stroke fatigue. This relation can be explained in several 
ways. As higher levels of exhaustion have been found to be a risk factor for a 
subsequent stroke,
20
 PSF  might be  one of the tell-tale signs for a forthcoming 
stroke. On the other hand it is plausible that for those patients who experience 
fatigue as an expression of psychological distress, it is this expression that 
manifests itself after the disturbing experience of stroke.  
 
1.3.2. Stroke variables  
 Stroke variables have rarely been found to be associated with fatigue. 
This is true for severity of stroke, number of strokes, neurological deficits, 
location and type of stroke. Three studies examined the differences between 
patients with a transient ischemic attack (TIA) and those with a definite stroke. It 
was found that stroke patients, even those with a minor stroke (NIHHS 
score=0)
59
, were significantly more fatigued than those with a TIA.
55, 57, 59
 This 
effect is not evident for number of strokes. Whereas one study reported that 
patients who had suffered recurrent strokes were more prone to fatigue than 
those with only a single stroke,
19
 another study did not find this association.
17
 
Also, conflicting findings on the relationship between neurological deficits and 
PSF have been reported. Whereas some studies found a significant association,
18, 
47, 49, 59, 60
 others did not.
14, 47, 55, 56
 Furthermore, several studies failed to find an 
association between severity of stroke and PSF.
19, 47
 Yet, white matter lesions 
proved to be related to fatigue in two
55, 60
 out of three studies.
47
  
Of the studies investigating the relationship between stroke type and 
PSF, only one reported increased levels of fatigue (assessed with the FSS) in 
patients after an ischemic attack in comparison with an intracerebral 
hemorrhage.
61
 Other studies found no significant differences between different 
stroke types.
14, 19, 46, 56, 62
 Although subarachnoid hemorrhage (SAH) was not 
included in most of these studies, prevalence rates of severe fatigue after SAH 
are similar to those after other types of stroke.
63-65
 
No study found global localization or type of stroke to be associated with 
PSF,
14, 18, 19, 46, 47, 49, 56, 58, 62
 except for infratentorial lesions that have been 
associated with a greater risk of PSF.
47
 Some studies have focused on more 
specific brain regions. Significantly higher incidences of PSF were found in 
patients with lesions in the internal capsule
66, 67
 and the basal ganglia than in 
patients with other stroke locations.
66
 Furthermore, studies classifying lesions on 
the basis of the artery involved have shown mixed results with regard to basilar 
  
20
infarctions.
55, 58
 Whereas in one study, no association with fatigue was 
reported,
55
 in the other study patients with basilar infarctions and little residual 
disability reported less fatigue impact than patients with severe disabilities as 
assessed with the modified Ranking Score. The authors thus argue that, opposed 
to the relative insensitivity of PSF to the severity of cerebral hemisphere 
ischemia, the extent of the basilar artery infarction might influence PSF.
58
 
However, in a later study by the same researchers, no association between 
basilar infarctions and PSF was substantiated.
55
 
 The results of the studies on localization and stroke type seem to fit with 
the concept of ‘central fatigue’ as proposed by Chaudhuri and Behan (2004; 
2004).
68, 69
 There are several functional circuits in the brain involving the basal 
ganglia, the thalamus, the anterior cingulate cortex, and frontoparietal cortex, 
consisting of both dopamine and serotonin systems.
68, 69
 Damage to each of 
these areas can affect the circuits and feedback loops involved, causing problems 
in e.g. movement control, attention and speed of information processing. The 
authors propose that central fatigue is caused by disruptions in the striatal-
thalamic-frontal loops, connecting the neostriatum with the prefrontal cortex. 
Herein, the basal ganglia have a key position because they subservice higher 
order aspects of motor control that regulate the motivation to undertake an 
activity and, thus, may relate to central fatigue: “the failure to initiate and/or 
sustain attentional tasks (‘mental fatigue’) and physical activities (‘physical 
fatigue’) requiring self-motivation (as opposed to external stimulation)”.
68, 69
 
Thus, according to the above-mentioned theory, infarctions of the basal 
ganglia as well as of other regions involved in the striatal-thalamic-frontal loop 
may cause PSF. One study has indeed found an association between PSF and 
basal ganglia infarction.
66
 Most other studies, however, did not report the 
specific lesion sites of the patients included, so that this relationship could not 
be further substantiated. Still, this theory might explain the absence of a 
relationship between lesion size and fatigue, not only in stroke patients but also 
in patients with MS.
11
  
 Recently, the hormonal origin of PSF has been emphasized. Activation of 
the cytokine system has been associated with inflammation after stroke,
32
 and 
peak levels of proinflammatory cytokines have been found to correlate with 
infarct volume, functional outcome and mortality after one year.
33
 Furthermore, 
cytokine-receptors can be found throughout the hypothalamic-pituitary-adrenal 
axis (HPA-axis) which in turn plays a central role in stress responses. Specifically, 
after stress, HPA-axis functioning as well as increase in proinflammatory 
cytokines can induce sickness behaviors such as social withdrawal, apathy and 
sleepiness in order to allow the individual to recuperate from the stress. 
However, chronic alterations in these systems have been reported as more 
detrimental and subsequently, as possible causes for chronic fatigue in 
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neurological afflictions such as traumatic brain injury (TBI) and multiple sclerosis  
(MS).
32, 70-72
 
 In addition, HPA-axis deregulation such as putative abnormalities can 
affect the striato-thalamo-cortical loop
68, 69
 and, thereby, central fatigue as 
mentioned previously. Until now, only two small studies on this subject have 
been conducted in stroke and SAH patients.
39, 73, 74
 One study with SAH patients 
concluded that, since only three out of 10 patients showed some degree of 
pituitary dysfunction, impaired pituitary capacity may contribute but is not 
necessary to develop PSF.
73
 The other study found that, after excluding patients 
with high depression scores and pre-stroke fatigue, patients who fulfilled the 
criteria for PSF had markedly higher levels of serum C-reactive protein levels 
than patients without PSF.
74
 Thus, although these studies did not show direct 
links with fatigue, it is plausible that alterations of cytokine levels and HPA-axis 
deregulation might (partly) explain fatigue in patients with stroke.  
In summary, it is evident that PSF can occur after any kind of stroke with 
any kind of severity, and that multiple causation of fatigue as a result of brain 
injury may be a distinct possibility. Furthermore, severe fatigue has been found 
to be as frequent in stroke patients as in patients with other types of progressive 
and non-progressive brain damage, such as multiple sclerosis (75%),
75
 
Parkinson’s disease (33-81%),
76
 traumatic brain injury (50%-80%)
76, 77
 or brain 
tumors (40%).
78
 Despite these commonalities regarding fatigue in neurological 
patients, some reviews have concluded that, since direct associations between 
lesion sites and fatigue are weak, PSF is not directly caused by the brain damage 
suffered.
20
 Thus, not surprisingly, many studies have focused primarily on clinical 
and psychological variables as possible direct causes for PSF. Although fatigue is 
undoubtedly related to a number of these variables as discussed below, it is 
unfortunate that the central origin of PSF has been largely disregarded in these 
studies, since this could have provided a more comprehensive view on this 
extensive problem.   
 
1.3.3. Clinical variables 
  Amongst the clinical variables related to PSF, sleep disturbances, pain 
and physical disability have received most attention. Some studies have also 
taken into account current co-morbidity and medication. Although associations 
between these clinical variables and PSF have been found, the relationships are 
often complex and uncertain. 
  Sleep disturbances are frequently found in stroke patients. Sleep-related 
breathing disturbances, for example, are found in 50-70% of the patients and 
sleep-wake cycle disturbances in 10-50%.
79
 These sleep disturbances might 
provoke sleepiness and low rest levels. Therefore, a high concurrent prevalence 
of PSF and sleep disturbances can be expected. Yet, only a surprisingly small 
amount of studies on PSF have taken sleep disturbances into account (see table 
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2). Five out of seven studies found a weak relationship between PSF and sleep 
disturbances, such as insomnia or frequent awakening.
16, 49, 55, 56, 80
 However, 
these associations found in two studies disappeared when controlling for 
depression
49
 or when entered in a multivariate analysis.
16
 Unfortunately, the 
majority of the studies used questionnaires
16, 80
 or even single questions
46, 49, 56
 to 
assess sleep disturbances. These tools are probably not adequate to assess the 
full scope of common sleep disturbances after stroke, especially milder forms of 
sleep apnoea. Even though sleepiness is different from fatigue,
28
 sleep apnoea 
seriously affects rest and may thus exacerbate PSF.
41
 
  Chronic pain after stroke is increasingly recognized, with reported 
prevalence rates ranging from 11% to 53%.
4, 81
 Furthermore, stroke patients 
often report other bodily pain and headache. Although one study reported no 
relationship between PSF and pain, in this study only one question to assess 
fatigue and one to assess pain were used.
56
 The few other studies covering both 
PSF and pain are quite consistent in finding small to moderate associations (see 
table 2),
19, 82, 83
 but one study found a strong relationship between pain and 
fatigue impact.
61
  
 There are a few studies in which the relation of PSF with concomitant 
diseases and medication use was investigated. Although patients with stroke 
consistently showed more concurrent diseases and higher use of medication, 
only weak associations between these variables and PSF have been found. No 
associations between fatigue severity and concurrent cardiac disease, diabetes 
or angina pectoris have been reported.
20, 46, 49, 56, 58, 80
 Only one study reported a 
significant relationship between diabetes mellitus and fatigue impact.
55
 In a 
study investigating the relationship between blood pressure and PSF, the results 
showed that both hypertension and hypotension were related to PSF, as was the 
use of antihypertensive medication.
57
 However, two other studies did not find 
hypertension to be related to fatigue impact.
55, 58
 
 Studies relating PSF to physical disability are few and difficult to 
compare, since the assessment tools and methods used vary considerably. A 
noteworthy difference seems to lie in the use of either the Barthel Index (BI) or 
the modified Ranking Scale (mRS) as a measure of disability or ADL-dependence. 
In general, no associations have been found between the BI and several different 
fatigue scales (FSS
16, 80
; FIS
84
, CIS-f
47
, SF-36
17
 and AED
18
) except for one study 
using the MFI-20
45
. The opposite seems to hold true for the mRS which has 
almost consistently been found to be associated with PSF. Associations were 
found with the FSS,
58, 82
 VAS-f
49
 and a single question on fatigue,
56
 but not with 
an interview of Astheno- Emotional Disorder.
18
 It has been suggested that the BI 
has a substantial ceiling effect
63
 and, furthermore, that the mRS seems to be 
more sensitive and responsive as compared to the BI in assessing disability after 
stroke.
85
 Thus, it seems that the mRS is preferable in PSF research.  
  
23
 
-  Chapter 1. General Introduction -    
 Other studies taking into account physical disabilities also show 
conflicting findings. Two out of three studies using the Motricity Index (MI) as an 
assessment tool for paresis did not find an association between the severity of 
paresis and the FSS score.
35, 46, 80
 Physical functioning as assessed with the Short 
Form-physical functioning (SF-phys) was not related to SF-vitality in a large cross-
sectional study,
86
 but it was associated with FSS scores in two other studies.
16, 17
 
Lastly, less reported assessment tools such as the Sickness Impact Profile- 
ambulation and single questions regarding ADL or speech impairment have all 
resulted in finding associations with fatigue, regardless of the fatigue scale 
used.
15, 19, 87-89
 Overall, prevalence rates of PSF were found to be high, even in 
patients with minor physical disabilities.
14, 22
  
  Recently, a systematic review was conducted on the association 
between PSF and physical fitness. Based on three studies, the authors concluded 
that there was no significant association between PSF and the efficiency of gait, 
peak exercise capacity, number of steps per day, or self-reported exercise level.
34
 
This conclusion is congruent with two other studies (not included in the review) 
on walking efficiency
89
 and aerobic fitness.
44
  
  Although there appears to be no unambiguous relationship between PSF 
and physical disability, some aspects of ambulation capacity and physical fitness 
may still be relevant, because physical disability might induce physical 
deconditioning leading to fatigue. On the other hand, severe fatigue might have 
a negative impact on functional ability and general health.
19
 It is possible that the 
lines of causality differ between patients and for various activities. For instance, 
basic activities, such as dressing and toileting, are generally less affected by 
fatigue than activities that are more dependent on choice and demand greater 
initiative, such as sexual intercourse,
49
 shopping
18
 and vocational activities.
18, 20, 90
 
It is likely that fatigued patients can get themselves to do basic daily life tasks, 
but spend too much energy on these basic tasks to feel sufficiently fit to engage 
in other activities. However, as of yet, this is no more than a hypothesis that, 
although it seems to have substantial face validity, needs to be thoroughly 
examined.  
 
1.3.4. Sociodemographical variables 
Associations with demographical variables do not aid in the identification 
of patients at risk of developing PSF. As some studies have found older age to be 
related to PSF,
19, 46, 84
 others found an association with younger age,
43, 47
 or no 
association at all.
14, 16-18, 56-58, 62, 66, 91
 With regard to sex, some studies have found 
female gender to be related to PSF,
17, 19, 46, 62, 66
 but others have not.
14-16, 18, 47, 49, 56-
58, 91
 Level of education is not associated with PSF either according to a majority 
of studies.
16, 17, 49, 91
 Employment status, especially being unemployed, showed an 
association with PSF,
49, 58, 90
 but in a study by Naess et al (2005) this relationship 
disappeared when functional outcome was taken into account.
58
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Studies focusing on social functioning found that there was an 
association between PSF and diminished social functioning as measured with the 
SIP-68,
82
 or the social functioning subscale of the SF-36.
83
 A study taking into 
consideration the social relationships of patients found that there was a negative 
association of PSF with sexual functioning as well as with social contacts with 
friends and acquaintances (but not with partner or family).
18
 A plausible 
explanation for this finding is that PSF limits the amount of energy that can be 
spent on social interactions and that, as a result, patients choose to spend their 
energy to those people that are closer to the home and heart. Furthermore, 
living alone (or not being married) was associated with PSF only in one study,
19
 
but not in others.
16, 46, 56, 92
  
Studies taking lifestyle into consideration found no conclusive evidence 
for cigarette smoking,
49, 56, 58
 use of alcohol,
49
 or Body Mass Index
16, 58
 to be 
related to PSF. In a pilot study in Sweden, the relationship between nutrition, 
mood and fatigue was studied in 89 elderly stroke survivors 6 months after 
discharge from hospital,
93
 since eating difficulties and nutritional deficits are 
frequent problems after stroke. It was found that being female and feeling 
fatigued was related to poor nutritional status as assessed with six questions of 
the Mini Nutritional Assessment-Short Form. The authors argue that this 
relationship may be bidirectional. On the one hand, fatigue may cause difficulties 
in preparing food and may impede motivation to eat, leading to a lack of 
nutritional intake. On the other hand, poor nutritional intake may exacerbate 
fatigue.
93
  
Thus, although demographical variables and lifestyle seem to have little 
relationship with PSF, it is evident that PSF can have a negative impact on social 
relationships and nutritional intake. For the clinician it is important to take the 
latter aspect into consideration, since it can easily be overlooked. 
 
1.3.5. Psychological variables 
Depression is a common problem after stroke with an estimated 
prevalence of about 30%.
94
 Since fatigue is a symptom of depression, as stated in 
the DSM-IV-TR, an overlap between both symptoms is unavoidable.
9, 20, 22
 Indeed, 
moderate to high associations between PSF and depressive symptoms are a 
consistent finding in the literature, not only in stroke patients,
14, 15, 19, 35, 46, 49, 58, 66, 
80, 82, 95
  but also in patients with TBI,
96
 MS,
97
 and in healthy subjects.
82, 96
 Yet, in 
the studies that specifically looked at stroke patients who suffer from depressive 
symptoms and/or fatigue, a clear dissociation between the two phenomena was 
always present in some patients.
14, 15, 46, 49, 57, 58, 98, 99
 This dissociation indicates 
that, although a co-occurrence of fatigue and depressive symptoms is common, 
these symptoms cannot be viewed as a unitary construct or affliction.   
  Anxiety after stroke is also commonly reported. It is estimated that 
approximately 20% of all patients with stroke will experience serious anxiety at 
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some point in time.
100
 A few studies have reported a weak association of anxiety 
level with fatigue severity
19, 47
 and fatigue impact.
57, 62
 
  Studies on the relationship between PSF and other psychological 
variables are scarce. Although merely very limited and specific psychological 
constructs were found to be related to PSF (increased locus of control towards 
powerful others
46
 and emotion-oriented coping
84
), these findings have had 
relatively far reaching consequences in the field. For one, these findings have 
been repeatedly referred to as evidence for a psychological basis of PSF. They 
have even led some authors to conclude that PSF is associated with 
personality.
20
 Undoubtedly, this possibility still needs further research. Since 
interventions on a psychological level are quite feasible and because the 
relationship between PSF and psychological factors is still elusive, a study on the 
psychosocial profile of patients with PSF was conducted in this thesis (chapter 3).  
 
1.3.6. Cognitive performance  
A number of studies on PSF has focused on cognitive impairments. Most 
of these studies used the Mini Mental State Examination (MMSE) to asses 
cognitive performance, and none of these found an association with PSF.
18, 46, 47, 
58, 66, 80
 However, the MSSE is a rather coarse instrument and does not detect 
subtle cognitive impairments after stroke, such as mental slowness or attention 
deficits.
101
 Furthermore, in the MSSE ceiling effects are known to occur. Likewise, 
another study found no relationship between performance on the Trail-Making 
Test (TMT) and fatigue impact.
35
 The TMT is a short test and, used in isolation, 
not suitable to measure the whole array of executive processes, let alone other 
cognitive functions.
101
 Thus, it can be concluded that no associations between 
PSF and ‘crude’ measures of cognitive functioning have been found.  
In contrast, studies using more extensive
65, 67
 or in-depth 
neuropsychological assessment tools
102
 do support the notion of an association 
between PSF and cognitive (dys)functioning. The results of these studies suggest 
that (subtle) attention deficits seem to be related to fatigue.
67, 102
 This suggestion 
is in line with the findings of other studies that subjective concentration 
problems are associated with PSF.
15, 82
 Because in daily life stroke patients are 
confronted with many more attention demanding situations than in the 
structured and distraction-free setting of a clinical test situation, even relatively 
small attention deficits can become problematic, for example during 
conversations or when driving a car. If patients compensate for such attention 
deficits by mobilizing more attentional resources, they may experience more 
fatigue. Thus, it can be expected that fatigue will increase during the day in PSF-
prone patients more than in healthy controls, who do not have to recruit such 
additional mental resources. 
The above-mentioned mechanism regarding attention and 
compensation has been proposed by Van Zomeren et al (1984) and referred to 
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as the ’cognitive coping hypothesis’.
103
 This hypothesis postulates that fatigue is 
mainly due to the additional (compensatory) effort made by brain injured 
individuals to meet the attentional demands of everyday life as a result of their 
cognitive deficits.
103
 As these cognitive deficits are ubiquitous after stroke, in this 
thesis the view is adopted that the primary cause of fatigue is the recruitment of 
attentional resources according to the cognitive coping hypothesis (chapter 5).  
 
Section 2: The management of fatigue 
 
In 2009, a Cochrane systematic review of interventions for PSF was 
published.
21
 Herein, McGeough et al reviewed the few available disease-specific 
treatments and concluded that there was insufficient evidence to alleviate PSF, 
either by pharmacological or by non-pharmacological means. The few possible 
treatment options included the administration of fluoxetine, investigated in a 
randomized double blinded controlled trial, which did not improve PSF but 
decreased depressive symptoms.
104
 In a small trial, patients after SAH were less 
exerted when receiving tirilazad mesylate,
105
 however, more than half of the 
patients were not available for follow-up.
21
 A chronic-disease self-management 
program, not specifically aimed at fatigue, was not effective in reducing fatigue 
after stroke.
106
 Furthermore, a small study of modafinil showed that this drug 
decreased fatigue severity by a very small margin in patients with brain stem and 
thalamic strokes, but not in patients with cortical infarctions.
107
 Lastly, a study on 
the treatment of sleep disordered breathing by continuous positive airway 
pressure showed a decline of fatigue only in those patients suffering from sleep 
apnea syndrome.
108
 More importantly, this treatment seemed to have negative 
effects on some aspects of functional health. In summary, these studies provide 
little basis for the development of clinical guidelines. It has however repeatedly 
been suggested that  tailored educational programs might aid fatigued stroke 
survivors.
42, 46
 
Unfortunately, the literature on other neurological conditions, such as TBI or 
MS, does not yield more conclusive evidence. In systematic reviews of the 
literature Belmont et al (2006)
109
 and Lee et al (2008)
110
 concluded that there is 
only little evidence-based advice that can be offered to patients with TBI and 
MS, respectively. A handful of studies on the benefit of pharmacological agents, 
such as modafinil, suggested some effectiveness in reducing daytime sleepiness 
without improvement of overall fatigue and with a risk of undesirable side 
effects. One study suggested positive effects of an energy conservation course
111
 
aimed at teaching MS patients to cope with fatigue by implementing rest, energy 
efficient planning of activities, efficient use of body mechanics and effective 
communication.  
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In short, at the start of the present project, no evidence-based treatments or 
guidelines for PSF were available, nor was there strong evidence available from 
studies of patients with other neurological diseases. Yet, in the St. 
Maartenskliniek in Nijmegen a treatment module specifically targeted at PSF had 
been evaluated in a pilot study with positive effects on fatigue severity.
10
 This 
treatment module consisted of a combination of exercises, patient education, 
goal setting, energy compensation strategies and some elements of cognitive 
behavior therapy. It was then decided by the Cognitive Rehabilitation 
Consortium in the Netherlands that this treatment should be evaluated 
thoroughly.
112
 Thus, the description and the evaluation of this treatment form 
the core of this thesis. The central objective is to provide first directions in 
dealing with this common, chronic and debilitating affliction called PSF. 
 
Research questions, and outline of the thesis 
  
As described above, there are several important issues regarding PSF. First, it is a 
highly prevalent and troublesome consequence of stroke, requiring medical 
attention. However, qualitative studies have suggested that PSF is still a 
neglected problem in healthcare, even though patients report that receiving 
insufficient information on the subject causes significant distress. Second, no 
consensus on the definition or diagnostic criteria for PSF exists. As a 
consequence, many different assessment tools tapping into different constructs 
are being used. This hampers not only the comparison of research results, but it 
also confuses clinicians as to which tool to use in practice. Although the FSS is 
the most frequently applied tool to determine PSF, it assesses fatigue impact 
rather than fatigue severity, and there is no consensus on which criterion to 
apply for the diagnosis PSF. A third problem concerns the still poorly understood 
etiology of PSF. A better understanding hereof would be of great value in the 
development of targeted treatments. Many researchers presume that altered 
brain mechanisms might constitute the direct cause of fatigue after stroke. On 
the other hand, somatic problems and psychological distress have consistently 
been found to be related to PSF. Yet, the direction of these associations is still 
unclear and knowledge of other possible psychological factors is scarce. Taken 
together, considering the current lack of knowledge concerning diagnosis and 
treatment of PSF, the following research questions form the outline of this 
thesis:  
1. Is there a problem of underdiagnosis of PSF in the Netherlands? Do patients 
receive sufficient information about PSF in Dutch healthcare and is this 
related to personal or clinical characteristics?  
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2. Do patients with PSF have specific psychological or social characteristics? If 
so, could knowledge of these characteristics aid in the development of 
effective treatments? 
3. How does the one-dimensional FSS psychometrically compare to the multi-
dimensional CIS20-R? To what extent do both commonly used fatigue scales 
assess the same construct?  
4. What components should be part of a comprehensive treatment protocol for 
PSF, taking into account the emotional, cognitive and physical aspects of 
fatigue?  
5. Is such a comprehensive treatment approach effective to reduce PSF in the 
chronic phase after stroke?  
These questions are addressed in seven chapters divided into two sections:  
 
Section 1. The trouble with fatigue.  
 Chapter 2 addresses research question one and presents an internet-
based study on the information about PSF provided to patients in the 
Netherlands. It reports on the data of 538 participants who completed a 
questionnaire containing questions about whether they had received 
information on PSF as well as questions about their fatigue (impact, severity, 
onset time and nature of fatigue), their perceived need for treatment, 
demographic characteristics and the perceived difficulty level of the 
questionnaire. It is also investigates whether this provision of information is 
related to personal or clinical characteristics, as it is conceivable that elderly 
patients or patients with a low educational level may receive less information 
compared to younger and higher educated people. 
 
 Chapter 3 addresses research question two and presents a study on the 
psychological and social characteristics of patients with severe PSF. Herein the 
data of 88 outpatients is used. These patients completed a relatively extensive 
array of questionnaires regarding psychosocial aspects. Thus, a profile consisting 
of symptoms of depression, anxiety, psychological distress, somatic complaints, 
coping styles, social support and self-efficacy is obtained. These data are 
compared to reference groups of healthy controls and patients with other 
chronic diseases. Fatigue is assessed by the FSS and the CIS20-R and associations 
between these fatigue scales and the psychosocial variables are calculated. 
Moreover, it is discussed whether targeting these associated variables might aid 
in reducing fatigue.  
  
 In chapter 4 investigates the psychometric properties and underlying 
constructs of two widely used fatigue assessment tools: the CIS20-R and the FSS 
(research question three). Both questionnaires were filled out by 196 patients 
with stroke and 112 age-matched controls. The internal consistency and 
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convergent validity are calculated. Next, factor analysis is conducted to examine 
the item structure and underlying constructs of these questionnaires.   
 
Section 2. The management of PSF.  
 Chapter 5 deals with research question four.  In this chapter the 
treatment protocol “COgnitive and GRaded Activity Training for post-stroke 
fatigue (COGRAT)”, based on the treatment module “Dealing with fatigue“ 
developed in the Sint Maartenskliniek, is described. The treatment comprises 
two complementary ingredients. The first is a COgnitive treatment (CO), teaching 
patients cognitive strategies that allow them to make more efficient and 
sagacious use of their energy. The other part consists of GRaded physical Activity 
Training (GRAT) aimed at improving physical strength and stamina. Both 
treatments are offered in parallel during a twelve-week period. Although the 
general outcome of a pilot study of the “Dealing with fatigue” module showed a 
decline of fatigue and psychological distress, several adaptations were deemed 
necessary. First, patients often suffer from attentional problems and are, 
therefore, easily distracted and, subsequently, fatigued. For this reason, the 
maximum group size was scaled down from eight to four patients. Second, 
because Cognitive Behavioral Therapy (CBT) has been found effective in non-
neurological patients with fatigue, CBT was more strongly incorporated into the 
treatment. A third major adaptation included the development of a graded 
activity training protocol based on the recommendations of the American Heart 
Association
113
.  
  
 In chapter 6 the results of a multi-center randomized controlled trial 
evaluating the effectiveness of the COGRAT treatment as described in chapter 5 
are reported for patients in the chronic phase after stroke (research question 
five). In this study, after a qualification period of three months, 83 chronic stroke 
patients suffering from severe PSF are randomized to either the cognitive 
treatment (CO) alone or a combination of cognitive treatment and graded 
activity training (COGRAT). The patients are assessed at four time points, two 
prior to treatment, one immediately after treatment, and the last time at 6 
months follow-up. Fatigue is assessed with two fatigue scales. It is hypothesized 
that COGRAT is more effective in reducing fatigue than CO alone.  
 
 Finally, chapter 7 summarizes the main findings of this thesis and 
provides a general discussion. The results of the studies presented in the 
previous chapters are discussed in the context of the existing literature on PSF as 
well as the most important methodological issues related to the studies. In 
addition, recommendations for future research are made and first practical 
directions for researchers and clinicians faced with patients that suffer from PSF 
are provided, specifically regarding assessment and treatment techniques.  
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Table 1. Definitions of post-stroke fatigue and fatigue in neurological disorders. 
 Definition Affliction Applied by 
1 Difficulty in initiation of or sustaining voluntary 
activities requiring self motivation. Pathological 
fatigue is thus best understood as an amplified 
sense of normal (physiological) fatigue that can 
be induced by changes in one or major 
variables regulating work output. 
 
Fatigue in 
neurological 
disorders 
 
Chaudhuri & 
Behan 
68, 
69
(2000;2004) 
2 Subjective fatigue can be described as a feeling 
of early exhaustion developing during mental 
activity, with weariness, lack of energy and 
aversion to effort.  
Objective fatigue being: a failure to maintain a 
required output (physical or mental) during a 
task.  
 
PSF Staub et al 
12, 
22
(2001a; 2001b) 
Staub & Carota 
9
(2005) 
Barker Collo, 
2007
24
 
3 A reversible decrease in or loss of abilities 
associated with a heightened sensation of 
physical or mental strain, even without 
conspicuous effort, due to an overwhelming 
feeling of exhaustion, which leads to an 
inability to sustain, or a difficulty in sustaining, 
even routine activities. 
 
PSF Bogousslavsky
27
 
(2003) 
White et al 2012 
31
 
4 Pathological fatigue is a state characterized by 
weariness unrelated to previous exertion levels 
and is usually not ameliorated by rest: 
A feeling of physical tiredness and lack of 
energy that was described as pathological, 
abnormal, excessive, chronic, persistent, or 
problematic.   
 
PSF De Groot et al
43
 
(2003); Lerdal & 
Bakken
20
(2009) 
Kutlubaev et al 
(2011)
39
 
5 Subjective sensation of fatigue is defined as: an 
overwhelming sense of tiredness, exhaustion, 
lack of energy, or difficulties of sustaining 
routine actions.  
 
PSF Naess et al 
(2005)
58
 
6 A condition accompanied by subjective feelings 
of physical and psychological exhaustion 
making daily living activities impossible or 
difficult. It may be reversible or chronic, 
unrelated directly to effort.  
 
 
 
PSF Jaracz et al 
(2007)
84
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Table 1. Continued 
7 A feeling of lack of energy, weariness, and 
aversion to effort. 
PSF Mead et al 
(2007) 
50
; Lewis 
et al (2011)
89
 
Barbour & Mead 
(2012)
41
 Duncan 
et al (2012) 
34
 
 
8 A subjective experience, that includes 
symptoms as rapid inanition, persisting lack of 
energy, exhaustion, physical and mental 
tiredness and apathy 
 
PSF Valko et al 
(2008)
91
 
9 The subjective lack of physical or mental energy 
to carry out usual and desired activities as 
perceived by the patient. 
 
PSF Tang et al (2009; 
2010)
17, 66
 
10 A reduced capacity for work following a period 
of mental or physical activity:  
2 different kinds of fatigue: motor fatigue and 
cognitive fatigue: motor fatigue refers to a 
decrease in motor performance during 
sustained attention, whereas cognitive fatigue 
refers to a decrease in performance during 
sustained cognitive activity. 
 
 
PSF, fatigue 
in patients 
with MS 
and healthy 
controls 
Claros-Salinas 
(2010)
102
 
11 A sense of exhaustion, lack of perceived energy 
or tiredness distinct from sadness or weakness 
 
PSF Lerdal et al 
(2010)
16
 
12 Fatigue is a psychophysiological state that acts 
on the subject’s motivation to engage in and/ 
or to continue strenuous physical or cognitive 
activities. 
Fatigue as a subjective condition, which can be 
assessed by specific questionnaires, must be 
strictly distinguished from fatigability, which is 
defined as reduction of a physical or mental 
performance during a prolonged task. 
 
PSF & 
fatigue in 
neurological 
disorders 
Romani et al 
(2008)
71
 
13 A subjective lack of physical and/or mental 
energy that is perceived by the individual or 
caregiver to interfere with usual or desired 
activities 
 
 
Fatigue in 
patients 
with MS 
and PSF 
Barrit & Smithard 
(2011)
33
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Table 1. Continued 
14 A profound sense of tiredness, lack of energy, 
and feeling of exhaustion following acute 
stroke 
 
PSF Kirkevold et al 
(2012)
42
 
15 Over the past month, there has been at least a 
2-week period when the patient has 
experienced fatigue, a lack of energy, or an 
increased need to rest every day or nearly 
every day. This fatigue has led to difficulty 
taking part in everyday activities.  
 
PSF,  
case 
definition 
Lynch et al 
(2007)
62
 
16 Astheno emotional disorder is a psycho-organic 
syndrome, termed by Lindqvist-Malmgren, 
which includes in mild forms; increased 
fatigability, impaired concentration, memory 
difficulties, irritability and emotional instability. 
In more severe forms it also includes 
impoverishment and sluggishness, slowness of 
thought, lack of overview and reduced capacity 
for abstraction. 
 
Astheno-
emotional 
disorder 
Carlson (2003)
18
 
Rödholm (2001; 
2002)
114, 115
 
17 General exhaustion, lack of initiative and 
increased sleep demand 
Post-
aneurismal 
SAH fatigue 
Brandt et al 
(2004)
73
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Table 2. Studies of post-stroke fatigue: study design, patient samples, time post stroke, questionnaires 
used, and associations found. 
Authors  Study design,  
Population, N, 
Mean age (yrs) 
Time post 
stroke 
Fatigue Assessment 
Questionnaire, cut-off, 
prevalence of PSF  
Associations with fatigue 
Andersen 
2011
90
 
Longitudinal, 
Cohort,  
Stroke, N=83 
<60 yrs, employed 
prior to stroke 
Mean age 54 
10 days, 1 
year & 2 
years 
MFI-20 (PSF: MFI-20 general 
fatigue ≥  12) 
At 2 years 57% PSF 
(scores and percentages at 
other assessment dates are 
not specified; part of the 
study of Christensen 
2008
45
). 
 
- Fatigue at 10 days, and at 1 and 2 years post-stroke, was an 
independent determinant of the chance of returning to work 
after stroke at 1 and 2 years post-stroke.  
Appelros 
2006
56
 
Cohort,  
first –ever stroke, 
N= 253 
Mean age 74.5 
1 year Single Question (yes/no):  
53% indicated fatigue 
- Fatigue was associated with neurological deficits (NIHSS: 
OR=1.1) and physical disability (Modified ranking scale: OR=1.4). 
- No associations with pain, depressive symptoms, age, gender, 
stroke type or pre-stroke risk factors (hypertension diabetes, 
heart disease, smoking) were found (all p>.05). 
 
Carlsson 
2003
18
 
Longitudinal,  
First – ever mild 
stroke < 75 years, 
and living together 
with spouse. N 
=75 
Mean age 60 
1 year Interview on astheno-
emotional disorder (AED) 
including specific question 
on fatigue 
72% indicated fatigue 
- Of the patients with AED (71%) 51% were depressed (DSM-IV 
criteria), and 49% were not depressed. 
- AED correlated with life satisfaction, leisure situation, vocational 
situation, sex –life, contact with friends and symptoms of 
depression (all p<.05).  
- AED was not related to ability to self-care, financial situation, 
partner relationship, family life, neurological impairment (SSS), 
cognitive deficits (MMSE), ADL (BI), age, sex, handicap (OHS) or 
stroke localization (all p>.05).  
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Table 2. Continued 
Choi-Kwon 
2005
49
 
Cross-sectional,  
First-ever stroke, 
between 40 & 80 
yrs, mRS<4, 
MMSe>23, N=220 
 
3-27 months 
Mean:15 
months  
VAS-f (1-3: mild; 4-6: 
moderate; 7-10 severe 
fatigue) 
57% (70.4% mild; 18.4 % 
moderate  
11.2%  severe PSF) 
FSS mean score: 3.0 ± 1.4 
FIS (Fatigue Impact Scale) 
mean score: 1.4 ± .5 
Question on frequency of 
PSF: 44% 20-29 days a 
month 
Question on daily duration 
of PSF: 
88% < 6hrs a day, 12% 6-24 
hrs a day. 
 
- Pre-stroke fatigue was frequent (38%) and associated with PSF 
(OR=33.46) 
- Association between PSF and depressive symptoms (GDS; 
OR=2.67), however of patients without depression (GDS ≤10) 
50% had PSF.  
- PSF was associated to mRS (OR=3.25) and decreased sexual 
activity (OR=2.46). 
- PSF was not related to specific lesion location, lesion size, 
medication use, gender or age. 
Christensen 
2008
45
 
Cohort, 
longitudinal,  
First ever stroke, 
N=165 
Mean age 65 
 
HC, N= 653 
chronic disease  
N= 416 
Mean age 48 
10 days, 3 
months, 1 
year & 2 
years 
MFI-20 (cut-off: MFI-20 
general fatigue ≥  12) 
At 10 days; 59% PSF, mean 
score 12 ± 5 
At 3 months; 44% PSF, mean 
score 11 ± 5 
At 1 year; 38% PSF, mean 
score 10 ± 4 
At 2 years 40% PSF, mean 
score 10 ± 4 
HC and chronic disease 
combined, 32% above cut-
off,  mean score of 10 ± 4 
 
- Functional outcome (BI<60) was associated with PSF 
- No associations found for lesion site  
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Table 2. Continued 
Eskesen 
1984
116
 
 
 
 
Longitudinal, 
cohort,  
SAH,  N=42 
Mean age: 51 
 
3-64 months 
Mean:36 
months 
 
 
Single question (yes/no) 
41% indicated fatigue 
 
Glader 
2002
19
 
Cross-sectional, 
longitudinal,  
Stroke, N=3667 
2 years Single Question: do you feel 
tired: 
Always:  10% 
Often: 29.2% 
39.2% PSF 
- Dependency and not returning to home was related to PSF (PSF 
often, OR= 2.44.- PSF always OR=5.15), as was self-reported 
general health, feelings of anxiety, pain and depression (all 
p<.005). 
- Patients with PSF at year 2 were more likely to die before year 3 
than those without PSF(OR= 1.64) 
- Patients with speech impairment, living in an institution prior to 
stroke, dependent on ADL prior to stroke or with worse general 
health had more fatigue (all p<.001). 
- PSF was not related to number of strokes or stroke type. 
 
Harbison 
2009
57
 
Cross-sectional,  
Stroke,  N=69 
TIA,  N= 31 
Independent 
(MRS>2) 
Mean age 69  
 
1-6 months FSS (cut-off: FSS > 4) 
Stroke pt 51% PSF, mean 
score: 3.8  
TIA pt 23%, mean score: 3.0 
- Fatigue impact was higher and more prevalent in stroke pt than 
in TIA pt 
- Hypertension (OR:3.1; p=.05) and low daytime diastolic blood 
pressure (OR: 4.2; p=.004) were both associated with fatigue 
impact, as was blood pressure medication.  
- FSS was associated with anxiety (HADS-A:r=.37; p=.009) and 
symptoms of depression (HADS-D; r=.42; p=.002).  
- Double dissociation was found: 23% of non-depressed (HADS-A 
&HADS-D ≤ 7) had FSS>4. And 31% of pt with FSS<4 had higher 
depression scores (HADS-A &HADS-D > 7).  
- No associations were found for age, gender, mean daytime or 
night-time blood pressure (systolic and diastolic blood pressure).   
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Hellawell 
1999
64
 
Longitudinal, 
cohort,  
SAH,  N=28 
Mean age: 50  
 
6, 12 & 24 
months 
HISC (Head Injury  Symptom 
Checklist) 
Single question on whether 
fatigue is present as a 
symptom.  
Prevalence of symptom at 6 
months 64%, 12 months 
59% and 24 months 59% 
 
- Fatigue was the most common problem reported by patients, 
followed by passivity 61%-47%-46%, and memory problems 
50%-52%-56%. 
 
Jaracz 
2007
84
 
Cross-sectional,  
First-ever stroke 
N=50 
(60% mild, 40% 
moderate stroke) 
Mean age: 55  
 
3 months FIS  
(3 subscales: physical, 
psychological and social) 
No clear cut-off specified 
30% of pt indicated to 
experience severe and very 
severe fatigue impact in 
several domains. 
- Most severe fatigue impact was found for physical functioning 
domain, but no association with functional deficit (BI) was 
found.  
- Depressive symptoms (BDI) were associated with psychological 
fatigue impact only  
- Emotion oriented coping (CISS) was associated with higher 
fatigue impact, whereas task oriented coping was associated 
with lower fatigue impact 
- No associations with fatigue impact were found for sex,  and 
side of lesion (R/L) 
 
Koopman 
2009
82
 
 
 
 
 
 
 
Case-control 
Prospective, 
N=44 CVT 
(cerebral venous 
thrombosis) and  
44 HC, 
(functionally 
independent)  
Median age: 31   
median 63 
months 
(range 12-
124) 
FSS 
Stroke pt 30% PSF (FSS>5), 
mean score: 4.2 
HC 7% FSS>5, mean score: 
2.8 
- Associations in patients were found for fatigue impact with 
headache (Headache Impact Test: r=.47, p<.001), depressive 
symptoms (CES-D: r= .43, p=.004) subjective concentration 
problems (EuroQuol cognition: r=.59, p<.001), functional 
outcome (mRS; r=.75, p<.001) and the psychosocial impact (SIP; 
r=.69, p<.001). 
- No associations with fatigue impact were found for age, sex, 
symptoms at admission and time post-onset. 
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Lewis 
2011
89
 
 
 
 
 
Cross-sectional,  
Stroke  N=66 
independent 
ambulatory  
Mean age: 71 
 
Median 160 
days (range: 
84-280 
days). 
SF-36 vitality subscale (SF-
VIT) 
PSF-prevalence not specified 
Mean score: 53.6±20.6 
- Physical fitness (Lower limb extension power; Nottingham 
Power Rig) was related to VIT (r=.38, p=.003, N=58).  
- Walking economy (VO2) was not related to SF-VIT 
 
 
Lerdal 
2011
16
 
 
 
 
 
 
 
 
Longitudinal,  
Acute stroke (<15 
days), N=115  
Mean age 68 
Mean 5 days FSS  
FSS<4=low/no fatigue; FSS 4-
4.9=moderate fatigue; FSS ≥  
severe fatigue 
PSF: 33% moderate fatigue; 
24% severe fatigue 
Mean score is not given. 
- FSS was related to declared pre-stroke fatigue (overall 
prevalence 30%; r=.39), physical ambulation (SF-physical, r=-.4) 
and depressive symptoms (BDI-II, r=.31, all p<.05) in multiple 
linear regression.  
- FSS was not related to sex, ADL (BI), sleep quality, body mass 
index, respiratory disease or use of sleep medication when 
controlled for in  multiple linear regression (all p>.05). 
Mead 
2011
86
 
 
 
 
 
 
 
 
 
 
 
Cross-sectional, 
Longitudinal,  
Stroke , N=1080  
Mean age: 71  
 
Mean 64 
weeks 
(Sd:30) 
weeks  
SF-36 vitality subscale (SF-
VIT) 
Median SF-VIT: 37.5 
 
- Vitality was higher in males than in females (median SF-VIT 40 vs 
35).  
- Increasing age, worse emotional role function (SF-36; r=.38, 
p<.001) and worse mental health (SF-36; r=.20, p<.001) were 
associated with less vitality. 
- Less vitality was associated with reduced long-term survival 
rates in 2/4 models. 
- SF-VIT at follow up was not independently predicted by stroke-
(sub)type, baseline atrial fibrillation, baseline systolic blood 
pressure, and other SF-36 subscales: physical function, bodily 
pain, general health and social function. 
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Michael 
2006 
117
; 
Michael 
2007
118
 
Cross-sectional,  
Hemiparetic 
Stroke,  
N=53
117
 
N=79
118
 
Mean age 65 
Mean 10 
months (6-
120 months) 
FSS: (cut-off: FSS > 4) 
PSF 46%
117
 
PSF 42%
118
 
Mean score 3.28 ± 1.36
118
 
- FSS was not related to ambulatory activity or fitness (stride 
counts, step activity intensity and VO2 peak) 
117, 118
 
- FSS was related to lessened balance (Berg balance scale) and 
poorer falls efficacy (both p<.01).  
 
Naess 
2005
58
; 
Naess 
2006
83
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cohort,  controlled  
Longitudinal,  
Young stroke, 
N=192 
HC, N=212 
Mean age: 48 
Mean: 6 yrs 
(range: 1.4-
12.3) 
FSS 
58, 83
 
52% PSF (FSS>4) 
Stroke pt mean score: 4.1 ± 
1.7 
HC mean score: 3.44 ± 1.3 
 
SF-36-vitality
83
 
Stroke pt mean score: 57 
HC mean score: 61 
- Fatigue impact was independently associated with being a 
stroke patient depressive symptoms (Nottingham Health Profile-
emotional reaction), diabetes mellitus and migraine (all 
p<.001)
58
. 
- In stroke patients FSS was independently related to depressive 
symptoms, reduced functional state and basilar artery 
infarctation through an interaction with functional state (mRS; 
all p<.001)
58
. 
- Anxiety (1 item of MADRS) was associated with FSS in patients 
with depression (MADRS>6; 39% of patients), but not in patients 
without depression (MADRS<7)
58
. 
- FSS was related to unemployment in patients
58
 however SF-36-
VIT was not
83
. 
- FSS in patients was not related to sex, age, MMSE, lesion site, 
severity of neurological deficits at admission, BMI, myocardial 
infarctation, angina pectoris, smoking, hypertension or post-
onset time.
58
 
- SF-36-VIT was lower in women than in men
83
.  
- FSS in patients was independently related to SF-36 subscales: 
vitality (r=-.56), role physical (r=-.31), physical functioning (r=-
.30), general health (r=-.44), social functioning (r=-.29; all 
p<.001) and mental health (r=-.19, p<.05)
83
.  
- SF-36-VIT in patients was not related to age, sex, marital status, 
education or mRS
83
.  
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Naess 
2010
61
 
 
 
 
 
 
 
Prospective, 
longitudinal,  
Ischemic stroke 
N=328 
Hemmorhage 
N=29 
TIA  N=51 
Mean age 68 
Mean: 372 
days 
(range 185-
757 days) 
FSS  
No prevalence rates of PSF 
are specified 
ICVA mean score 4.4 
Haemorrhage mean score: 
3.0 
TIA mean score: 3.5 
 
 
- FSS was independently related to pain (VAS-scale: 
OR=3.4,p=.001).  
Noble 
2008
119
 
Longitudinal, 
cohort, 
SAH, N=105 
Mean age at start 
52 
3 & 13 
months 
MFSI-SF (Multidimensional 
fatigue symptom inventory-
short form).  
Cut-off and mean scores not 
stated. 
At 3 months: 59% 
pathological fatigue 
At 13 months: 36% 
pathological fatigue 
 
- Variance of fatigue was predicted for 57% by PTSD-symptom 
severity scale (p<.001). In this study 37% of participants met the 
criteria for PTSD.  
Ogden 
1997
120
  
 
 
 
 
 
Cross-sectional, 
SAH,  N=123 
Mean age: 49 
4-7 yrs 
Mean time 
not 
specified 
Single questions on fatigue 
and on daytime sleepiness.  
Separate items not specified. 
35% of pt indicated 
fatigue/daytime sleepiness.    
- Daytime sleepiness/fatigue correlated significantly with 
difficulties maintaining sleep at night(r= .34, p< .001), 
personality changes (r = .30, p<.001), and complaints of poor 
memory (r = .32, p<.001).  
 
Ones 
2005
121
 
 
 
 
Cross-sectional, 
controlled, 
Stroke, N=88 
HC, N=40 
Mean age 63 
> 6 months 
Mean time 
not 
specified 
Nottingham Health Profile –
energy score 
Stroke mean score: 66.4 ± 
32.7 
HC mean score: 20.5 ± 30.7 
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Park 2009
80
 
 
 
 
 
Cross-sectional, 
Stroke, N=40 
Mean age 60 
Mean: 33 
months ± 27 
FSS 
30% PSF (FSS≥4) 
mean score: 3.6 ± 1.5 
- FSS was associated with depressive symptoms (BDI, r=.47, p<.05) 
and fatigued patients had more often sleeping problems 
(interview) than none fatigued (p,.05). 
- FSS was not related to Motricity index, BI or MMSE. 
 
Passier 
2010
88
; 
 
 
 
Passier 
2011
65
 
 
 
 
 
 
 
 
Cross-sectional, 
SAH, N=111 
Mean age 53  
 
Longitudinal, 
SAH, N=108 
Independent  
Mean age 53 
3 months 
 
 
 
 
12 months 
Single question (yes/no) in 
questionnaire:  
90% indicate presence of 
fatigue
88
 
 
FSS
65
 
71% PSF (FSS ≥4) 
Mean score: 4.8 
- FSS was higher in patients with physical impairments (GOS < 5, 
FSS=5.5 vs GS=5, FSS=4.3), an in patients with cognitive 
impairment (impaired, FSS=5.5, no impairment, FSS=4.4) 
65
 
- Main associations were found between FSS, anxiety (STAI), 
passive coping style (UCL), depressive symptoms (BDI-II) and 
level of impairment (GOS). 
65
 
- No differences were found for age (below and above 52yrs), 
sex, education (High vs low), location of aneurysm (anterior vs 
posterior), treatment procedure (coiling vs surgery), or the 
presence of complications. 
65
 
 
 
Powell 
2004
87
 
 
 
 
 
 
Longitudinal, case-
control, 
SAH, N= 48 
Mean age 47  
 
9 & 18 
months 
Single question with 3-point 
scale 
Prevalence fatigue SAH pt 9 
months: 62% mild-moderate, 
19% severe fatigue 
Prevalence fatigue SAH pt at 
18 months: 65% mild-
moderate, 10% severe 
fatigue 
- Fatigue was associated with lower independence (Brain Injury 
Community Rehabilitation Outcome). 
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Rodholm 
2002
115
; 
 
 
 
 
Rodholm 
2003
114
 
 
 
Longitudinal, 
cohort, 
SAH, N= 63
115
 
Mean age at start  
51; 
SAH, N=119
114
 
Mean age 52 
 
3,6 & 12 
months
115
 
 
 
 
 
12 
months
114
 
Astheno-emotional disorder 
(AED) diagnostic tool 
At 3 months: 60% 
At 6 months: 49% 
At 12 months (N=63): 38 
%
115
 
At 12 months(N=119):51% 
114
 
- AED was associated with pre-existing arterial hypertension. 
115
 
- AED was not associated with age or worse brain injury (RLS85 
levels and Fisher grades). 
115
 
 
 
 
 
 
 
Schepers  
2006
46
 
 
 
 
 
 
 
 
Longitudinal, 
First ever 
Supratentorial 
stroke, N=167 
Mean age at start 
56 
Admission, 6 
& 12 months 
FSS (PSF: FFS>4) 
At admission: 51.5 % PSF, 
mean: 4.1 ± 1.3 
At 3 months: 64.1% PSF, 
mean: 4.5± 1.2 
At 12 months: 69.5% PSF, 
mean 4.7± 1.3 
- Independently related to FSS at 12 months were depressive 
symptoms (CES-D: β=.34, p<.001) and age (β=.17, p=.02). Locus 
of control (MHLC-powerful others), was associated with FSS in 
univariate analysis (r=.24, 0=.002), but not in multivariate 
(p=.09). 
- FSS at 12 months was not predicted by sex, co morbidity, marital 
status, lesion side and type of stroke, motricity index, MMSE, 
trail making test or sleeping problems. 
 
Schuiling 
2005
122
 
 
 
 
 
 
Longitudinal, 
cohort, 
SAH, N= 83 
Mean age 53 
1-3.4 yrs 
Mean: 1.7 
yrs. 
 
- Single question in Sleep 
Diagnosis Questionnaire: 
31% of pt indicate feeling 
very tired  
- SF-36, question on vitality: 
53% indicate feeling often 
tired.  
 
- Sleep disturbances were associated with tiredness.  
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Table 2. Continued 
Snaphaan 
2011
47
 
 
 
 
 
 
 
 
 
Longitudinal, 
Stroke, N= 108 
Mean age at start 
65 
2 & 18 
months 
CIS-f (PSF: CIS-f>35) 
At 2 months: 35% PSF, 
mean: 30.3 ± 14.6 
At 18 months: 33% PSF, 
mean 29.5 ± 13.9 
- At 2 and 18 months, younger age (OR 0,95), depressive 
symptoms (HADS-D; OR 1.4; OR 1,3), Anxiety symptoms (HADS-
A; OR 1,2, and infratentorial lesions (only for CIS-f at 2 months: 
OR 4.7)  were associated with CIS-f. 
- Fatigue at 2 months was related to fatigue at 18 months (OR 
1.2).  
- Not predictive of fatigue at 18 months were sex, marital status, 
education, MMSE, Barthel Index, mRS, NIHSS, lesion location, a 
history of depressive symptoms or Age-related white matter 
changes (all p>.05).  
Tang 
2009
66
;  
Tang 2010 
17
 
 
 
 
 
 
 
 
 
Cross-sectional, 
Stroke, 
N= 334
66
 
N=458
17
 
Mean age 66 
3 months FSS (PSF: FFS>4) 
66
 
23.4% PSF 
66
 
Mean score 3.1 ± 1.4  
17
 
 
SF-VIT 
Mean score 64.6 ± 21.3 
17
 
- In patients with PSF, there were more basal ganglia infarcts, and 
internal capsula infarcts, whereas brainstem and cerebellar 
infarcts were less common (p<.05).
66
  
- FSS was related to SF-VIT score (r=-.61, p<.001), and other 
HRQOL scales of SF-36: mental health (r=-.50), role-emotional 
(r=-.43), general health (r=-.40), social functioning (r=-.40), bodily 
pain (r=-.37), role-physical (r=-.31) and physical functioning (r=-
.30; all p<.05). 
17
 
- SF-VIT was related to depressive symptoms (GDS, r=-.60, 
p<.001), but not to Barthel Index, MMSE, Age, NIHSS, marital 
status, education, or previous stroke. 
17
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Valko 
2008
91
 
Cross-sectional, 
Stroke, N= 235 
Mean age 63  
 
MS, N=188 
HC, N=454 
Sleep-wake 
disorders N=429 
For stroke pt 
mean post-
onset time: 
1.2± .6 yrs 
(range .33-2 
) 
FSS (PSF: FFS≥4 / FSS>5.2) 
Stroke: FFS≥4=49%, 
FSS>5.2=31%  mean score: 
3.9 ± 1.9 
MS: FFS≥4=69%, 
FSS>5.2=45%  mean score: 
4.7 ± 1.6 
HC; FFS≥4=18%, 
FSS>5.2=3.5% mean score: 
3.0 ± 1.1 
Sleep-wake: FFS≥4=62%; 
FSS>5.2=36% mean score: 
4.3 ± 1.6 
 
VAS-f 
Stroke mean score: 4.7 ± 2.6 
MS mean score: 4.8 ± 2.5 
HC mean score: 3.5 ± 2.2 
Sleep-wake mean score: 5.1 
± 2.4 
 
- For stroke pt No associations were found for FSS with age, post-
onset time, gender or educational status.  
- The association between FSS and VAS-f was high (in stroke, 
r=.70, in MS: r=.79, in sleep wake r= .71, in HC r=.52; all p<.01).  
Van der 
Port 2007
35
 
Prospective, 
cohort, 
First ever 
(supratentorial) 
stroke, N= 223 
Mean age at start 
57 
6, 12 & 36 
months 
FSS (PSF: FFS≥4) 
At 6 months: 68% PSF, 
mean: 4.4± 1.2 
At 12 months: 74% mean 4.7 
(SD not given) 
At 36 months: 58%, mean 
4.3 (SD not given) 
- FSS between 6 and 36 months was related to motor function 
(MI), perceived HRQOL (SIP68), and depressive symptoms (CES-
D; all p<.05). 
- FSS was not independently related to IADL (Frenchai Activities 
Index) and ADL (BI) when controlled for motor function and 
depressive symptoms. 
- FSS was not related to age, gender, co morbidity, or time to 
complete the trail making task ( all p>.05). 
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Van der 
Werf 2001
15
 
Cross-sectional,  
Case-control, 
stroke outpatients 
>1 yr post-onset, 
N=90 
HC, N=50 
Mean age 62 
 
mean 3.8 
years (±2.9 
yrs) 
 
CIS-f (PSF: ≥ 40):  
Stroke, 51% PSF, mean score 
35.4 ± 14.6 
HC: 12% severe fatigue, 
mean score 21.2 ± 13.1 
- CIS-f was related to perceived disability (SIP7, in patients r=.65, 
in HC r=.78, both p<.001).  
- Stepwise regression: in stroke most variance of CIS-f was 
explained by physical impairment (SIP-ambulation, 34%), then 
depressive symptoms (BDI-PC, 11%), then cognitive complaints 
(SIP-alertness). In HC, most variance was explained by 
depressive symptoms (56%).  
- CIS-f was not related to post-onset time 
 
Visser-Meily 
2009
123
 
Cross-sectional, 
SAH, N=141 
Mean age 51 
23–52 
months 
Mean: 36 
months 
 
FSS (PSF: FFS≥4) 
67% PSF  
Mean score: 4.6 
- Fatigue impact was related to Health related quality of life 
(Stroke Specific Quality of Life) in bivariate comparisons (r=.73) 
and in multivariate analyses.  
 
Wendel 
2008
124
 
Cross-sectional, 
Stroke, N= 84 
Mean age 74 
Mean: 26 
months 
(range: 18-
36) 
 
Single question (yes/no) 
45% indicated fatigue and 
poor concentration 
 
 
Winward 
2009
59
 
Cohort, 
Minor stroke, 
N=73,  
median age 74 
TIA, N=76 
Median age 73 
 
6 months Chalder fatigue scale 
(cutoff=3) 
Stroke: 59%, median score: 
4 
TIA 29%, median score: 1 
- Fatigue was more prevalent in stroke than in TIA (OR: 3.14) even 
when controlling for anxiety, depression, medication and even in 
stroke patients with minor stroke (NHHS=0).  
- Within stroke group, prevalence of fatigue increased with stroke 
severity (NHHS, p<.001).  
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Table 2. Continued 
Abbreviations: BI: Barthel Index, BDI: Beck Depression Inventory, BDI-PC: Beck Depression Inventory-Primary Care, CES-D: the Center for Epidemiologic 
Studies Depression scale, CIS-f: Checklist Individual Strength-fatigue scale, FIS: Fatigue Impact Scale, FSS: Fatigue Severity Scale, GDS: Geriatric Depression 
Scale, GOS: Glasgow Outcome Scale; HADS-A: Hospital Anxiety and Depression Scale-Anxiety subscale; HADS-D: Hospital Anxiety and Depression Scale-
Depression subscale; HC: Healthy controls, HISC: Head Injury Symptom Checklist, HRQOL: Health Related Quality of Life, MADRS: Montgomery-Asberg 
Depression Rating Scale, MFI-20: Multidimensional Fatigue Inventory-20, MFSI-SF: Multidimensional Fatigue Symptom Inventory-Short Form, MHLC: 
Multidimensional Health Locus of Control, mRS: modified Ranking Scale, NIHSS: National Institutes of Health Stroke Scale, OHS: Oxford Handicap Scale, PSF: 
Post-Stroke Fatigue, PTSD: Post Stroke Depression, SAH: Subarachnoid haemorrhage, SF-36: Short form health survey-36, SIP: Sickness Impact Profile, SSS: 
Scandinavian Stroke Scale, STAI: State-Trait Anxiety Inventory, UCL: Utrechtse Coping Lijst, VAS-f: Visual Analogue Scale-fatigue. 
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“The cure for boredom is curiosity. There is no cure for curiosity” 
Dorothy Parker (1893-1967) 
48 
 
Abstract 
Objective. To evaluate the need for information and treatment of post-stroke 
fatigue (PSF) in community dwelling patients with stroke in The Netherlands.  
Methods. Data were obtained from a Dutch internet-based questionnaire. The 
amount of information received about PSF, self-management and other treatment 
options, and the perceived need for treatment were scored. PSF was assessed 
with two Visual Numerical Scales of fatigue severity (VNSF), the Fatigue Severity 
Scale (FSS7), and by scoring the nature (physical versus mental) and onset time of 
PSF.  
Results. Data were available of 538 stroke survivors (mean age 52 years, 45% men, 
and mean time since onset 2.7 years). Severe fatigue (both VNSF items ≥7; 48%) 
and severe fatigue impact (FSS7 > 5; 68%) were frequent. Most participants (57%) 
experienced both physical and mental fatigue. Only 17% of the respondents 
indicated to have had received sufficient information about PSF and 7% about 
treatment options, whereas 56% expressed a substantial need for treatment. The 
need for treatment was moderately associated with fatigue severity and fatigue 
impact, whereas information status was not related to any demographical, fatigue, 
or stroke characteristic.  
Conclusions. PSF is a significant symptom after stroke requiring medical attention 
and treatment. The results of this survey indicate that patients do not receive 
adequate information on PSF. 
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Introduction  
 Persisting fatigue is a common and debilitating consequence of stroke 
even in patients with good recovery.
18, 20, 27, 43
 Prevalence rates of post-stroke 
fatigue (PSF) are substantial, varying between 38 and 73%.
20
 These rates seem to 
be stable over time, with no marked decline after the post-acute stage to even 
years following the injury.
15, 44-46, 58
 As no unequivocal associations with clinical or 
demographical variables, such as stroke type, age, sex or education, have been 
found, all patients who have experienced a stroke may be at risk to develop this 
symptom.
20
 Furthermore, PSF has been found to have a negative effect on quality 
of life,
18, 35
 rehabilitation outcomes
29
 and even mortality.
19, 55, 86
 However, PSF is 
often misdiagnosed
29-31
 and evidence-based clinical guidelines for dealing with PSF 
are scarce.
21, 125
 
 The pathogenesis of PSF is still poorly understood
20, 34, 39, 86
 but believed to 
be multifactorial.
16, 20, 39, 46, 55, 86, 92
 Although direct associations with biological 
markers have been demonstrated only in a few studies,
39
 the brain damage itself 
is suggested to be a primary cause for the experienced fatigue.
69, 80, 102
 
Furthermore, associations with psychological distress such as depressive 
symptoms and anxiety have been repeatedly found.
20
 The direction of this 
association has not been established, but somatic complaints seem to mediate 
this association.
92
 Moreover, the consistent finding of double dissociations 
between these symptoms underscores the distinction between these 
syndromes.
27, 92, 104
 However, psychological distress may certainly exacerbate 
fatigue and vice versa.  
 It has been accepted that PSF is a multifaceted phenomenon, including 
the severity of fatigue and the impact of fatigue on daily life.
20
 Although no 
uniform definition of PSF exists, it is generally defined as ‘a subjective experience 
of extreme and persistent tiredness, weakness or exhaustion after stroke, which 
can present itself mentally, physically or both and which is unrelated to previous 
exertion levels’.
22, 125
 Since this definition is intrinsically subjective and no 
derivative assessment tools have been specifically constructed for patients with 
stroke, a large variety of fatigue rating scales have been used in research and 
clinical practice.
33, 39
 Some of these tools assess the dimension of fatigue severity, 
such as Visual Analogue Scales
51
 or the Checklist Individual Strength.
52
 Others, 
such as the Fatigue Severity Scale, measure the impact of fatigue in daily life.
54
 
The assessment of both aspects is needed to comprehensively assess PSF and to 
warrant the comparability of different studies.  
 A few qualitative studies in small focus groups have demonstrated that 
patients with PSF report a great need for information on the syndrome
30, 31
 
Patients reported that the lack of information led to confusion and distress, which 
in turn elongated the time needed to adjust to the fatigue
31
 They want to 
understand their experience of fatigue, have it diagnosed or explained so that 
50 
 
they are less overwhelmed by it and can know what to do about it.
30
 Studies on 
the treatment of fatigue in patients with stroke and in patients with other 
neurological disease suggest that patient education, teaching energy conservation 
strategies and graded activity training can be helpful in the management of 
fatigue.
111, 125, 126
 
 Despite the importance of education and treatment for patients with PSF, 
little research has been conducted to quantitatively identify the need for 
education and treatment possibilities amongst stroke survivors.
21, 125
 Furthermore 
PSF is often not accurately recognized.
29-31
 The aim of the present study was to 
investigate the current provision of patient information and healthcare in the 
Netherlands, by an internet-based questionnaire, and to relate these needs to 
demographic, fatigue and stroke characteristics. 
 
Methods 
 Data were obtained from a Dutch internet-based questionnaire. External 
links to the website were placed on the Dutch Wikipedia site about Stroke and on 
the website of the Netherlands Brain Foundation (Hersenstichting). All 
participants who spontaneously completed the questionnaire consented with its 
use for scientific research. No feedback about results or financial reward was 
given and data were anonymously collected.  
To identify current information and need status, questions about the 
amount of information received with regard to (i) PSF, (ii) self-management 
techniques, and (iii) treatment had to be answered on a 5-point Likert Scale 
(ranging from none to ample information) as well was the need for treatment of 
PSF (from none to a great need). The sum of the information scores was used 
(range 0-15) to indicate information status.  
A Visual Numeric Scale was used to assess the severity of fatigue (VNSF). 
The VNSF consisted of questions about perceived fatigue severity (ranging from 0: 
no fatigue to 10: extreme fatigue) at present (question 1) and over the past 2 
weeks (question 2). A score above 6 on both VNSF items was regarded as severe 
fatigue.
127
 The mean of both items was used for statistical analysis.  
The Fatigue Severity Scale-7 (FSS7)
16
 is a well-validated tool to assess 
fatigue impact. It contains the last 7 items of the original 9-item FSS,
54
 to be 
scored on a 7-point Likert Scale. A mean score was calculated and a higher score 
than 5 indicated severe fatigue impact (range: 1-7).
16, 54
 
 Additional questions about the nature of PSF (physical versus mental) and 
post-onset time of fatigue had to be answered on a 5-point Likert Scale. 
Furthermore, data were collected regarding date of stroke, age, years of 
education, marital status and employment. Questions on the assessment itself 
were posed last, with regard to the amount of help participants received during 
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the assessment, the time needed to complete the questionnaire and the 
perceived difficulty of the questionnaire. 
 
Data analysis 
 Double and faulty entries were identified by comparing, demographic and 
stroke characteristics and subsequently discarded. Questionnaires not 
independently completed were analyzed separately. Of all the correct entries, 
descriptive statistics were calculated. The association of information status, 
fatigue severity (VNSF) and fatigue impact (FSS7) with demographic data, age, sex, 
education, time post-stroke, onset time of fatigue and nature of PSF was tested 
using Pearson’s correlation coefficient for continuous and χ
2
-tests for categorical 
variables. All analyses were conducted using SPSS version 18 for Windows, with 
Sidak correction for multiple analyses (p<.004).  
 
 
Results 
 Between April 2009 and June 2011 the website drew 9,204 unique 
visitors. The questionnaire was completed 575 times. Of these 538 could be 
included, since 33 respondents sent in multiple questionnaires and 4 participants 
had not had a stroke. Primary analyses were then performed on 479 
questionnaires, since 59 entries indicated that they had been filled in with the 
assistance of another person (50) or had been completed by a proxy (9).  
Table 1 list the patients’ demographic and clinical characteristics, together 
with their information status and need for treatment, related to the scores on 
fatigue severity (VNSF) and fatigue impact (FSS7). Except for younger age, no 
associations between PSF and demographic variables were found.  
 Only 17% of the participants indicated they had received sufficient 
information about PSF and 7% felt they had received sufficient information about 
treatment options. In contrast, 54% of the respondents expressed a substantial 
need for treatment. Patients who had no need for treatment (11%) experienced 
less severe fatigue (VNSF: M=5.0 ± 2.0) and reported less fatigue impact (FSS7: 
M=4.8 ± 1.5) than those currently receiving treatment (VNSF M=7.1 ± 1.8; FSS7 
M=5.6±1.4) or those expressing some to substantial need (VNSF M=6.7±1.7; 
FSS7=5.5±1.2, p<.001). The amount of need for treatment was associated with 
fatigue severity and impact, but not with any demographical or stroke variable (all 
p>.004).Information status was not related to any stroke, fatigue or demographic 
characteristic (all p>.004).  
The experienced nature of PSF on a physical to mental dimension differed 
greatly between participants χ
2
(4)=55.33, p<.001, with 57% of the patients 
expressing both physical and mental fatigue components (figure 1). No 
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associations were found between the nature of PSF and VNSF, FSS7 or 
information status (χ
2 
tests, all p>. 01). 
Regarding the questionnaire, 51% reported having no difficulty at all 
completing the tool, 30% a little difficulty, 14% some, and 5% had substantial 
difficulties with filling in the questionnaire. For most participants (53%) 
completing the questionnaire took less than 5 minutes, 37% needed 5-10 minutes, 
8% needed 11-20 minutes, and only 2% needed more than 21 minutes. 
Questionnaires that were completed with the help of others or by proxies 
differed with those completed independently on several accounts. Respondents 
requiring help were older (61.3 ±1.8 years), less likely to be employed (20%), 
experienced more severe fatigue (VNSF M=7.7±1.6), took longer to fill in the 
questionnaire (Median 6 to 10 minutes) and reported more difficulty filling in the 
questionnaire. 
 
Figure 1. Frequency of experienced nature of fatigue (N=479) 
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Table 1. Participants characteristics and correlations with VNSF and FSS7 (N = 
479) 
 Mean ± SD % VNSF, r(p)  FSS7, r(p) 
Demographic and stroke data    
 Age (y) 52.4 ± 10.8 -.15 (<.001) n.s. 
 Time since stroke (y)  2.73 ± 4.72 n.s. n.s. 
 Gender Male  45% n.s. n.s. 
 Education (y)  12.9  ±  2.5 n.s. n.s. 
 Living with partner 74% n.s. n.s. 
 Currently employed  57% n.s. n.s. 
Fatigue     
 Fatigue severity (VNSF) 6.54 ± 1.85    .39 (<.001) 
 Both VNSF scales  ≥7  48%   
 Fatigue impact (FSS7)  5.52 ± 1.23 .39 (<.001)  
 FSS7 > 5 69%   
 PSF (VNSF≥7 ) since:  n.s. n.s. 
       Pre-stroke 18%   
  Stroke 53%   
   1-6 months post-stroke 19%   
  > 6 months post-stroke 10%   
Information and needs   
 Sum of information scores 5.87 ± 2.88 n.s. n.s. 
 Information received on PSF*  n.s. n.s. 
  None 37%   
  Some 46%   
  Sufficient 17%   
 Information on self-management *  n.s. n.s. 
  None 50%   
  Some 37%   
  Sufficient 13%   
 Information on treatment*  n.s. n.s. 
  None 63%   
  Some 30%   
  Sufficient 7%   
 Need for PSF-treatment*  .34 (<.001) .31 (<.001) 
  Currently receives treatment 10%   
  No need 10%   
  Some 24%   
  Substantial 56%   
* Categories are combined to none (none), some (a little & some) and sufficient (sufficient 
& ample/a great need). 
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Discussion 
 This internet-based study was conducted to evaluate the need for 
information and treatment concerning PSF in community-dwelling patients with 
stroke in the Netherlands. The results indicate that fatigue is still a neglected 
symptom after stroke, because most of the participants did not receive sufficient 
information about (the causes) of fatigue (83%), about self- management 
techniques (87%) or other treatment options (93%). This worrisome lack of 
information shows a remarkable contrast with the fact that 54% of participants 
indicated a substantial need for treatment for PSF.  
A large proportion of the participants in the present study experienced 
severe fatigue as assessed with the VNSF (48%) and reported a severe fatigue 
impact as assessed with the FSS7 (69%). The moderate association between both 
scales reveals that different aspects of PSF were measured. Interestingly, fatigue 
scores were neither associated with sex, time post stroke, nor with the onset time 
or nature of PSF. Only a small negative correlation with age was found. However, 
patients who did not complete the questionnaire independently were more 
severely fatigued and older than those filling in the questionnaires without 
assistance. These results emphasize the persistence of fatigue complaints after 
stroke, irrespective of when or by whom they are reported.  
Most participants experienced fatigue both physically and mentally, which 
underscores the notion that PSF includes both components. The finding that the 
need for treatment was associated with fatigue severity and fatigue impact is 
understandable and emphasizes the importance of providing appropriate 
information. The result that the need for information itself was not associated 
with fatigue scores indicates that even patients with relatively mild fatigue should 
receive adequate information about PSF and its treatment options. It is possible 
that patients in fact have received information on PSF and treatment options, but 
due to their mental fatigue they were unable to remember the information. In 
this case, the provision of information should be more adequately tailored to the 
fatigability and the use of written information such as leaflets could be of aid.
128
  
This study may have been subject to bias. Most importantly, especially 
participants with a great need for information and/or need for treatment can be 
expected to search the internet for information about PSF and its treatment 
options. As a result, figures about fatigue severity, fatigue impact and lack of 
information may have been confounded by selection bias. On the other hand, 
63% of the participants had received at least some information about PSF and 
37% about treatment options. In addition, our respondents were relatively young 
(52 years of age), highly educated (>12 years), and 57% still were employed, 
suggesting preserved cognitive functions, which should have enabled them to 
receive and ask for appropriate information. Another limitation is that PSF scores 
may have been influenced by pre-stroke fatigue or fatigue as a result of 
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concurrent disease(s) occurring after stroke. Yet, pre-stroke fatigue was reported 
in only 18% of the participants with severe fatigue, while 71% experienced the 
onset of fatigue within 6 months after stroke.  
 
Conclusion 
 PSF is an important clinical symptom after stroke, requiring attention by 
medical professionals, as well as treatment and/or care. It is, however, still a 
neglected phenomenon in the Netherlands. 
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« I prefer gazing at the stars still left in my sk,y instead of searching for 
those lost to me » 
Patient XX (in 2010, with permission) 
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Abstract 
Objective. To obtain a psychosocial profile of patients with post-stroke fatigue 
(PSF), which could aid in optimizing treatment strategies.  
Methods. Eighty-eight outpatients with severe PSF measured with the Checklist 
Individual Strength-fatigue subscale (CIS-f) and the Fatigue Severity Scale (FSS) 
were selected. Depression and anxiety, psychological distress, coping, social 
support, and self-efficacy of this group were compared to reference groups of 
healthy controls and patients with other chronic diseases. Associations between 
psychosocial characteristics and fatigue were calculated.  
Results. Compared to healthy controls, patients with PSF reported more 
psychological distress, less problem-focused coping, and more positive social 
support. Minor or no differences were found in comparison with other chronic 
patients. The CIS-f correlated with somatic complaints and the FSS with cognitive 
complaints.  
Conclusion. Patients with PSF show a psychosocial profile comparable to patients 
with other chronic disease. Implications for diagnosis and treatment are discussed. 
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Introduction 
 In recent years, researchers have become increasingly interested in one of 
the most common and persisting complaints after stroke, that is, post-stroke 
fatigue (PSF).  PSF is best described as a feeling of early exhaustion with 
weariness, lack of energy and aversion to effort
22
 that develops during physical or 
mental activity and is usually not ameliorated by rest.
43, 95
 The percentages of 
patients  reporting fatigue after stroke ranges from 38% to 77%,
129
 and these 
percentages do not seem to decline in the chronic stage.
15, 46, 129
 Furthermore, PSF 
appears to be related to higher mortality rates and poorer rehabilitation 
outcomes.
19
 However, the pathogenesis of PSF is still poorly understood and, until 
now, effective treatments are still lacking.
129, 130
  
 Although the mechanisms leading to PSF are still elusive, its origin is 
believed to be multifactorial.
129
 PSF may be a direct result of organic brain 
damage,
9
 as it has often been reported in other types of brain disease, such as 
trauma brain injury.
96
 However, only a few associations of fatigue with biological 
markers have been reported in the stroke population.
129
 In other words, although 
stroke severity may play a role, there is little evidence linking lesion size or 
location to PSF.
43, 46, 49, 129
 The origin of PSF could also be related to psychosocial 
factors, which has been the focus of numerous studies (see Lerdal et al 2009 for 
an overview).
129
 Of all psychosocial factors, the most investigated are depression, 
anxiety, coping skills, social support and self-efficacy. Nevertheless, also in this 
area, unequivocal findings are scarce.
129
 
 Because fatigue is generally considered as a symptom of depression, an 
overlap between both phenomena seems undeniable.
9, 22, 129
 Indeed, an 
association between fatigue and depressive symptoms is a consistent finding in 
the literature not only in stroke patients,
15, 19, 46, 49, 66, 80, 82, 95
 but also in patients 
with traumatic brain injury
96
 and in otherwise healthy subjects.
82, 96
 Yet, in those 
studies that specifically looked at patients who suffer from depressive symptoms 
and/or fatigue, a clear dissociation between the two phenomena was also present 
with groups of patients reporting just fatigue or depression.
15, 46, 49, 98
 The same 
seems to be true for anxiety.
19
 The studies that have examined coping style, self-
efficacy and social support suggest that emotion-oriented coping,
95, 119
 locus of 
control directed to powerful others,
46
 and lack of social support
129
 are also 
associated with PSF. These studies are, however, few in number and cross-
sectional in design and did not specifically focus on patients for rehabilitation 
purposes.  As a result, the nature of the psychosocial profile of patients suffering 
from PSF is still largely unknown, proving only scant clues for optimizing the 
treatment of PSF.
129, 130
    
 The aim of this study was to obtain a psychological and social profile of 
stroke patients, with severe PSF selected for the rehabilitation, to the one of 
healthy control subjects and patients with other chronic diseases and to 
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investigate the strength of the association between fatigue and several 
psychosocial variables. Knowledge about this psychosocial profile can help to 
optimize PSF treatment.  
 
Methods 
Subjects 
 Data were gathered from patients with PSF who participated in a larger 
multi-center study (COGRAT: Effectiveness of Cognitive and Graded Activity 
Training on PSF).
131
 In this study 231 patients were recruited via their treating 
physicians and psychologists (n=64), through an article about the COGRAT study in 
various newspapers (n=151), or based on their consent for renewed contact given 
in earlier studies (n=16). The study was approved by the local ethics committee 
and all eligible subjects signed an informed consent.  
 For the COGRAT study outpatients in the chronic stage of stroke (at least 4 
months post stroke) were identified, according to the following criteria: (1) age 
between 18 and 70; (2) last stroke episode longer than 4 months ago (either 
cerebral infarction, or intracerebral or subarachnoid hemorrhage; single or 
recurrent); (3) severe fatigue (Checklist Individual Strength 20R- fatigue subscale
52
 
≥ 40) and (4) ability to walk independently. Patients were excluded from the study 
if they had (1) severe visual hemi-neglect, Behavioural Innattention Test ≤ 129
132
; 
(2) severe memory deficits (Rivermead Behavioural Memory Test
132
 (screening 
score > 8); (3) executive impairments (Behavioural Assessment of the 
Dysexecutive Syndrome
132
 < borderline); (4) moderate to severe aphasia (Token 
Task
132
 >12); (5) severe cardiac or pulmonary disease; or (6) co-morbid depression 
(Hospital Anxiety and Depression Scale depression scale > 10). If the HADS 
depression scale score was between 8 and 10, a clinical interview (MINI DSM-
IV)
133
 was conducted to exclude patients with clinical depression. 
 Of the 124 excluded patients, 47 (54%) were not severely fatigued and 21 
had too high levels of depression. The remaining 56 patients met one or more 
other exclusion criteria, such as memory deficits, mobility deficits or aphasia. 
Nineteen more patients withdrew consent before complete assessment. Thus 88 
patients (38%) were finally included. These participants did not differ significantly 
with regard to age and gender (alpha = 0.05) from the nonparticipants and those 
excluded based on too high levels of depression. 
  
Demographic and Clinical Assessment 
 Data on age, sex, marital status, educational level, stroke type and side, 
were obtained from the patients and their medical records.  Severity of paresis 
was assessed with the Motricity Index (MI) of the affected lower extremity.
134
 The 
MI was recorded because lower extremity paresis is strongly related to balance
135
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and mobility after stroke
136
 and because mobility might be associated with post-
stroke depression.
137
  
 
Assessment of Fatigue 
 Two widely used and well-validated measures of fatigue were used in this 
study, the subscale fatigue of the Checklist Individual Strength 20R (CIS-f)
52
 and 
the Fatigue Severity Scale (FSS).
54
 The CIS-f consists of 8 out of 20 items of the 
questionnaire, asking about fatigue severity in the two weeks before the 
assessment, to be indicated on a 7-point Likert scale (range 8-56). Patients with a 
score ≥ 40 on this subscale were defined as being severely fatigued.
15
 In the FSS, 
individuals rate their agreement with nine statements on a 7-point Likert scale 
concerning fatigue severity, frequency and impact on daily life. The mean score 
(range 1-7) is then calculated. The threshold for moderate to high impact of 
fatigue using the FSS is commonly set at either 4 or 5.
51
  
 
Psychosocial Assessment 
 To study the psychosocial characteristics of patients with PSF, self-report 
questionnaires regarding depression, anxiety, psychological distress, coping, social 
support and self-efficacy were used. Depression and anxiety were measured with 
the Hospital Anxiety and Depression Scale (HADS).
138
 The HADS is a 14 item self-
report measure, with seven items forming a Depression subscale and another 
seven constituting an Anxiety subscale. Each item is rated on a four-point scale, 
ranging from 0 to 3, with 3 reflecting the highest distress. Total scores for each 
subscale range from 0 to 21 and are categorised as normal (0-7), mild (8-10), 
moderate (11-14) or severe (15-21).
139
 
 The Symptom Checklist-90 (SCL)
140
 measures psychological distress.
141
 The 
scale consists of 90 items scored on a 5-point Likert scale. Nine psychopathology 
scores can be derived and the total score (GSI) reflects a global severity index of 
psychological distress. Furthermore, a personality severity index (PSI) to assess 
personality problems can be calculated.
142
 This is done by transferring raw scores 
to SCL-90R scales, and then comparing the mean scores of the scales 
interpersonal sensitivity, hostility and paranoid ideation to the mean value of the 
remaining scales.  
 Coping strategies were assessed with the Coping Inventory for Stressful 
Situations (CISS).
143
 Forty-eight items are scored on a 5-point Likert scale, resulting 
in three subscales: Problem-focused coping, Emotion-focused coping and 
Avoidance-focused coping.  
 Social Support was assessed with the Social Support List (SSL-12)
144
 that 
consists of twelve statements regarding perceived positive and negative social 
support from the primary social network. Positive support is described by three 
subscales: everyday support, support in problem situations, and esteem support. 
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 The Self-Efficacy Scale (SES) was used to assess the sense of control in 
relation to fatigue complaints.
145
 It consists of 5 statements each scored on a 5-
point scale. The total scores range from 5 to 25, with a higher score reflecting 
more sense of control.  
 
Data Analysis 
 Descriptive statistics (i.e. mean and standard deviation (SD)) were 
calculated for all psychosocial characteristics. These values were compared to 
known reference values and derived Z-scores from healthy controls and patient 
populations (General practice, Traumatic Brain Injury, chronic pain, Multiple 
Sclerosis, Parkinson’s disease, Cancer, Rheumatoid Arthritis, and Chronic Fatigue 
Syndrome) reported in the literature.
139, 140, 143, 144, 146-148
 Based on these Z-scores, 
different categories were labeled as follows: < -1.28=very low, <-.84=low, <-
.525=below average, between -.525 and .525= average, >.525= above average, > 
.84 high and >1.28 very high. 
 The presence of personality problems was determined by calculating a PSI 
from the raw scores of the SCL. Associations between the CIS-f-FFS fatigue scales 
and gender, marital status, lesion characteristics and PSI were calculated with Χ2 
analyses. Spearmen rank correlations were calculated with the ordinal 
demographical, stroke and psychosocial characteristics. Then a stepwise multiple 
regression analysis was performed on the variables significantly associated with 
fatigue to establish their unique contribution. All data analyses were computed 
with SPSS version 17.0 using Holm’s correction to adjust for multiple analyses.
149
  
 
Results  
 Demographic data, severity of paresis, fatigue scores and stroke 
characteristics are summarized in Table 1. Scores on both fatigue scales indicated 
on average ‘severe fatigue’. On the CIS-f, 92% scored above 40. On the FSS, 92.0% 
scored above 4 and 69.3% above 5. The mean MI was 90.2 indicating on average 
mild lower extremity paresis. Mean postonset time since last stroke was 4.3 years, 
which did not differ significantly between single and recurrent strokes. 
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Table 1 –Demographic data, severity of paresis, stroke data and fatigue scores (n=88) 
Demographics   
Age, mean (SD) 54.6  (8.8) 
Gender, male, no. (%) 46 (52.3%) 
Living together/married, no. (%) 71 (80.7%) 
Educational level, median (SD), (1=low to 7=high) 5  (1.2) 
Severity of paresis  
Motricity Index, mean (SD) 90.2 (13.6) 
  
Stroke  
Time since last lesion, mean (SD) 4.3 (5.3) 
Single Stroke, no (%) 67 (76.1%) 
    Ischemic stroke 
a
, no (%) 64 (72.7%) 
    Hemorrhage 
b,
 no (%)
 
6 (6.8%) 
    Subarachnoid hemorrhage, no (%) 9 (10.2%) 
    Mixed 
c
 ,no (%)
 
4 (4.5%)  
Fatigue 
        CIS-f, mean (SD); range 
        FSS, mean (SD); range 
 
45.4 (5.6) 
5.2 (1.0) 
 
CIS-f = Checklist Individual Strength subscale fatigue 
 
FSS= Fatigue Severity Scale 
a
 ICVA category: 18 left hemispheric, 44 right hemispheric, 4 infratentorial, and 3 bilateral 
b  
Hemorrhage category: 4 right hemispheric,  2 bilaterial 
c 
 Mixed:  4 infratentorial and other lesion.  
 
Psychosocial characteristics  
 To investigate the psychosocial characteristics of the patients, the scores 
were compared to reference values obtained from norm groups of healthy 
controls and patients groups from general practice and with various chronic 
afflictions (Table 2). The HADS, anxiety scores were comparable to other patient 
groups, but high compared to the general population. Using the Z-score derived, 
above-mentioned categories,
139
 60.2% of the patients scored normal, 17% mild, 
18.2% moderate and 4.5% severe on HADS-anxiety. On the depression subscale of 
the HADS, we found high scores compared to both the general population and 
general practice patients. Still, 64.8% of our subjects had normal and the 
remaining 35.2% only mild depressive symptoms. The scores on the SCL were 
generally high compared to healthy controls but, in comparison to other patient 
groups, the SCL scores were average, except for the subscale ‘Obsessive 
Compulsive’ which was above average, reflecting more subjective cognitive 
complaints. The PSI is a categorical value and could, therefore, not be compared 
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to reference values. Nevertheless, the incidence rate indicated that 93.2% of the 
patients were free from personality problems.   
 As for coping strategies, our patients showed slightly lower levels of 
problem-focused and avoidance strategies than healthy controls. However, in 
comparison to other patient groups, they scored average or above average for all 
strategies. Furthermore, our patients received more positive social support with 
as many negative social interactions compared to healthy controls and other 
patient groups. Compared to patients with chronic fatigue syndrome (CFS),
148
 they 
reported to be ‘more in control’ when assessed with the SES. 
 
Associations of demographic, clinical and psychosocial characteristics with fatigue 
 Table 3 shows the correlation coefficients of demographic, clinical and 
psychosocial characteristics with both fatigue scores. No associations with either 
fatigue scale (CIS-f or FSS) were found for demographics, stroke characteristics or 
severity of paresis (MI).  
 The CIS-f scale showed a statistically significant but moderate association 
with SCL-Somatic and SCL-depression. The FSS was only related to the Obsessive 
Compulsive subscale of the SCL. No other significant associations were found for 
any psychosocial measure. The combined Positive social interactions of the SSL 
were analyzed post hoc, yielding no significant results.  
 Multiple regression analysis was performed only for the CIS-f with 
associated variables, since the FSS was associated with just one psychosocial 
variable (Table 3). SCL-SOM significantly predicted CIS-f scores, β = .54, t(86) = 
5.89, P < .001. SCL-Dep did not add significantly to the model (P = .78) with no 
concerns for multicolinearity (VIF = 1.56, tolerance = .64).  
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Table 2 – Means and standard deviations of baseline psychosocial characteristics of PSF 
patients in comparison with healthy controls and patients with other chronic disease 
(n=88)  
Scale at inclusion Mean (SD) 
Study group 
 
In comparison to: 
Healthy controls 
 
 
Patient groups 
 
Psychosocial characteristics 
 
HADS 
General population 
57-65 years 
(n=1901)
146
 
General 
practice 
patients 
(n=112)
146
 
Traumatic Brain 
Injury-patients 
(n=100)
139
 
   Anxiety 7.27 (3.76) High Average Average 
   Depression 7.05 (2.37) High High Average 
 
 
 
Psychological distress: SCL 
Healthy controls 
(n=2092)
140
 
General 
practice 
patients 
(n=920)
140
 
Chronic pain 
patients  
(n=2461)
140
 
   Anxiety 15.08 (4.84) Above average/ high Average Average 
   Phobic Anxiety 9.13 (3.06) Above average/ high Average Average 
   Depression 27.44 (7.80) High Average Average 
   Somatic  22.25 (6.61) High Average Average 
   Obsessive 
Compulsive 
20.51 (6.47) Very high Above 
average 
Above average 
   Interpersonal 
Sensitivity 
26.98 (8.95) Average Average Average 
   Hostility 8.36 (2.45) Average Average Average 
   Sleep 
disturbances 
6.74 (3.21) Above average/ high Average Average 
   Total (GSI) 149.00 (35.80) High Average Average 
 
 
 
Coping styles (CISS) 
Working adults 
(n=683)
143
 
Multiple 
Sclerosis- 
patients 
(n=96)
143
 
Parkinson-
patients 
(n=75)
143
 
Problem focused  51.89 (10.98) Low Average Above average 
Emotion oriented 
coping 
35.75 (10.51) Average Average Above average 
Avoidance 40.55 (10.66) Below average Above 
average 
 
Above average 
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Table 2. Continued 
 
 
Social support  
(SSL-12) 
Healthy elderly 
(n=5279)
144
 
Cancer 
patients 
(n=475) 
Rheumatoid 
arthritis 
patients 
(n=246) 
Everyday support 10.69 (2.08) Above average   
Support in 
problem 
situations 
9.76 (2.24) High   
Esteem support 10.35 (2.10) High   
Negative social 
interactions 
 
9.91 (2.92) Average
147
 Average
147
 Average
147
 
 
 
Self-efficacy (SES) 
 Chronic Fatigue 
Syndrome- patients 
(n=292)
148
 
 
Self efficacy 16.57 (3.32)  Above average 
 
 
HADS= Hospital Anxiety and Depression Scale, SCL= Symptom Checklist-90, CISS= Coping 
Inventory for Stressful Situations, SSL-12=Social Support List, SES= Self Efficacy Scale. 
Reference values were derived from known norm groups or research data from different studies. 
From research data, means and Z-scores were calculated and categories were described based 
on Z-scores as follows: <-1.28=very low, <-.84= low, <-.525= below average, between -.525 and 
.525 = average, > .525= above average, >.84=high, and > 1.28= very high.  
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Table 3 - Correlation coefficients of demographic, clinical and psychosocial 
characteristics with PSF (n = 88) 
 CIS- f  FSS 
  Demographic data 
    Age
2
 n.s. n.s. 
    Gender
1
 n.s. n.s. 
    Marital status
1
 n.s. n.s. 
    Educational level
2
 n.s. n.s. 
 Stroke characteristics 
    Single or recurrent stroke
1
 n.s. n.s. 
    Lesion side of last stroke
1
 n.s. n.s. 
    Time since last stroke
2
 n.s. n.s. 
Severity of paresis (MI)
 2
 n.s. n.s. 
Psychosocial Characteristics 
Anxiety and Depression (HADS)
 2
 
   HADS- Anxiety n.s. n.s. 
   HADS- Depression n.s. n.s. 
Psychological distress (SCL)
 2
 
   Anxiety n.s. n.s. 
   Phobic Anxiety n.s. n.s. 
   Depression 0.35* n.s. 
   Somatic  0.53* n.s. 
   Obsessive Compulsive n.s. 0.36* 
   Intrapersonal Sensitivity n.s. n.s. 
   Hostility n.s. n.s. 
   Sleep disturbances n.s. n.s. 
   Total (GSI) 0.34* n.s. 
Personality Problems (PSI)
1 
n.s. n.s. 
Coping (CISS)
 2
 
   Problem-focused coping n.s. n.s. 
   Emotion-oriented coping n.s. n.s. 
   Avoidance n.s. n.s. 
   Distraction Seeking n.s. n.s. 
   Company Seeking n.s. n.s. 
Social Support (SSL-I-N)
 2
 
   Total Positive support n.s. n.s. 
   Negative social interactions n.s. n.s. 
Self-efficacy (SES)
 2
 n.s. n.s. 
1Χ2 analyses (categorical data) 
2 
Spearman rank correlation coefficients 
n.s. = not significant 
*significant at Holm’s correction (p<0.0011) 
CIS-f = Checklist Individual Strength fatigue severity subscale 
FSS= Fatigue Severity Scale  
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Discussion 
 The aim of this investigation was to obtain a psychosocial profile of 
patients suffering from severe PSF in order to tease out options for rehabilitation 
of fatigue. The results of this study suggest, however, that these patients are not 
characterized by a distinct psychosocial profile. In comparison to healthy controls, 
PSF-patients reported high psychosocial distress, high positive social support and 
low problem-focused coping. However, compared to other chronic patients 
groups, we found no marked discrepancies with regard to distress, coping styles, 
social support and self-efficacy. Moreover, independent associations with fatigue 
were found only for SCL-Somatic Complaints with CIS-f (r=.54; p<.001) and SCL-
Obsessive Compulsive with FSS (r=.35; p<.001) but not for any other psychosocial 
variables or stroke characteristics (e.g. time since stroke, single versus recurrent, 
nature of lesion and lesion side).  
 The subscale Obsessive Compulsive of the SCL might mimic the direct 
neurological consequences of stroke, since it includes items such as ‘trouble with 
thinking’, ‘mental slowness’, ‘needing to check things’ and ‘thinking things over’. 
Although no direct association between fatigue severity and severity of cognitive 
deficits has been found,
46, 80, 129
 a relationship between cognitive complaints, such 
as mental slowness, has been substantiated.
82, 150
 
 A probable cause for the experienced fatigue may be found in this light. 
Cognitive deficits may temporarily be compensated for by exerting increased 
mental effort, which may then cause fatigue.
103
 Indeed, widespread brain activity 
has been shown in patients with unilateral lesion of one cerebral hemisphere 
trying to perform a unimanual task with their affected hand.
151
 Such activities 
typically require a great amount of attentional resources, because subjects act at 
the limits of (or even beyond) their functional capacities.
152
 A parallel can be 
drawn from studies of traumatic brain injury where affected individuals showed 
more dispersion and more brain regions activated when engaged in an attention 
task than healthy controls.
153, 154
 
 Thus, PSF might be associated with underlying cognitive mechanisms that 
are independent of the extent of the brain lesion and of psychopathological 
problems related or unrelated to stroke.  If this notion is valid, it would be 
consistent with the finding that fatigue is almost as frequent in relatively mildly 
affected patients as in the more severely affected ones,
46, 129
 because it will 
become a problem whenever subjects try to overcome their individual limits. As 
soon as subjects are able to deal with their functional limitations more effectively, 
taking into account their limited attentional capacity and mental energy, fatigue 
may gradually become less severe.   
 The association between fatigue and somatic complaints could also be 
seen in line with this hypothesis. Somatic complaints could in part reflect physical 
consequences of stroke, pain or functional limitations, requiring more attentional 
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demand from the patient and thereby provoking fatigue. Another part of the 
somatic complaints could be explained as the physical expression of fatigue. For 
example, many patients report a heavy feeling in arms and legs, nausea or 
headaches when they become tired.  
 As in previous studies, we at first found an association between 
depression and fatigue on one of the fatigue scales.
15, 19, 46, 49, 66, 80, 82, 95
 However, 
this association was subordinated by somatic complaints in the regression 
analysis. A variant of this moderation effect has been previously reported, 
wherein the association between fatigue and depression became weaker when 
controlled for by sickness and impact on ambulation.
15
 This finding emphasizes 
not only the dissociation of fatigue and depression, but also the need to assess 
physical complaints in detail.  
 A rather unexpected but noteworthy finding of this study was that  both 
fatigue measurements used, the FSS and the CIS-f, were associated with 
completely different variables as shown in table 3. The use of more than one 
fatigue scale in clinical practice and research might therefore be warranted.  
 This study holds several limitations. Due to its cross-sectional design we 
are unable to infer causal relationships. Furthermore, our inclusion criteria 
restricted the variability of fatigue and mobility, thereby possibly lowering 
associations. The exclusion of patients with severe cognitive deficits, depression 
and motor problems might be considered both a strength and a limitation of this 
study. The major limitation is that it precludes generalization to other stroke 
patients. On the other hand, this choice enabled us to single out the relationship 
between fatigue and psychosocial factors, without the influence of these 
confounding factors. 
 
Conclusions and implications for treatment 
 By comparing our study group to other reference groups, PSF patients 
displayed a ‘normal chronic patient’ psychosocial profile. Only cognitive and 
somatic complaints were associated directly with fatigue. We therefore propose 
that (a part of) the fatigue might be a consequence of the inadequate adaptation 
to diminished and or less efficient attentional resources after stroke.  
 Our findings suggest the following implications for treatment. Somatic 
complaints should be directly addressed, whenever possible. Grade physical 
activity programs might be an important contribution to the treatment of PSF, 
since exercise has been found to be helpful in improving physical and functional 
outcomes and to reduce fatigue in other medical conditions.
126, 155
 Such programs 
might help stroke patients to gradually increase physical activity without 
experiencing bodily symptoms.  
 Second, cognitive compensation strategies circumventing the limited 
energetic resources available to patients suffering from PSF might also be 
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beneficial. These compensation strategies could entail enhanced planning and 
variation of activities to foster a more regular pattern of activity and rest.
80
 Here, 
patient education and goal setting could be added to improve patient motivation 
and adherence.
156
  
 Third, since symptoms of depression and anxiety common in PSF patients, 
it is important to address these when present, since they may compromise self-
management.
157
  An augmented form of cognitive behavioral therapy, as 
proposed by Broomfield et al (2010),
158
 is a good starting point to address these 
issues. It takes into account cognitive deficits and grievance of loss of abilities and 
could also aid in implementing the behavioral changes needed to apply the 
compensation strategies. Lastly, our study points to the use of more than one 
scale to assess PSF, highlighting that fatigue is not only a common but also a 
complex and multifaceted syndrome.  
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“It is the vague and elusive. Meet it and you will not see its head. Follow it 
and you will not see its back”. 
Lao Tzu 60BC-513 BC 
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Abstract 
This study examined the psychometric properties and the underlying constructs of 
the Fatigue Severity Scale (FSS) and the Checklist Individual Strength (CIS-20r) in 
196 patients with stroke and 112 age-matched healthy controls. Since the FSS and 
the subscale “fatigue severity” of the CIS-20R (CIS-f) claim to measure fatigue 
severity, the study focused on these (sub)scales. Both (sub)scales were able to 
discriminate at scale and at item level between patients and healthy controls, 
except for items 1 and 2 of the FSS. The internal consistency was high for the FSS 
and the CIS-f (Cronbach’s α:  FSS = .893; CIS-f = .938). The convergent validity 
(Pearson Correlation) between the (sub)scales ranged from rp=.52 in patients to 
rp=.82 in healthy controls. Principal Axis Factoring analyses on all items of the FSS 
and the CIS-f combined were conducted to investigate underlying constructs. 
These revealed three factors: “Experienced fatigue”, “Fatigue impact” and 
“Physical condition”. Since the CIS-f loaded highly on “Experienced fatigue” and 
the FSS loaded mostly on “Fatigue impact”, these (sub)scales seem to measure 
different constructs that correlate only moderately in patients with stroke. These 
differences must be taken into consideration when selecting one of these fatigue 
scales for either diagnostic or research purposes.  
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Introduction  
Post-stroke fatigue (PSF) is a common and debilitating complaint
20, 22, 33
 
with prevalence rates ranging from 38% to 77%.
20
 Even after a minor stroke or a 
transient ischemic attack, fatigue has been reported in 56% and 29% of the 
patients at six months follow-up, respectively. 
59
 This wide variety of prevalence 
rates can be partially explained by the absence of a generally accepted and 
unambiguous definition of fatigue
20, 28, 33, 59
 and hence by a lack of reliable 
assessment. Unfortunately, a ‘golden standard’ for the assessment of PSF is 
unavailable given the absence of valid biological markers.
33
 Currently, fatigue can 
only be measured at a subjective level. This poses a further challenge to 
researchers and clinicians when developing measurements and assessing a 
patient’s condition. 
Due to the subjective nature of fatigue, self-report measures are the most 
commonly used instruments to assess PSF.
20, 28
 These instruments can be divided 
into one-dimensional and multidimensional scales.
28
 In one-dimensional scales 
fatigue is viewed as a unitary construct, whereas multi-dimensional instruments 
aim to measure different aspects of  fatigue, such as impact of fatigue, and 
concentration problems.
28
 Two widely used self-report scales to assess PSF are the 
one-dimensional Fatigue Severity Scale (FSS)
54
 and the multidimensional Checklist 
Individual Strength (CIS-20r).
52, 53
  
The FSS is one of the most frequently used scales to assess PSF.
20, 28, 51
 It is 
a one-dimensional scale originally developed for fatigue complaints after systemic 
lupus erythematosus and in multiple sclerosis. Later it has been applied to 
measure fatigue in other neurological conditions, such as traumatic brain injury 
(TBI) and stroke.
38, 159
 Until now, the average score on the FSS is most often 
utilized to assess fatigue severity in stroke patients,
28, 91
 although it was originally 
designed to reflect the impact of fatigue on daily life in persons with suspected 
fatigue.
28, 54
 
The CIS-20r is a multidimensional scale that assesses four dimensions of 
fatigue on different subscales: fatigue severity, concentration problems, reduced 
motivation and reduced physical activity level.
52, 53
 The CIS-20r is the list of choice 
in scientific studies of fatigue in the Netherlands and in Belgium. It has been used 
in different neurological conditions, such as TBI,
160
 brain tumors,
161
 multiple 
sclerosis and stroke.
15, 162
 Although the total score of the CIS-20r has  been 
reported to reflect fatigue severity in non neurological patients,
163
 in patients with 
stroke, only the CIS- fatigue severity subscale (CIS-f) is used to assess the severity 
of experienced fatigue.
15, 162
   
Although several self-rating scales of fatigue are currently available, 
including the FSS and the CIS-20r, none of these have been specifically designed 
for PSF.
20, 28, 50
 In addition, few studies have focused on the validity of these 
measures in patients with PSF. Together with the subjective nature of fatigue, this 
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gap in previous research poses difficulties to both researchers and clinicians in 
describing and assessing a patient’s condition after stroke.
20, 35
 Both the FSS and 
the CIS-f are utilized to measure fatigue severity
20, 28, 54
 and to detect changes in 
fatigue over time.
51, 52
 However, at face value, they seem to measure different 
constructs. In stroke patients they have been found to correlate with different 
psychological and neurological variables.
92
 In this perspective, the aim of the 
present paper is to first examine the psychometric properties of the (one-
dimensional) FSS and the (multi-dimensional) CIS-20r. An additional goal is to 
analyze the underlying constructs of both scales. 
 
Methods  
Participants and procedure  
Data was obtained from stroke patients who entered a study on the 
effectiveness of Cognitive and Graded Activity Training (COGRAT) for PSF 
(N=83),
164
 and by additional recruitment in three different rehabilitation centers 
(N= 113). In the COGRAT study the inclusion criteria were (1) being aged between 
18 and 70 years; (2) suffering from severe fatigue (CIS-f ≥ 40)
52
(3) not having 
severe cognitive deficits as assessed with the Rivermead Behavioural Memory 
Test (screening score>8),
165
 the Token Test (score>12)
166
 and the Behavioural 
Assessment of the Dysexecutive Syndrome
167
 (score < borderline), (4) not having 
co-morbid depression as assessed with the Hospital Anxiety and Depression 
Scale
138
 (Depression score > 10, and a clinical interview when the score was 8-
10),
133
 (5) absence of severe pulmonary or cardiac disease and (6) being able to 
walk independently. Additional 113 patients were outpatients recruited in three 
rehabilitation centers. The selection of these patients was based on age (over 18 
years of age), the presence of a stroke, living independently, and the ability to 
complete the questionnaires autonomously. For all patients, age, level of 
education and time since stroke were recorded. Furthermore, the present study 
included 112 age-matched healthy controls. These were contacted through 
acquaintances of the researchers. All participants provided written informed 
consent prior to participation, in accordance with the declaration of Helsinki. The 
local ethics committees of the centers approved the study. 
 
Measures  
The Fatigue Severity Scale (FSS) 
The Fatigue Severity Scale (FSS) is a one-dimensional scale which consists 
of nine items that are scored on a 7-point Likert scale, ranging from 1 (strongly 
disagree) to 7 (strongly agree). The fatigue score is calculated by means of nine 
item scores (range 1-7), with higher scores indicating higher levels of fatigue.
54
 In 
stroke research the cut-off score for severe fatigue is set either at 4 or 5.
51
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The Checklist Individual Strength (CIS-20r) 
The Checklist Individual Strength (CIS-20r) is a 20-item questionnaire 
designed to measure four aspects of fatigue during the previous two weeks: 
fatigue severity (CIS-f: 8 items), concentration problems (5 items), reduced 
motivation (4 items) and reduced physical activity level (3 items). Each item is 
scored on a 7-point Likert scale ranging from 1 (yes, that is true) to 7 (no, that is 
not true).
52, 53
  
In this study we focused specifically on the fatigue severity subscale (CIS-f) 
to measure PSF (range 8-56), because this subscale is more often used as a 
measure of fatigue severity than the subscales of the CIS-20r together. The CIS-f 
cut-off score for severe fatigue in patients with stroke or TBI is set at 40.
15, 160
  
 
Statistical Analysis 
Discriminatory analyses, internal consistency and concurrent validity of the FSS 
and the CIS-20r 
To compare the demographic and fatigue data of our groups, t-tests were 
used for interval and Chi-square-test for categorical variables. Then, Principal Axis 
Factoring (PAF) analysis with direct Oblimin Rotation was performed on all CIS-
20R items obtained from the stroke patients to determine the construct validity of 
the four subscales for this particular group. To investigate group differences in the 
FSS and the CIS-20r subscales, independent samples t-test were performed on 
scale and item levels. Two previous studies investigating the item structure of the 
FSS in stroke patients with Rash analyses have suggested the exclusion of the first 
two items. These items clearly lacked discriminatory value and could not 
distinguish healthy controls from patient groups.
168, 169
 Analyses were therefore 
performed on the 9-item and on the 7-item (FSS7) version of the FSS.  
The internal consistency was then calculated using Cronbach’s alpha, and 
Pearson’s correlation coefficient was computed to specify the convergent validity 
between the FSS and the CIS-f. Differences between the patient and control group 
were calculated by converting the correlation coefficients into z-scores, and 
determining the difference (zdiff) with the accompanying p value.  
To compare our data to the prevalence rates of PSF presented in the 
literature, we counted the number of respondents who scored above 4 and 5 on 
the FSS, and those with higher scores than 40 on the CIS-f. 
 
Dimensional properties of the FSS and the CIS-fatigue severity subscale 
A PAF with direct oblimin rotation was performed on the item scores of 
the FSS and the CIS-f for all subjects. This PAF was then carried out for stroke 
subjects and healthy controls separately, to investigate construct validity across 
stroke patients and healthy controls. Factors were identified according to the 
following criteria: (1) the bend of the curve in the scree plot; (2) the amount of 
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variance explained by the factors combined; (3) item loading of more than .4 on a 
factor; and (4) interpretability by the authors.
170
 All analyses were performed 
using SPSS version 15 for Windows. 
 
Results 
Discriminatory analyses, internal consistency and concurrent validity of the FSS 
and the CIS-20r 
Comparisons between demographic variables of patients and healthy 
controls revealed a significant difference in educational level (p<.05) (Table 1). 
PAF analysis of the CIS20-R in stroke patients largely confirmed the separation of 
the items in the already existing four subscales, fatigue severity (CIS-f; eigenvalue 
7.18, % of variance 33.78, α=.88), concentration problems (eigenvalue 2.61, % of 
variance 11.00, α=.86), reduced motivation (eigenvalue 1.43, % of variance 5.3, 
α=.82), and reduced physical activity level (eigenvalue 1.79, % of variance 7.1, 
α=.81). Only the CIS-f item 8 loaded >.4 on both the CIS-fatigue subscale and the 
reduced motivation subscale. Therefore, the existing CIS-f subscale of the CIS-20r 
was used as an independent measure of fatigue severity in subsequent analyses. 
Patients scored higher than healthy controls on the FSS and on all CIS-20r 
subscales (Table 1). Analysis on an item level of the CIS-f and FSS scales revealed 
that patients differed significantly from the control group, except for items 1 and 
2 of the FSS (Table 2).  
 
Table 1. Demographic and fatigue data of patients and healthy controls. 
       
Variable 
Patients  
N=196 
M(SD) 
Healthy controls 
N=112 
M(SD) P 
Age, Mean (SD)  55.23 (9.01) 53.46 (9.09) .098 
Time since stroke (years) 3.97 (4.96)   
Gender, male (%)  50.0%  41.9% .174 
Education (1-7), median  5 6 <.001 
CIS fatigue severity 38.90 (10.92) 19.53 (11.40) <.001 
CIS concentration problems 22.43 (8.07) 11.04 (6.55) <.001 
CIS motivation 15.31 (6.50) 9.72 (5.05) <.001 
CIS physical activity 12.61 (5.33) 6.16 (3.77) <.001 
CIS-20r total score 89.94 (22.82) 47.35 (22.11) <.001 
FSS7 5.09 (1.39) 2.44 (1.47) <.001 
FSS 4.96 (1.25) 2.82 (1.27) <.001 
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The internal consistency (α) of the FSS and the CIS-f was .893 and .938, 
respectively. For the FSS this consistency increased to .910 after deletion of item 1 
and to .916 after deletion of item 2. With both items deleted (FSS7) α increased to 
0.933. The Pearson correlation (rp) between CIS-f and FSS for all participants was 
.774 and between CIS-f and FSS7 it was .797 (both p<.001). The Pearson 
correlations for patients and healthy controls and the differences between groups 
are listed in table 3. Figure 1 shows the scatter plot of both the FSS7 and the CIS-f. 
  
  
Table 2. Means of individual items of the FSS and CIS-f for patients and healthy 
controls 
Items Patients  
 
N=196 
M(SD) 
Healthy 
controls 
N=112 
M (SD) 
 
 
 
p 
Mean 
difference 
(SD) 
CIS-f     
 1. I feel tired 5.3 (1.8) 2.6 (1.9) <.001 2.7 (.2) 
 2. Physically I feel exhausted 4.5 (2.0) 2.1 (1.8) <.001 2.4 (.2) 
 3. I feel fit (reversed) 4.8 (1.8) 2.4 (1.6) <.001 2.5 (.2) 
 4. I feel weak 3.7 (2.1) 1.8 (1.3) <.001 1.9 (.2) 
 5. I feel rested (reversed) 5.1 (1.8) 2.9 (1.9) <.001 2.2 (.2) 
 6. Physically I feel I am in a bad condition 4.3 (2.0) 2.3 (1.7) <.001 2.0 (.2) 
 7. I get tired very quickly 5.8 (1.7) 2.5 (1.9) <.001 3.2 (.2) 
 8. Physically I feel I am in good shape (reversed) 5.2 (1.9) 3.0 (1.9) <.001 2.2 (.2) 
      
FSS     
 1. My motivation is lower when I am fatigued 5.4 (1.7) 4.9 (1.6) .039 0.4 (.2) 
 2. Exercise brings on my fatigue 3.6 (2.1) 3.4 (1.9) .427 0.2 (.2) 
 3. I am easily fatigued 5.3 (1.8) 2.5 (1.7) <.001 2.8 (.2) 
 4. Fatigue interferes with my physical functioning 5.3 (1.7) 3.4 (2.0) <.001 1.9 (.2) 
 5. Fatigue frequently causes problems for me 4.1 (1.9) 2.0 (1.5) <.001 2.2 (.2) 
 6. My fatigue prevents sustained physical 
functioning 
4.6 (2.1) 2.3 (1.7) <.001 2.3 (.2) 
 7. Fatigue interferes with carrying out certain 
duties and responsibilities 
5.4 (1.8) 2.8 (2.0) <.001 2.6 (.2) 
 8. Fatigue is among my three most disabling 
symptoms 
5.8 (1.8) 2.2 (1.9) <.001 3.6 (.2) 
 9. Fatigue interferes with my work, family, or 
social life 
5.1 (1.9) 2.0 (1.6) <.001 3.2 (.2) 
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Table 3. Pearson correlations between CIS-f, FSS and FSS7 in patients and 
healthy controls 
 rp 
Patients 
rp Healthy 
controls 
Zdiff Ptwo-tailed 
CIS-f and FSS .520* .783* 1.76 .079 
CIS-f and FSS7 .543* .806* 1.87 .062 
* p<.001 
  
Figure 1. Scatterplot of the FSS7 and the CIS-f for patients and healthy controls 
 
Since items 1 and 2 of the FSS did not contribute to internal consistency 
nor to discriminatory value, we used the score of the remaining 7 items to 
determine whether participants scored above the cut-off scores of 4 or 5. The 
percentage of healthy controls scoring above 4 was 12.5% and 8% scored above 5 
on the FSS7. In the patients these percentages amounted to 77% and 61.2%, 
respectively. On the CIS-f 9.8% of the healthy controls scored above the cut-off 
score of 40, whereas for patients this percentage was 52.6%.  
 
Dimensional properties of the FSS and the CIS-fatigue severity subscale 
Since the item to N ratios in patients (196:17) and in healthy controls 
(112:17) were small, we chose to first analyze the data of both groups and then 
perform separate group analyses, to investigate whether the original factors of 
both scales would hold up. In all three analyses, after exploration of the scree 
plot, the amount of variance explained and the initial eigenvalues, three 
independent factors were identified explaining more than 51% of the variance. 
The individual loadings in these analyses were all higher than .4, except for FSS 
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item 1. The results of these PAF analyses with direct oblimin rotation are 
presented in table 4.   
The PAF analyses revealed item loadings and factors largely similar to 
those of the original scales across the subject groups, with factor 1 consisting of 
only CIS-f items and factor 2 of uniquely FSS items. Items that loaded high on 
factor 3 were CIS-f 6, CIS-f 8 and FSS item 2. Differences across subject groups 
were found for items 6 and 8 of the CIS-f, and FSS items 1, 2, 8 and 9. In stroke 
patients CIS-f items 6 and 8 were not clear-cut, both loading over .4 on factors 1 
and 3. In healthy controls, CIS-f item 8 loaded only on factor 3 and greater 
differences were found with regard to the distribution of the FSS items. FSS item 1 
did not load on any factor, item 5 was not clear-cut and items 2, 8 and 9 now 
loaded most strongly on factor 1. 
 
Table 4. Principal axis factoring on FSS items and items of CIS-f in patients and 
healthy controls  
 
 Patients and Healthy 
controls (N=308) 
Patients 
(N=196) 
Healthy controls 
(N=112) 
Item Factor Factor Factor 
1 2 3 1 2 3 1 2 3 
CIS-f 1 .775   .831   .941   
CIS-f 2 .705   .688   .805   
CIS-f 3 .795   .633   .734   
CIS-f 4 .747   .642   .754   
CIS-f 5 .726   .663   .821   
CIS-f 6 .841  .346 .532  .540 .305  .541 
CIS-f 7 .687 .281  .741   .676  .246 
CIS-f 8 .706  .283 .472  .460   .742 
FSS1  .361   .418  - - - 
FSS2   .456   .547  .436  
FSS 3 .413 .524  .255 .546  .591  .284 
FSS 4  .566   .436 .225  .680  
FSS 5  .721   .598  .510 .559 -.258 
FSS 6 .271 .500 .266  .425 .421  .557 .206 
FSS 7  .853   .830  .225 .667  
FSS 8 .234 .747   .774  .573 .367  
FSS 9  .755   .752  .565 .380  
Eigenvalues 9.68 1.35 1.03 6.72 1.99 1.43 9.41 1.38 1.05 
% of 
variance 
55.2  5.3  3.5  36.9 8.9 5.6 53.6 6.0 3.3 
 Rotation converged in 
13 iterations. 
Rotation converged in 
8 iterations. 
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Interpretation of the factors was based primarily on the analysis of the 
patient’s data, since both the FSS and the CIS-f have been designed for patients 
suffering from fatigue, and the constructs seemed to differ between patients and 
healthy controls. Moreover, in stroke patients the correlations between the 
factors were moderate at best, allowing the interpretation of different factors 
(factors 1 and 2 rp= .44; factors 1 and 3 rp= .23: and factors 2 and 3 rp=.31). 
Factor 1 consisted largely of items referring to the subjective feelings of 
weakness and tiredness in patients with stroke (CIS-f items 1: “I feel tired”; 2: 
“Physically I feel exhausted”; 3: “I feel fit (reversed)”; 4: “I feel weak” ; 5: “I feel 
rested (reversed)”;  and 7: “I get tired very quickly”). Therefore this factor was 
named “Experienced fatigue”.   
Factor 2 consisted exclusively of FSS items, except for item 2 in the patient 
population. This factor mainly contained items covering the impact of fatigue on 
daily life functioning (items 4: “Fatigue interferes with my physical functioning”; 5: 
“Fatigue causes frequent problems for me”; 6: “My fatigue prevents physical 
functioning”; 7: “Fatigue interferes with carrying out certain duties and 
responsibilities”; 8: “Fatigue is among my three most disabling symptoms” and 
9:”Fatigue interferes with my work, family, or social life”) and to a lesser degree 
items on fatigability (item 3: “I am easily fatigued”) and motivation (item 1: “My 
motivation is lower when I am fatigued”). Therefore, this factor was labelled 
“Fatigue impact”. In healthy controls the items covering the debilitating effect of 
fatigue on daily life activities were included in factor 1. The distinction with factor 
2 (fatigue impact or fatigue as a disability) was less clear. 
Factor 3 referred to the CIS-f and FSS items covering physical fitness (FSS 
item 2: “Exercise brings on my fatigue”, CIS-f item 6: “Physically I feel I am in a bad 
condition”). Consequently, this factor was named “Physical condition”. 
 
Discussion 
In the present study it was found that both the one-dimensional Fatigue 
Severity Scale (FSS) and the multidimensional Checklist Individual Strength-20r 
(CIS-20r) have good psychometric properties and adequately discriminate stroke 
patients with PSF from healthy controls. However, analyses of the (sub)scales that 
aim to measure fatigue severity (the FSS and the subscale “fatigue severity” of the 
CIS20-R (CIS-f)) reveal that these scales assess different dimensions of fatigue. The 
FSS was found to assess the impact of fatigue on daily life functioning, whereas 
the CIS-f mostly reflected experienced fatigue. Furthermore, the convergent 
validity of both scales was only moderate in stroke patients. These results indicate 
that these tools cannot be used interchangeably to assess PSF.  
The average score on the FSS is most often utilized to assess fatigue 
severity in stroke patients.
28, 51, 91
 However, the tool was originally designed to 
reflect the impact of fatigue on daily life in patients known to suffer from 
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fatigue,
28, 54
 a distinction that is not always recognized.
51
 Moreover, none of the 
items of the FSS ask about the severity of fatigue. Thus, taken together with the 
results of this study, it is questionable whether the FSS is a valid scale for the 
assessment of fatigue severity in patients with stroke.  
The FSS has its own merits. It is a short, easy to administer self-rating tool, 
which assesses the impact of fatigue on the daily life of patients with stroke. For 
diagnostic and research purposes, however, the first two items (1) “my motivation 
is lower when I am fatigued”, and (2) “exercise brings on my fatigue” should be 
used with caution. In this study, these two items did not distinguish between 
healthy controls and patients with stroke and both items consistently reduced the 
internal consistency of the scale. Previous studies using Rasch analyses have 
suggested the deletion of these two items for use in neurological patients.
168, 169
 
Most likely, these items are too generic to aid in the differentiation between 
pathological and normal fatigue.  
 The results of this study showed that most of the CIS-f items loaded on 
the factor “Experienced fatigue”. However, the meaning of items 6 and 8 was not 
clear-cut, because they also loaded on “Physical condition”. In the preliminary 
analyses, item 8 did not load on the CIS-f subscale, but on the CIS-20r subscale 
motivation. This corresponds to the findings by Staub & Bogousslavsky (2001b) 
who  suggested that the CIS-f essentially assesses the physical component of 
fatigue.
12
 This is  congruent with the findings of a previous study
92
 where we 
found that the CIS-f showed a clear association with somatic complaints in 
patients with severe PSF. This is an important aspect to be considered in stroke 
patients when using the CIS-f. Although fatigue is often experienced both 
mentally and physically, patients with predominantly mental fatigue might be at 
risk of being underdiagnosed with the CIS-f. In contrast, PSF in patients with little 
physical stamina and or many physical impairments could be overemphasized by 
using the CIS-f.   
This study has some limitations. We assessed the psychometric properties 
of both scales by calculating the internal consistency and convergent validity in 
patients with stroke and healthy controls. As we used a cross-sectional design, we 
were unable to examine the usefulness of the scales to detect changes over time 
(responsiveness) in stroke patients. Furthermore, 42% of the included patients 
participated in the COGRAT study
164
 in which only patients with a CIS-f score of 40 
or above were included. Therefore, it is possible that the variability within our 
data was restricted and, thus, the generalizability compromised. Nevertheless, the 
standard deviations of the patient scores were comparable to those of healthy 
controls, which makes it unlikely that the influence of selection bias was severe.  
 The findings of this study have implications for both clinical practitioners 
and researchers. First, the results underscore the multidimensional and subjective 
nature of PSF. In assessing this complex symptom, researchers and clinicians need 
84 
 
to make sure that they select the most appropriate fatigue scale and are not 
misled by the name of the scale.
28
 When studying fatigue severity, the CIS-f is 
preferable over the FSS. On the other hand, the FSS is more suitable to assess the 
impact of fatigue on daily life. The FSS is shorter and easier to administer, whereas 
the CIS-20r provides a multidimensional assessment not only of “Experienced 
fatigue” and “Physical condition” (CIS-f subscale), but also of the influence of 
fatigue on “Concentration problems”, “Motivation” and “Activity” (other 
subscales). Hence, this difference in the information provided must be taken into 
consideration when selecting a fatigue scale for either diagnostic and/or research 
purposes.  
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Section 2. The Management of fatigue 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Nobody realizes that some people expend tremendous energy merely to be 
normal” 
Albert Camus (1913-1960) 
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“Creativity is allowing yourself to make mistakes. Art is knowing which ones 
to keep” 
Dilbert, Scott Adams (1957-) 
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Abstract  
Purpose: Post-stroke fatigue is a common and debilitating complaint, which has 
only recently received attention in clinical rehabilitation. Until now, no evidence-
based treatments have been available for the condition. Therefore, a new 
treatment was designed to reduce post-stroke fatigue complaints: Cognitive and 
Graded Activity Training (COGRAT). 
Rationale: Following the premise that post-stroke fatigue is primarily caused by 
brain damage, the treatment aims to prevent fatigue and to manage existing 
fatigue symptoms. The purpose of the added graded activity programme is to 
reduce fatigue by changing cognitions and enhancing physical fitness. 
Theory into practice: COGRAT consists of a cognitive treatment and graded activity 
programme in small groups over 12 weeks. In the cognitive treatment, patients 
receive education on post-stroke fatigue and register their activities and fatigue to 
gain insight into their daily agenda and fatigability. Patients are then taught 
several compensation strategies. Cognitive behavioural therapy is used to 
diminish anxiety, facilitate behavioural change and manage fatigue symptoms. 
The graded activity programme consists of walking on a treadmill, strength 
training and home work assignments. Maximum heart rate and strength are 
increased from 40% at the beginning of the training to a maximum of 70%. 
Considerations for future improvements: COGRAT is currently being evaluated in 
outpatients with severe post-stroke fatigue in a multicentre randomized 
controlled trial. Preliminary data suggest both positive short- and long-term 
effects. Adaptations for other neurological patient groups suffering from fatigue 
are suggested. 
 
 
91 
 
 
-  Chapter 5. COGRAT, a treatment protocol for PSF  -    
Introduction 
 In recent years, rehabilitation professionals and researchers have become 
increasingly interested in Post-Stroke Fatigue (PSF). PSF is a frequently reported 
and debilitating consequence of stroke, both in the post-acute and in the chronic 
stages,
11
 occurring in 38% to 77% of the patients.
129
 Although an exact definition 
of PSF is still lacking because of its subjective nature,
9, 129
 it is best described as “a 
feeling of early exhaustion, developing during mental activity, with weariness, lack 
of energy and aversion to effort” (Staub & Bogousslavsky, 2001; p 75).
22
 Rest 
usually does not ameliorate the fatigue.
43
 Moreover, the feeling of physical 
tiredness and lack of energy is characterised as abnormal, excessive, chronic or 
problematic.
68, 69
 PSF is related to poorer outcomes in rehabilitation, reduced 
quality of life and increased mortality.
14, 19, 171
  
 Despite the high prevalence rates of PSF, even in patients that seem to 
have recovered well,
14, 22
 a comprehensive treatment is still lacking.
129, 130
 A 
systematic review of PSF treatments by McGeough et al (2009)
21, 130
 concluded 
that there is insufficient evidence to guide practice, neither by pharmacological 
nor non-pharmacological means. Until now, only a few cause-specific treatments 
have been developed.
130
 Other fatigue relieving evidence-based treatments have 
only been aimed at non neurological populations.
71, 129
  
 Against this background a PSF treatment module “Dealing with fatigue” 
was implemented in a day clinic specialized in chronic stroke patient 
rehabilitation. The treatment consisted of a 12-week program in which patients 
received cognitive treatment once a week from a neuropsychologist, alongside an 
exercise programme twice a week. Evaluation of pre- and post treatment 
measurements of 16 patients showed significant decline of fatigue, as measured 
with the Checklist Individual Strength fatigue scale and psychological distress, as 
measured with the Symptom Checklist-90 (both p<.001).
172
   
 On the basis of recommendations of this pilot study, the treatment 
protocol was adapted in several ways. The most important changes include: 
limitation of group size to four participants, more consistent use of cognitive 
behavioural techniques and the development of a treatment protocol for graded 
activity training. This treatment, Cognitive and Graded Activity Training (COGRAT) 
is currently being evaluated in a multi-centre randomised controlled trial in the 
Netherlands.
131
 Preliminary data of 40 patients showed significant decline of 
fatigue severity and psychological distress, both on post treatment and on follow-
up assessment (p<.001), as measured with the above mentioned instruments.
173
  
 To describe the treatment here, first the underlying rationale and the 
main principles of COGRAT will be illustrated. Subsequently, a more detailed 
account of the practice of the treatment protocol will be presented for both the 
Cognitive Treatment and the Graded Activity Training. Text box case illustrations 
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of consenting patients in the COGRAT trial are provided to clarify basic concepts. 
Introductions of the two patients presented are given in Box 1. 
 
 
Rationale of COGRAT 
 The rationale of COGRAT, its aims and treatment elements are shown in 
Table 1. One of the starting points of the treatment of PSF is that energy levels 
cannot be restored to the pre-morbid level. In neurological practice it is generally 
agreed that brain damage is the primary cause for excessive fatigue.
22, 43, 69, 72
 
Although the mechanisms relating fatigue to cerebral damage are still elusive, a 
plausible theory is the cognitive “coping hypothesis” proposed by van Zomeren et 
al (1984).
103
 This hypothesis postulates that fatigue is due to the additional 
compensatory effort spent by brain-injured individuals in meeting the demands of 
everyday life as a result of their cognitive deficits.
36, 96, 103 
Evidence for this notion 
follows from two sources: (1) studies on the relationship between attention 
deficits, mental effort and subjective fatigue
37, 38, 174, 175
 and (2) imaging studies of 
patients with Traumatic Brain Injury or Multiple Sclerosis. These patients show 
higher levels of cerebral activation than healthy controls during attentionally 
demanding tasks to compensate for their processing deficits, which may increase 
experienced fatigue.
153, 154, 176, 177
  
 Thus, the cognitive-behavioural part of COGRAT is principally aimed at 
providing stroke patients with cognitive strategies that allow them to make a 
more efficient and sagacious use of their remaining cognitive resources in order to 
manage existing and prevent forthcoming fatigue. In order to implement these 
strategies, patients are first educated on the possible aetiology of PSF and fatigue 
symptoms. Second, patients log their activities and subsequent fatigue. With the 
Box 1  
Case 1: LD is a man aged 56 years who had always been active in many 
areas. He describes his life prior to stroke as one dedicated to fun and looking 
for opportunities to ride his motorcycle. Four years ago he suffered a 
subarachnoid haemorrhage and, since then, he has had to relearn walking. His 
right arm and leg showed severe motor deficits. Adjusting his life after stroke 
was a major issue during the first two years. He now still suffers from 
concentration problems, lack of initiative and severe fatigue.  
 
Case 2: YB is a woman aged 45 years who had sustained a stroke in the left 
frontal lobe 2 years ago. She still practices her former job as a hospital nurse, 
but feels she is inadequate to do so due to concentration problems and severe 
fatigue. After work, she reports being irritable when the phone rings and not 
having enough energy to engage in activities with her husband and children. 
She experiences guilt about having to let her husband take over most of the 
parenting and housekeeping and for no longer being the same “fun” person. 
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help of analysis and feedback from the therapist, patients then gain insight into 
their activity and fatigability patterns. Last, three compensation strategies are 
taught to help patients prevent fatigue: alternation of exerting and relaxing 
activities, improvement of planning and regular relaxation.  
 
Table 1.  Rationale and main elements of Cognitive and Graded Activity Training 
on post stroke fatigue.  
 Rationale Treatment aims Treatment elements 
1 Primary fatigue is 
caused by brain 
damage, therefore 
energy levels cannot be 
fully restored  
- Prevent fatigue 
- Manage existing 
fatigue 
- Patient education  
- Improvement of insight into 
activity and fatigability patterns 
- Adaptation of activity patterns to 
present energy levels by 
compensation strategies 
 
2 CBT is effective in 
chronic fatigue 
syndrome  
- Foster behavioral 
change 
- Decrease fatigue 
related anxiety 
- Change unhelpful thoughts by 
means of structural 
implementation of CBT in sessions 
and homework assignments 
 
3 Increased physical 
fitness may decrease 
fatigue 
- Enhance physical 
fitness  
- Decrease fatigue 
- Graded Activity Training: with 
training of endurance, strength 
and flexibility 
 
 Furthermore, evidence from studies on treatment in chronic fatigue 
syndrome 
178
 suggest that cognitive behavioural therapy (CBT) is helpful in 
reducing fatigue. In the COGRAT treatment a form of CBT, 
179
 has been 
incorporated systematically in the treatment. In this treatment CBT is explained as 
follows. ‘Unhelpful or irrational thoughts about a given situation lead to unhelpful 
emotions and behaviours. The situation is taken as given. It is the thoughts about 
the situation which cause our emotions and our behaviour.’ These automatic 
thoughts are identified and challenged with the help of the therapist. Together 
with the group of patients more suitable and realistic thoughts are then 
formulated and practiced by the patient in order to facilitate helpful behaviour 
and decrease unhelpful emotions. The aims of CBT are to foster behavioural 
change, to decrease fatigue related anxiety and to help accept and manage 
existing fatigue symptoms. 
 For example, when a patient sees the pile of laundry still to be ironed, the 
thought may arise ‘I must finish this all now’. When the situation (i.e. the pile of 
laundry) is taken as given, this thought is not helpful since ironing the entire pile 
of laundry in one stretch may be too tiresome. When the patient then finds him- 
or herself too tired to continue, the thought ‘I cannot even finish this pile, 
therefore I am worthless’ may lead to depressive feelings and unfruitful behaviour. 
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Therefore, changing negative thoughts into more helpful and realistic ones such 
as ‘I can stop now and finish this later and that is perfectly ok’ will aid the patient 
in both implementing behavioural change and in accepting fatigue. 
 Last, a graded activity program is given alongside the cognitive treatment 
to diminish experienced fatigue through improved physical fitness. Clinical 
observations show that lack of physical exercise frequently leads to secondary de-
conditioning and reduction of cardiovascular fitness in stroke patients.
117
 
Furthermore, it has been found that exercise therapy effectively alleviates fatigue 
in numerous other medical conditions.
71, 126, 180-182
 Regular exercising may 
therefore reduce experienced fatigue, which in turn can teach patients that 
physical activity is trainable and exercise is compatible with life after stroke.
183
 In 
addition, programmes that use graded activity do not only increase the physical 
fitness of patients, but also have a preventive effect on subsequent stroke or 
other cardiovascular diseases.
184, 185 
The exercises and loads of the program are 
based on the recommendations for Stroke Survivors of the American Heart 
Association,
113, 184
 taking into account the safety for this patient group in view of 
their vascular frailness. 
 
Theory into practice 
 The COGRAT treatment consists of both a cognitive treatment and a 
graded activity training given alongside for twelve consecutive weeks. It has been 
specifically designed for patients who suffer from severe fatigue after stroke as 
their primary complaint. Furthermore to participate in the graded activity training, 
patients must be able to deambulate independently in order to walk on the 
treadmill. Several exclusion criteria must be considered, such as cognitive 
disorders that may limit basic understanding or retention of information (e.g. 
severe deficits in attention, memory, executive functioning and language skills). 
 The cognitive therapy takes place once a week for 2 hours and is given by 
a neuropsychologist with ample knowledge and experience of CBT and PSF. The 
treatment is given to small groups of four patients in a quiet environment. This 
choice was based on the findings of our pilot study, where patients in larger 
groups experienced difficulty concentrating and, thus, benefited less from the 
treatment than patients in smaller groups. For instance in small groups, patients 
with mild attention deficits will profit more from the examples brought forward 
by other group members due to fewer distractions.  
The graded activity training is given twice a week for two hours by a 
physiotherapist with ample knowledge of and experience with stroke patients. 
This programme may be given to the whole group of four or to pairs, depending 
on the facilities available (e.g. sufficient treadmills). The organisation of the 
COGRAT treatment is described in Table 2. 
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Table 2. Organisation of the COGRAT treatment 
 Cognitive treatment Graded Activity Training 
Therapist/ 
Physiotherapist 
Neuropsychologist with 
knowledge of: 
- PSF 
- CBT 
- Group therapy 
Physiotherapist with 
knowledge of: 
- stroke 
 
Patients No severe cognitive deficits Able to walk independently 
Group size Maximum of 4 With 4, or in pairs 
Time Once a week, for two hours 
For twelve weeks 
Twice a week, for two hours 
For twelve weeks 
 
Cognitive Treatment  
 The cognitive treatment consists of twelve sessions. All sessions have a 
specific theme and are uniformly structured. At the start of each session, patients 
are first made welcome and the sessions’ programme is presented. Then the 
results of homework assignments given in the previous session are discussed. The 
therapist reinforces positive behavioural change and helpful thoughts verbalised 
by patients. Next, education on the theme of the session is given, followed by a 
break of at least 10 minutes. Patients are encouraged to ask for more or longer 
breaks when needed.  
 After the break, the second part takes place, in which the session theme is 
further elaborated. The therapist ensures that all participants understand the 
tasks at hand and gives personalised examples, whenever feasible. At the end of 
each session, 15 minutes are reserved to explain the next homework 
assignment(s). Patients also receive hand-outs of all information and homework 
assignments and they are encouraged to share their experiences and information 
with their relatives and close friends.  
 Furthermore, positive feedback is given to encourage patients in changing 
their beliefs and behaviours. At all times, the therapist takes great care in creating 
a safe group environment (e.g. Yalom and Leszcz)
186
 to facilitate group cohesion 
and an open attitude of patients, which is important for an optimal treatment 
outcome.
187
  
 During the 12 weeks of the cognitive treatment, three separate stages can 
be distinguished as shown in table 3.  
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Table 3. Architecture of the Cognitive Treatment 
Stage Sessions Therapeutic 
elements 
Homework 
1. Education and goal setting 1-3 A b c 1, 2, 3 
2. Introduction of CBT and 
insight into personal activity and 
fatigability patterns  
4-6 A b c D 1, 3, 4, 5 
3. Compensation strategies and 
CBT 
7-12 A b c D E f g 1, 4†, 5, 6 
Therapeutic elements  
(letters in bold* are the main treatment 
elements, the other letters are supporting 
therapeutic actions)  
 
A*: Education 
b: Meaningful and personalised information 
and examples 
c: Feedback, modelling and reinforcement of 
active behaviour 
D*: CBT 
E*: Insightful practice of compensation 
strategy 
f: Relapse prevention 
g: Assertiveness 
Homework assignments 
 
1: Reading information leaflet of 
the session 
2: Contemplating treatment goals 
3: Set and practice individual sub-
goal 
4: Practice with CBT 
5: Logging activities and fatigue 
6:Practice with compensation 
strategy set in individual sub-goal 
 
†
CBT homework assignments are 
given in stage three to those 
patients who need further change 
in their beliefs to facilitate the 
behavioural change. 
 
 
Stage 1: Education and goal setting 
 The first stage has a psycho-educational character. It consists of the 
sessions: (1) Introduction, (2) Individual goal setting and (3) Goal setting and 
presentation.  In these three sessions, patient education on the possible aetiology 
of PSF and fatigue symptoms is repeatedly given. Also since sleep disturbances are 
common sequelae of stroke
188
 that may directly influence fatigue,
56, 80
 sleep 
hygiene is illustrated.  
 In the first session the organisation of the treatment is explained and the 
compensatory nature of COGRAT is emphasised. Furthermore, patients are 
carefully instructed on how to formulate 2 or 3 individual SMART (Specific, 
Measurable, Attainable, Realistic and Timely) treatment goals.
189, 190
 
 The second session is an individual session to help patients in wording 
their goals realistically and attainably, and to manage treatment expectations. 
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When sleeping disturbances are present, solving these disturbances is always part 
of the first goal. Every subsequent week, with the help of the therapist, patients 
formulate an achievable action plan that helps them to realise one of their 
treatment goals.  
 In the third session, patients design posters of their goals and present 
these to their peers. On these posters they indicate their current goal status on a 
visual analogue scale (VAS) by giving themselves a grade between 1 (not achieved 
at all) to 10 (completely achieved). Next, they clarify the levels they would like to 
achieve at the end of the treatment.  
 Every week, after they have presented their achieved homework results, 
patients are encouraged to update their VAS-marks on the posters to reinforce 
positive and active behaviour. The posters are displayed in the treatment room to 
visualize individual goals and improvements. 
  
 
 
Stage 2: Introduction in CBT/RET and insight into personal activity and 
fatigability patterns. 
 The second stage consists of the following sessions: (4) Introduction to 
CBT, (5) CBT and the relationship between activities and fatigue and (6) Activity 
Registration.  
 In session 4, CBT is introduced by the simplified formula: ‘Event + Thought 
= Feeling & Behaviour’. This formula is then practiced by matching it to personal 
experiences. To further help patients apply these principles in daily life, they 
receive a CBT-workbook in which these principles are illustrated and in which 
concrete exercises involving fatigue and concrete session themes are 
incorporated. To enhance the patients’ understanding of the close relationship 
between their activity pattern and fatigue, they are given a homework assignment 
Box 2  
LD had difficulty adjusting to a life in which he could not participate in pre-
morbid activities. He was very impressed with the information given to him 
about PSF and especially about the possible causes of fatigue. Finally it made 
sense to him, he said. Because he had trouble initiating activities, he ended up 
doing nothing but watching TV, which in itself became a straining activity. 
Incorporating daily duties was formulated as a goal. This involved explicit 
planning: 
“I want to do things, be active. Therefore I will plan my daily activities and 
resting periods ahead, so that I will know what to do when the time comes. I 
will use a day planner in order to achieve this.” 
Although, at first, he was reluctant to plan his life so rigorously, he gradually 
became aware that his lifestyle was detrimental. Thus, he became motivated to 
try the ‘planning approach’. 
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in which they log their activities and experienced fatigue on an hourly basis during 
two weeks.  
 In session 5, first a repetition and elaboration on CBT is presented. A 
number of frequent ‘unhelping’ thoughts are identified and matched with the 
experiences of the patients. With personal examples of patients ‘helpful thoughts’ 
are identified and given to practice as homework assignments. Furthermore, 
activities and subsequent levels of fatigue that have been logged during the 
previous week are already considered within the group for possible relationships. 
 In session 6, a colour coding is introduced in which activities are linked 
with different colours in order to visualize activity patterns. The coding are: sleep 
(blue), passive relaxation (brown), active relaxation (yellow) and 
work/productivity (red). These colours are then applied to the worst and least 
fatiguing day of the logged weeks. Using the fatigue scores, patients are taught 
that it is not only the activity itself, but also the duration and intensity level of the 
activity as well as the intermittent rest that influence and determine fatigue 
severity (e.g. Box 3). 
 
 
 
Stage 3: Compensatory strategies 
 In the third stage, three compensation strategies aimed at implementing 
behavioural change, are consecutively presented and practised. The modification 
of activity patterns follows from the insight gained from the colour coding 
exercises. This stage consists of the sessions (7) Compensation one: Alternating, 
(8) Mid-term evaluation, (9) Compensation two: Planning, (10) Compensation 
three: Relaxation, (11) Dealing with surroundings and (12) Evaluation.  
 In session 7 and the subsequent homework assignments, patients are 
taught how to incorporate the alternation of activity and rest into their daily 
activities. Through to the logging exercises, patients have been made more aware 
Box 3 
YB had a “moment of epiphany” when she logged all her activities and fatigue 
during a week. She said she never would have imagined that she was still doing 
almost as much work and household chores as before the stroke. Furthermore, 
she noted that she was already exhausted at work after lunch and after 
meetings. The common denominator was that she developed fatigue during 
activities with many surrounding sounds and when communicating with more 
than two persons at the same time. For instance, lunchtime did not bring active 
(yellow) or passive (brown) relaxation, but resembled strenuous activity (red). As 
a sub-goal she then chose to allow herself to “drift off” during meetings and, 
instead of having lunch with all her co-workers, she would take a walk with just 
one of them. At the next session when YB presented her achievements on this 
homework assignment, she reported to have more energy due to fewer “red” 
activities and a more “yellow” lunch. As a result she felt the return of pleasure in 
her work.  
 
99 
 
 
-  Chapter 5. COGRAT, a treatment protocol for PSF  -    
of how long a certain activity may last before they experience fatigue (e.g. 20 
minutes). They are then taught to take short resting periods (e.g. 5 minutes), or by 
engaging in a relaxing activity, instead of completing the task uninterruptedly. 
Hence, the total time spent on the task can be elongated (e.g. 3x 20 minutes with 
breaks). Different means of taking small breaks and reminding oneself to rest in 
time are discussed.  
 In session 8 all the behavioural changes and achievements up to this point 
are emphasized and verbally reinforced. Furthermore, this session allows for 
repetition of previous exercises and information when needed.  
 In session 9 beter planning, is introduced. Good planning helps to 
structure and maintain activity patterns that prevent fatigue, to retain an 
overview of tasks and activities, and to communicate new activity pattern to 
relatives and close friends (e.g. Box 4).  
 Session 10 is devoted to relaxation and the role of leisure activities. 
Patients often have trouble to relax for several reasons. First, energy expenditure 
has changed after stroke. Activities that were once relaxing may now have 
become quite demanding. Second, following the cognitive coping hypotheses, the 
physiological costs of tasks requiring attention are higher after brain damage
36, 38, 
96, 103, 177
 and these may lead to distress.
9
 Furthermore, blood pressure changes 
significantly during attention-demanding tasks and may remain altered for a 
longer period of time in patients after brain damage.
37, 175
 Both hypertension and 
hypotension have been linked to fatigue after stroke.
57
 In order to normalize 
blood pressure levels to healthier proportions and reduce the physiological costs, 
it is crucial for patients to actively bring themselves into a more relaxed condition. 
To help patients relax, recorded exercises are offered. Patients can then practice 
these exercises at home.  
 In session 11, specific attention is given to expressing ones needs and 
boundaries. Furthermore, patients are taught how to explain their fatigue and 
fatigue-avoiding behaviours to the people in the direct social environment. This 
skill equips patients with timely statements regarding their needs and (in)abilities. 
 Finally, in the last session (12), each patient presents his/her treatment 
goals and the steps already taken to reach these goals. Finally, the patients award 
themselves with final points on their Goal-posters for their achievements. All 
these steps, including the helpful thoughts and the action plans, are written and 
taken home by the patients. 
 In sessions 10 through 12, as a part of relapse prevention, the therapist 
also assists the participants in finding adequate reactions and thoughts to 
situations in which fatigue is present.  
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Physical Graded Activity Training 
 The graded activity training consists of two treatment sessions per week 
over 12 weeks. The program focuses on endurance, strength and flexibility. The 
training follows the principle of progressively increasing intensity of both heart 
rate and muscle strength
113, 184
 as illustrated in the training schedule in table 4.  
 In order to ensure the proper heart rate and loads used during exercises, 
measurements of individual heart rate and muscle strength are taken during the 
first session (baseline) as well as after six weeks to adjust the training intensity for 
each patient. Ideally, the maximum heart rate (MaxHR) is assessed by a baseline 
graded exercise test with ECG monitoring.
184
 
 Endurance is trained by walking on a treadmill using gradually increasing 
inclination rather than increasing speed 
184, 185
 and by increasing the total time 
walking both during the training and at home. When needed, hand rail support or 
‘unweighting’ devices (i.e. harnesses that serve to ‘lift’ patients) are used to 
enable patients to walk on the treadmill. At the start of the training, patients walk 
twice for 10 minutes at 40% MaxHR. The heart rate is then kept constant for two 
weeks, during which the walking duration increases following a fixed regimen (see 
Table 4). In the second session patients walk twice for 15 minutes and in the third 
session for 18 minutes. In the fourth and last session of these two weeks, walking 
Box 4 
LD first greatly opposed to better planning, since he “had never planned in his 
entire life”. However, having learned from the logging exercise that his days 
were nearly empty and being confronted not only with his inability to initiate 
activities but also with his memory problems, he agreed that better planning 
could indeed make his life easier.  
LD started by writing down his trips to the clinic and whether he had already 
organised his transport. He then no longer needed to call the taxi-office to verify 
whether or not he had already arranged transport. From that point on, he 
planned adequate rest before and after his visits and on specific occasions 
during the day, before inserting other tasks and social engagements in his day 
planner. Because LD always had had difficulty initiating tasks, he was taught to 
look at his planner regularly, to specify each activity in it, and to plan fixed times 
to update his agenda. In order to allow for unplanned visits from his friends, LD 
reserved about 2 hours a day as “unplanned social activities”.  
After two weeks LD noticed that he needed to think less about what he would do 
each day. By “just doing” the things that were written down, he experienced that 
he not only accomplished far more activities, but that he was also less tired than 
before. Furthermore, he was now able to check which tasks he had already 
finished and which ones were still due. A week later, LD proudly stated that his 
friends had now completely approved and accepted his “resting periods” and 
“social hours”, because they had experienced that he had more energy during 
their common activities. 
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duration is increased to twice 20 minutes. In weeks 3 and 4, the training heart 
rate is set at 50% MaxHR, which is gradually increased every two weeks to 70% 
MaxHR at the end of the 12-week programme.  
 Another part of endurance training consists of taking walks at home and 
gradually lengthening these. At the start of the program, patients are asked to 
walk twice a week for twenty minutes. This increases to twice 40 minutes in week 
seven, to twice 40 minutes plus twice 20 minutes a week at the end of the 
programme.  
 Muscle training is aimed to increase strength. This training consists of core 
muscle training and weight lifting with upper and lower body limbs. Core muscle 
exercises are adapted to the individual abilities. In every session three different 
exercises are practiced with 10 to 15 repetitions each in three sets. Weight 
training consists of lat pull down, chest press and leg press. As with the endurance 
training, a graded exercise regimen is specified. Patients start training of upper 
body limb training with three sets at 40% of maximal muscle strength (1RM), and 
lower body muscles limbs at 55% 1RM. The specified 1RM is upheld during these 
two weeks, with only the number of repetitions per set increasing from 10 to 15. 
The weight is then gradually, with two-week steps, increased to a maximum of 
70% 1RM at the end of the program, as illustrated in table 4.  
 Each session lasts 2 hours and is uniformly structured. First, patients train 
endurance by walking twice on a treadmill, followed by a resting period of 30 
minutes. Then, patients proceed to muscle training. Afterwards, all trained 
muscles are carefully stretched to improve flexibility. Lastly patients are 
encouraged to practice their homework; taking walks to promote generalisation 
of improved physical activity. All individual achievements are registered and made 
available for patients to optimize their motivation. 
 It is important to note, however, that some adaptations to the training 
load may be necessary, especially in patients using beta-blockers. This medication 
is known to reduce the heart response to exercise, which limits the validity of the 
heart rate as a measure of physical load 
191
. Therefore, Borg’s rating of perceived 
exertion 
192
 is used in each session to individually adjust the training when 
necessary. First, the physiotherapist carefully explains the meaning of all scales to 
promote valid and reliable assessments 
193
. When training is perceived as too 
demanding (BORG > 14), training intensity is temporarily diminished with 5%. 
When training load is perceived as too low (BORG < 11), training intensity is 
increased by an extra 5%. The training intensity is, however, always maintained 
between the 40% and 70% margins to ensure both safety and effectiveness.  
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Figure 4 Graded Activity Training Schedule 
 Endurance 
training*  
(minutes  at 
%MaxHR) 
Upper body 
training ** 
(number of sets 
x repetitions at 
%1RM) 
Lower body limbs 
** 
(number of sets x 
repetitions at  
%1RM) 
Core muscle 
training *** 
(number of sets x 
repetitions) 
Homework **** 
(times a week x 
minutes) 
Exercise  Walking on 
treadmill  
Lat pull down 
and Chest press 
Leg press Core muscle 
exercises 
Walking 
Week 1-2  
Baseline 
Measurements            
 
2 x 10m 40%  
2 x 20m 40% 
 
3 x 10 40%  
3 x 15 40% 
 
3 x 10 55%  
3 x 15 55% 
 
3 x 10  
3 x 15 
 
2 x 20m 
Week 3-4 2 x 10m 50%  
2 x 20m 50% 
3 x 10 50%   
3 x 15 50% 
3 x 10 60%  
3 x 15 60% 
3 x 10  
3 x 15 
2 x 30m 
Week 5-6 
 
2 x 10m 60%  
2 x 20m 60% 
3 x 10 55%  
3 x 15 55% 
3 x 10 65%  
3 x 15 65% 
3 x 10  
3 x 15 
2 x 40m 
Week 7-8 
Reassessment of 
MaxHR and 1RM   
 
2 x 10m 60%  
2 x 20m 60% 
 
3 x 10 55%  
3 x 15 55% 
 
3 x 10 65%  
3 x 15 65% 
 
3 x 10  
3 x 15 
 
2 x 40m 
Week 9-10 
 
2 x 10m 65%  
2 x 20m 65% 
3 x 10 60%  
3 x 15 60% 
3 x 10 70%  
3 x 15 70% 
3 x 10  
3 x 15 
2 x 40m and  
1 x 20m 
Week 11-12  
Final assessment of 
achieved results 
2 x 10m 70%  
2 x 20m 70% 
 
3 x 10 65%  
3 x 15 65% 
3 x 15 70% 
 
3 x 15  
 
2 x 40m and  
2 x 20m 
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%MaxHR = percentage of Maximum Heart Rate; %1RM = percentage of Maximal Muscle Strength; m = minutes 
 
Graded Activity Training is given twice a week for two hours. During every two-week-period (weeks 1-2, weeks 3-4,… weeks 11-
12) there are four sessions in which a gradual increase in minutes of endurance training and number of repetitions of muscle 
training takes place. Training intensity of endurance and muscle training is monitored with the BORG-scale and temporarily 
adjusted when appropriate. 
 
* Endurance training is practiced at the given %MaxHR twice in every session. Minutes walked twice increase from 10 minutes, 
to 15 minutes the second session, to 18 minutes in the third and 20 minutes in the fourth session. Heart rate is monitored 
and inclination is adjusted to achieve the desired heart rate. 
** Upper and Lower body muscle training is always practiced in three sets at the given 1RM, with the number of repetitions 
increasing during the two-week-periods from 10 in the first, 13 in the second, 14 in the third and 15 in the fourth session. 
*** Core muscle exercises are adapted to the individual abilities. In every session three different exercises are practiced with 
10 to 15 repetitions each in three sets.  
**** Homework consists of taking walks. Every week a number of walks and time walked is set and evaluated. 
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Discussion 
 Post-stroke fatigue is a common chronic condition after stroke, 
characterised by persistent and debilitating feelings of exhaustion.
11, 129
 However, 
up to date no comprehensive treatments were available.
130
 Therefore, on the 
basis of a pilot study,
172
 we designed a treatment protocol specifically for patients 
who report chronic fatigue as their major complaint or disability. Since the brain 
damage is hypothesised to be the primary cause of the fatigue,
22, 43, 69, 72, 103
 the 
treatment is not aimed at restoring pre-morbid energy levels. In contrast it 
provides patients with several compensation strategies to prevent and manage 
fatigue. Furthermore CBT is systematically applied to reduce fatigue related 
anxiety and foster behavioural change. Preliminary data of a multi-centre 
randomized controlled trial show promising results on both the checklist 
individual strength fatigue scale and the symptom checklist 90.  
 The studies on treatments of post-stroke fatigue that have been 
conducted previously have yielded equivocal results at best. Fluoxetine 
administration was ineffective for alleviating fatigue in a double-blind randomized 
controlled trial.
104
 Trialiazad mesylate decreased fatigue in a small trial of patients 
with subarachnoid haemorrhage, however, more than half of the patients 
randomized were not available for follow-up.
21
 A small study on modafinil showed 
a decrease in fatigue severity in patients with brainstem and thalamic strokes, but 
not in patients with cortical infarctions.
107
 Furthermore, a study on the 
improvement of sleep-disordered breathing showed decline of fatigue only in 
those patients suffering from sleep apnoea syndrome.
108
 Last, post-stroke fatigue 
was not reduced by a chronic disease selfmanagement programme not specifically 
aimed at fatigue.
21
 
 In conclusion, these studies provide little basis on which to design a 
comprehensive treatment for post-stroke fatigue. In addition, studies of 
interventions in other neurological conditions such as traumatic brain injury or 
multiple sclerosis are scarce or offer little evidence-based advice, 
11, 110
 other than 
that exercise may be helpful.
21
 Systematic reviews of other nonneurological 
populations, however, provide a number of fruitful leads. First, in cancerrelated 
fatigue they show that interventions specifically aimed at fatigue (with education 
and activity management) are more effective than interventions not aimed 
specifically at fatigue.
194
 Second, in chronic fatigue syndrome CBT has been found 
to be effective
195
 and exercise therapy promising.
182
 Therefore, these elements 
have been incorporated in the COGRAT protocol. Nevertheless, the premise that 
in neurological patients, fatigue primarily caused by brain damage is upheld and 
therefore compensation strategies are taught to deal with existing fatigue. 
 The treatment protocol presented here has its limitations. The proposed 
treatment has been applied only in chronic stroke patients with relatively mild 
cognitive, emotional and physical impairments in an outpatient setting. Therefore, 
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several adaptations might be needed to apply a similar treatment in other types 
of stroke patients. For instance, when patients are in the subacute phase after 
stroke, emphasis might be laid on education of the patients, the caregivers and 
the therapists about fatigue and fatigability in order to properly adjust the 
training aimed at functional recovery. In patients who are not able to comply with 
the graded activity training due to physical limitations, personalized adaptations 
to the training tasks should be sought. 
 For patients with (severe) cognitive impairments, the cognitive training 
and education should be tailored to the individual possibilities. In addition, the 
caregivers should be explicitly included in the treatment to help these patients to 
gain insight and to restructure their lives. For those patients with problems 
initiating and stopping activities, the involvement of caregivers could be 
particularly beneficial. The caregivers may help the patients with external cues on 
when to initiate and stop certain activities. In patients with communicative 
problems, the basic principles of clear, repetitive and structured information 
should be adhered to even more fervently.
196
 Furthermore, the treatment 
protocol should probably make use of a more directive approach by the therapist 
and of less CBT. 
 Patients with fatigue due to other neurological conditions could 
presumably benefit from a similar treatment as presented in this paper. For 
patients with non-progressive brain damage such as traumatic brain injury or 
encephalitis, the COGRAT protocol is probably readily applicable. For patients with 
(potentially) progressive brain disorders such as multiple sclerosis or Parkinson’s 
disease, the same principles can still be upheld, although the graded activity 
training would need to be frequently adapted to the individual abilities. 
 
 
Clinical Messages 
o COGRAT seems a promising intervention to treat fatigue after stroke.  
o Patients receiving COGRAT should preferably have mild cognitive and/or 
physical impairments 
o Therapists giving COGRAT should have knowledge of post-stroke fatigue 
and cognitive behavioural therapy and be able to adjust treatment to 
individual abilities.  
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“It takes a lot of energy to be negative. You have to work at it. But smiling 
is painless. I'd rather spend my energy smiling.” 
Eric Davis (1962-) 
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Abstract 
Background and purpose— Fatigue is a common, persistent consequence of 
stroke and no evidence-based treatments are currently available to alleviate 
fatigue. A new treatment combining cognitive therapy (CO) with graded activity 
training (GRAT), called COGRAT, was developed to alleviate fatigue and fatigue 
related symptoms. This study compared the effectiveness of the COGRAT 
intervention with a CO only intervention after a 3-month qualification period 
without intervention.  
Methods— This randomized, controlled, assessor-blind clinical trial was 
conducted in 8 rehabilitation centres. Eighty-three stroke patients (> 4 months 
post stroke) were randomly assigned to 12 weeks of CO or COGRAT after 
qualification. Seventy-three patients completed treatment and 68 were available 
at follow-up. Primary outcomes (Checklist Individual Strength – subscale Fatigue 
(CIS-f); self-observation list - fatigue (SOL-f)) and secondary outcomes (Hospital 
Anxiety and Depression Scale, Stroke-Adapted Sickness Impact Profile, SOL-pain, 
SOL-sleep-D, 6-Min Walk Test) were collected at baseline (before and after 
qualification period) and after treatment (immediate and 6-months follow-up).  
Results— The qualification period showed stable outcome measures. Both 
treatments showed significant beneficial effects on fatigue (CIS-f: ηp
2
=.48, p<.001) 
and other outcomes (except pain and anxiety) with intention-to-treat analyses. 
Gains for the COGRAT group exceeded those in the CO group on number of 
individuals showing clinical improvement on the CIS-f (≥ 8 points: 58% vs 24%) and 
on physical endurance (ηp
2
=.20, p<.001).  
Conclusions— A 12-week cognitive therapy program can alleviate persistent 
fatigue after stroke. The best results are obtained when cognitive therapy is 
augmented with graded activity training. 
Clinical trial registration—URL: http://www.trialregister.nl. Unique identifier: 
NTR2704 
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Introduction 
 Fatigue is a common and often persisting consequence of stroke that 
negatively affects rehabilitation outcome, functional independency in daily life 
activities, quality of life and mortality.
20, 197
 Although the definition of post-stroke 
fatigue (PSF) is still subject of debate,
20, 197
 it is generally agreed that it is “a 
subjective experience of extreme and persistent tiredness, weakness or 
exhaustion after stroke, which can present itself mentally, physically or both and 
is unrelated to previous exertion levels”
20, 28, 58, 197
 Prevalence rates are as high as 
38% to 73% without spontaneous amelioration in the chronic phase.
20
 Moreover, 
research on its natural history shows that PSF often does not diminish even years 
after stroke. 
15, 45, 46, 58
 The etiology of PSF seems to be multifactorial. On the one 
hand, direct relationships have been described between the type and extent of 
the brain lesion, with infratentorial lesions, infarction of the basal ganglia and 
recurrent stroke yielding a greater risk of fatigue.
20, 47, 58, 66
 On the other hand, 
depression, anxiety, reduced functional health status, sleep disturbances, pain 
and poor physical fitness have all been associated with PSF.
1
 Overall, the exact 
mechanisms of origin and persistence of PSF are still elusive
20
 and no effective 
pharmacological or non-pharmacological treatment for PSF is yet available.
197
 
 Evidence from other patient populations with chronic fatigue suggests 
that tailored cognitive behavioral therapy, exercise therapy 
126, 181
 and teaching 
energy conservation strategies
111
 are effective means to alleviate chronic fatigue 
and related psychological and physical symptoms. Against this background, we 
developed a 12-week group cognitive treatment (CO) tailored to the stroke 
population, including elements of cognitive behavioral therapy (CBT) and teaching 
compensation strategies aimed at pacing and relaxation.
198
 A Graded Activity 
Training (GRAT) was offered alongside the cognitive treatment. GRAT consisted of 
walking on a treadmill, strength training and physical fitness homework 
assignments. A full description of these interventions has been published 
previously.
198
  
 The aim of this study was to compare the effectiveness of a combined 
intervention (COGRAT) with that of CO alone on fatigue and associated 
psychological and physical variables. As the long-term beneficial effects of 
physical fitness training after stroke are still subject to debate and because 
functional benefits of physical training tend to taper off at a later stage,
199
 we did 
not include a separate GRAT group. We hypothesized that both CO and COGRAT 
would alleviate fatigue, but COGRAT would be more effective than CO alone, 
especially with regard to physical endurance. 
112 
 
Methods 
Study design  
A multi-centre, randomized controlled study preceded by a qualification 
period was designed using block randomization per treatment center. Outcome 
measures were administered by blinded assessors and were gathered via self-
report questionnaires. Patients did not receive feedback on any of the 
assessments during the trial. 
Eligible patients were first assessed on the primary and secondary 
outcome measures (T0) and then entered a waiting list period of three months, 
during which no rehabilitation took place. The benefits of this so called 
’qualification period’ are that previous therapeutic effects are washed out, that 
poor compliers can be identified prior to randomization, and that a stable baseline 
of the outcome measures can potentially be established.
200
 Immediately after the 
qualification period, the outcome measures were administered again (T1). 
Thereafter, when 8 patients were available at a center, randomization of 
individual patients to an intervention group (CO or COGRAT) took place by means 
of 8 sealed envelopes. If only 4 patients were available at a center, all patients 
were assigned to one intervention group by means of a sealed envelope. Directly 
after treatment another assessment took place (T2), while a follow-up assessment 
was performed after 6 months (T3). 
The study was approved by the regional Medical-Ethical Committee for 
Research Involving Human Subjects and the local Medical-Ethical Committees of 
the 8 participating Dutch rehabilitation centers. The study was conducted 
according to the Declaration of Helsinki
201
  standards. All patients provided 
written informed consent. 
 
Patients 
 Between April 2008 and February 2010, community-dwelling patients who 
had had a stroke were approached through their treating physicians and 
psychologists, through newspaper articles or based on participation in previous 
studies. Patients were eligible if they (1) had sustained a stroke more than 4 
months before recruitment, (2) reported severe fatigue (Checklist Individual 
Strength – subscale Fatigue score ≥ 40
 15, 52
), (3) were aged between 18 and 70 
years and (4) were able to walk independently. Patients were excluded if they had 
severe cognitive deficits (Behavioral Inattention Test ≤ 129
 132
; Rivermead 
Behavioural Memory Test-screening score <8 
132
; Behavioural Assessment of the 
Dysexecutive Syndrome < borderline 
132
; Token Task >12 
132
) or severe co-
morbidity, such as cardiac disease, pulmonary disease or depression (Hospital 
Anxiety and Depression Scale – depression subscale score > 10,
138
 or based on a 
clinical DSM-IV interview 
133
 if the HADS depression subscore was 8, 9 or 10). 
Demographic and neurological data (age, sex, living situation, education level, 
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previous rehabilitation treatments, stroke type and hemisphere, time post onset 
of stroke, single vs recurrent stroke, Motricity Index 
134
) were obtained from the 
medical files.  
  
Interventions 
Based on the results of a pilot study to test the effects of cognitive treatment 
(emphasizing pacing and relaxation) on fatigue and psychological distress in 
patients with stroke, the size of the CO groups was set to a maximum of 4 patients 
198
. In addition, a GRAT protocol was designed including walking on a treadmill, 
strength training and homework assignments. Maximum heart rate and strength 
were slowly increased from 40% at the beginning of the training to a maximum of 
70% at the end of the 12-week program based on recommendations by the 
American Heart Association.
198, 202
 GRAT was given in groups of maximally 4 
patients as well. The CO group received weekly two-hour sessions of cognitive 
therapy for 12 weeks, In addition to group CO, the COGRAT group received 24 
two-hour sessions of GRAT twice a week for 12 weeks. During the study 
interventions, no other treatments were given. 
The neuropsychologists giving CO and the physiotherapists giving GRAT 
were all experienced in the rehabilitation of patients with stroke and worked 
within an academic setting. The neuropsychologists were also proficient in CBT. 
All therapists were trained and supervised by the principal investigator (AZ). All 
participants received daily homework assignments to enhance the therapeutic 
objectives. After each session, therapists rated patient attendance and patient 
adherence to treatment and homework on a 5-point Likert scale. Therapists also 
rated the percentage of the protocol that they had followed after each session.  
 
Primary outcomes  
The Checklist Individual Strength – subscale Fatigue (CIS-f)
52
 and a fatigue 
self-observation list (SOL-f)
203
 were used to obtain information on patient’s 
fatigue. Both tools are well validated and are widely used in the Benelux 
countries.
47, 148, 203, 204
 The CIS-f contains 8 questions on fatigue severity regarding 
the two weeks preceding the assessment. The CIS-f has good reliability, is 
sensitive to change,
28, 52
 and has been validated for the stroke population.
15, 47
 
Questions are answered on a 7-point Likert scale (1-7, summed range 8-56, higher 
scores represent greater fatigue). Patients with a score ≥ 40 were regarded as 
severely fatigued.
15, 203
 With the validated SOL-f, patients recorded their fatigue 
severity on a 5-point scale (0-4) four times a day (morning, afternoon, evening and 
bed time) for 7 days.
 
The daily fatigue score was the sum of these 4 scores (range 
0-16). The average daily fatigue score was calculated. 
148, 203, 204
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Secondary outcomes 
 Depression and anxiety were assessed with the Hospital Anxiety and 
Depression Scale (HADS).
138
 The HADS has been validated in patients with stroke 
and it consists of 14 items scored on a 4-point Likert scale (0-3): 7 items on the 
depression subscale (HADS-D) and 7 items on the anxiety subscale (HADS-A).
205
 
Subscale sum scores are categorised as normal (0-7), mild (8-10), moderate (11-
14) or severe (15-21).
139
  
 Functional health status was assessed with the well validated Stroke-
Adapted Sickness Impact Profile 30 (SA-SIP 30).
206
 This tool has 30 items and 
scores are calculated as a percentage of maximum dysfunction, ranging from 0% 
to 100%. A higher score indicates poorer functioning. In a well validated self-
observation list (SOL) patients recorded the amount of pain they experienced 4 
times a day on a 5-point scale (0-4). For each patient a mean pain score per day is 
available (SOL-pain, range 0-16).
148, 204
 A SOL was also used to record the quality of 
sleep. Patients indicated whether they had slept well, or recorded which of three 
sleep disturbances had occurred that night (difficulty falling asleep, restless sleep, 
early awakening). The amount of sleep disturbances was totalled for each day (0-
3). Scores were then expressed as the average amount of sleep disturbances per 
night (SOL-Sleep D, range 0-3). 
148, 204
   
 The 6-minute walk test (6MWT) is a validated tool to assess physical 
endurance.
207
 The total walking distance in meters (m) during 6 minutes was 
recorded. 
 Furthermore, after treatment (T2) patients were given a Visual Analogue 
Scale (VAS: range 0-10) to report patient satisfaction asking the question: “If I had 
to rate my satisfaction on treatment, I would rate it….”  
 
Clinically important change 
Clinically relevant improvement on the CIS-f was determined at follow-up 
(T3). At a group level, this was defined as a score below 35. This score is situated 
within two standard deviations of CIS-f scores in healthy controls.
148, 203, 208
 At an 
individual level, a clinically important reduction of fatigue was set at a reliable 
change index (RCI) greater than 1.96. This corresponds with a CIS-f score decrease 
of at least 8 points. This decrement has previously been reported as a clinically 
important improvement in individuals with fatigue.
203, 208
    
 
Statistical analysis 
It was calculated that a sample size of 48 patients per treatment group 
would be needed to detect a clinically relevant difference of 8 CIS-f points with a 
β-value of .10 and an α-level of .05.
203, 208
 Data analyses were performed using 
SPSS (version 18.0). Holm correction was used to control for multiple outcomes.
149 
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 Descriptive statistics were used to summarize demographic, stroke and 
baseline clinical characteristics. We then established whether changes on any of 
the outcome measures had occurred during the qualification period (T0 versus T1) 
using paired t-tests. All further analyses were performed on an intention-to-treat 
basis. Any missing values after treatment were imputed by carrying the last 
observation forward, adhering a conservative assumption with respect to 
treatment effects.  
 As a first step, analysis of covariance (ANCOVA) with the baseline scores 
as covariate was applied to the data. The interaction between Group and the 
covariate was significant for all outcome variables, which indicated non-parallel 
regression. For this reason, multiple analysis of variance (MANOVA) was done to 
establish treatment effects using Time (T1, T2, T3) as a within-subjects factor and 
Group (CO, COGRAT) as a between-subjects factor. Effect sizes were expressed in 
partial eta squared values (ηp
2
), which range from 0 to 1. 
 To establish the percentage of patients with clinically significant 
improvement in fatigue, CIS-f scores were dichotomized into clinically significant 
(RCI≥1.96) and clinically non-significant (RCI<1.96).
208
 We used χ
2
-test and 
associated contingency coefficients to examine between-group differences. 
To test whether any of the baseline characteristics was associated with 
study withdrawal or drop out, χ
2
-tests were used for categorical variables and 
unpaired t-tests for interval data.  
To investigate whether stroke characteristics affected treatment 
outcome, post-hoc analyses were performed for stroke type (ischemic, 
hemorrhage, subarachnoid hemorrhage (SAH) and mixed), single versus recurrent 
stroke, and post-onset time regarding all outcome measures at baseline and 
follow-up using analyses of variance (ANOVA) or t-tests.  
 
Results 
Patients 
 Patient flow (n=231) throughout the study is illustrated in the consort 
diagram in figure 1. The main reasons for non-participation were a CIS-f score 
below 40 (n=47) and symptoms of depression (n=21). Due to insufficient numbers 
of eligible patients at the different centers, individual randomization of 6 and 7 
patients took place in several instances. As a result some treatment groups 
contained 3 patients. Of the 83 patients randomly allocated to a treatment group, 
73 completed the treatment and were assessed at T2 (39 CO and 34 COGRAT). Of 
the 10 patients who discontinued treatment, 6 were assessed at T2. At follow-up 
(T3), 68 patients (82%) were still available for assessment.  
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Figure 1. Consort diagram 
 
 
Mean post-onset time of stroke in participants was 3.9 years (SD: 3.9). For 
five patients post-onset time exceeded 10 years. Sixty-three patients had been 
given prior rehabilitation (75.9%). More than half of all participants had received 
physiotherapy (61.4%) and/or occupational therapy (50.6%). Demographic and 
clinical characteristics of both treatment groups are listed in table 1. None of 
these characteristics was associated with study withdrawal (n=5; 6%) or 
discontinuation of treatment (n=10; 12%; all p>.05). 
   
Primary and secondary outcomes 
 Prior to the start of the interventions, after the three months qualification 
period, no significant change was found for any of the primary or secondary 
outcome measures. The values of the primary and secondary outcomes after the 
qualification period, at T1, T2 and T3 are shown in table 2. For the primary 
outcomes, after the treatment, main effects of Time were found (CIS-f p<.001; 
SOL-f p=.007). Effect sizes were substantial for CIS-f (ηp
2
=.48) and less for SOL-f 
(ηp
2
=.12). No interaction effects of Time with Group were found for either fatigue 
measures. Figure 2 illustrates that Time effects mainly occurred between T1 and 
T2 and remained stable at T3.  
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Table 1. Demographic and clinical characteristics of the patients (N=83)  
 CO 
Mean (SD) 
COGRAT 
Mean (SD) 
N 45 38 
Age (years) 54.8 (9.1) 55.6 (8.8) 
% male 48.9% 55.3% 
% living alone 24.4% 10.8% 
Education (median:1=lowest,7=highest) 5 (1.1) 5 (1.3) 
MI 90.2 (15.0)  90.1 (12.1) 
   
Stroke   
 Time since last stroke (years) 4.4 (4.2)  3.3 (3.9) 
  < 1 year post-stroke % 8.9% 13.2% 
  1-2 years post-stroke %  26.7% 34.2% 
  2-5 years post-stroke % 40.0% 34.2% 
  5-10 years post-stroke % 15.6% 15.8% 
  >10 years post-stroke % 8.9% 2.6% 
 Range .8 — 22.2 .4 — 23.0 
 Single 75.6% 73.7% 
 Recurrent 24.4% 26.3% 
Stroke type   
 Ischemic LH/RH/ bilateral 7/23/1 10/18/2 
 Hemorrhage LH/RH/ bilateral 1/1/1 3/0/0 
 Subarachnoid Hemorrhage 7 2 
 Other (infarct cerebellum & mixed) 4 3 
   
Prior rehabilitation  
(mean number of treatments: SD) 
75.6% 
(2.6: 1.8) 
76.3% 
(2.1: 1.8) 
 Physiotherapy % 60.0% 63.2% 
 Occupational Therapy % 51.1% 50.0% 
 Speech therapy % 26.7% 23.7% 
 Cognitive Therapy % 31.1% 31.6% 
 Psychological treatment % 57.8% 36.8% 
 Specialist counseling % 2.2% 0 
MI: Motricity Index
15 
LH: Left hemisphere; RH: Right hemisphere 
 
Small but significant main effects of Time were found for all secondary 
outcomes, except pain and anxiety. These effects also occurred between T1 and 
T2 and were stable at T3. Of all secondary outcomes, the 6MWT showed the 
greatest Time effect and there was a significant interaction effect with Group 
(p<.001, ηp
2
=.20). Figure 3 indicates that after treatment and at follow-up, 
physical endurance had improved more in the COGRAT group than in the CO 
group.  
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Figure 2. CIS-f scores at the 4 time points for the CO and COGRAT groups (N=83) 
 
 
Figure 3. 6-Minute Walk Test, distance walked in meters at the 4 time points for 
the CO and COGRAT groups (data of one patient are missing on all four occasions; 
N=82)  
 
Clinically important change 
 At follow-up, only the mean CIS-f score of the COGRAT group had 
improved to below 35. In contrast, the mean CIS-f score of the CO group was still 
(albeit marginally) higher than this cut-off score (table 2). At an individual level, 
more patients in the COGRAT group showed a clinically relevant improvement on 
the CIS-f than those receiving CO only (p=.002) (table 3).  
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Table 2. Outcome measurements (N=83)  
 Means (SD)  Analyses 
Outcome 
variables 
CO                               COGRAT Time* Group* Interaction* 
T1 T2 T3 T1 T2 T3 F p ηp
2
 F p F p 
CIS-f 42.1 (8.0) 34.8 (11.1) 35.5 (11.5) 44.6 (7.0) 35.6 (9.5) 33.5 (10.5) 37.74 <.001† .48 0.06 >.1 2.16 .121 
SOL-f 5.8 (2.3) 5.3 (2.6) 5.5 (2.7) 6.0 (2.7) 5.0 (2.3) 5.0 (2.6) 5.24 .007† .12 1.39 >.1 1.39 .256 
HADS-D 6.6 (3.1) 5.6 (3.3) 5.7 (3.3) 7.7 (2.7) 6.4 (2.6) 6.1 (3.4) 6.54 .002† .14 2.25 >.1 0.12 .884 
HADS-A 6.9 (4.1) 6.0 (3.8) 6.1 (4.0) 6.6 (3.9) 5.6 (2.9) 5.8 (3.6) 3.50 .035 .08 0.19 >.1 0.04 .963 
SA-SIP 18.2 (10.6) 18.1 (11.5) 16.4 (11.0) 21.1 (13.1) 15.4 (12.1) 15.7 (13.9) 6.69 .002† .14 0.00 >.1 3.25 .044 
SOL-sleep D .71 (.64) .58 (.56) .57 (.56) .71 (.49) .60 (.58) .49 (.51) 5.25 .007† .12 0.03 >.1 0.67 .516 
SOL-pain 2.3 (2.7) 2.3 (2.7) 2.1 (2.6) 1.9 (2.4) 1.8 (2.2) 1.9 (2.7) 0.27 .765 .01 0.41 >.1 0.17 .841 
6MWT 438 (123) 444 (112) 441 (123) 437 (107) 504 (94) 481 (92) 14.43 <.001† .27 1.98 >.1 9.72 <.001† 
*df values are omitted to improve legibility 
† signiﬁcant with Holm correceon for muleple outcomes: p<.008 for Time and p<.043 for Interaceon eﬀect 
CO, Cognitive Treatment; COGRAT, Cognitive and graded activity training; CIS-f,  Checklist Individual Strength-fatigue severity scale; SOL, Self Observation List (-f: 
fatigue severity scale; -sleep D, sleep disturbances;) HADS, Hospital Anxiety and Depression Scale (-D, depression subscale; -A; anxiety subscale); SA-SIP, Stroke 
Adapted Sickness Impact Profile 36; 6MWT, Six-minute walk test. 
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Table 3. Clinically relevant improvement (N=83) 
 CO No.(%) COGRAT No.(%) 
Improvement  11 (24.4%) 22 (57.9%) 
No Improvement   34 (75.6%) 16 (42.1%) 
Clinically relevant improvement (see text for definition) 
Likelihood ratio: χ
2
= 9.63, p=.002; Contingency coefficient = .322 
 
 
Control for confounding variables 
 Mean patient satisfaction was high (VAS 7.8) and did not differ between 
the treatment groups. Therapist adherence to the treatment protocol was greater 
than 98% in both groups. Overall, the patients showed good treatment 
compliance. There were no statistical differences between groups for the number 
of CO sessions (median 11 out of 12) or completed homework assignments (nearly 
always). The median number of GRAT sessions followed in the COGRAT group was 
23 out of 24.  
 Post-hoc analyses revealed no effects of stroke characteristics (stroke 
type, single versus recurrent stroke, post-onset time) on any of the outcome 
measures (all p>.05). Separate trend analyses of the outcome measures leaving 
out patients with SAH yielded the same statistically significant main and 
interaction effects, except for a non-significant effect of Time on SOL-f (F(70)=3.98, 
p=.023) (non-significant after Holm correction for multiple outcomes). 
 
Discussion 
 The results of this multi-center randomized controlled trial indicate that a 
cognitive therapy combined with graded activity training during a 12-week period 
reduces persistent PSF. Furthermore, beneficial effects remain stable at follow up 
and are not only found on two different measures of fatigue, but also on 
functional health status, symptoms of depression sleep and physical endurance. 
To our knowledge, this is the first study reporting significant reduction of PSF and 
related symptoms after a comprehensive treatment specifically tailored to the 
needs of this population. 
 Our results largely support the hypothesis that the addition of GRAT to 
cognitive therapy leads to a greater reduction of fatigue than when administering 
CO alone. Although at a group level both treatments resulted in almost similar 
benefits on the CIS-f, 58% of the COGRAT patients compared to 24% of the CO 
patients showed clinically relevant improvement at follow-up. In addition, as 
expected, physical endurance improved more after COGRAT than after CO alone. 
Directly after treatment, the increment in distance walked after COGRAT had 
almost reached the minimally important change of 70m.
207
 At follow-up, however, 
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this improvement had decreased to approximately 40m. This pattern of results 
suggests that (besides the physical benefits) improving physical endurance may 
help reduce PSF complaints. However, such an improvement is not a prerequisite 
for lasting beneficial effects of cognitive therapy on PSF.  
 The major strengths of this study are its multi-center design, the three-
month qualification period without any treatment, and the high level of treatment 
compliance and patient adherence. Although no independent rating of therapist 
adherence was performed, no conflicts of interest were present and all therapists 
had prior experience with scientific protocols. In addition, patients were generally 
satisfied with both treatments and the number of drop outs remained within 
acceptable limits.
209
 Moreover, four out of the 10 patients that did not complete 
their treatment withdrew for reasons unrelated to the intervention (figure 1), 
suggesting that both treatments were well tolerated.  
This study has, however, several limitations. The specific improvement in 
PSF due to COGRAT or CO cannot be teased out due to the absence of a sham 
control treatment. In addition, post-onset times in our study varied considerably, 
with five patients having suffered a stroke more than 10 years prior to enrollment. 
As we did not assess the full medical history of co-morbidities, we cannot 
attribute the presence of persistent fatigue solely to stroke in each patient. Yet, 
patients with a depression or severe cardiac or pulmonary disease were excluded. 
In addition, PSF has repeatedly been found to be a chronic condition with 
prevalence rates remaining relatively stable even years after stroke.
15, 45, 46, 58
 
Because no significant changes occurred in any of the outcome measures during 
the qualification period, the beneficial effects observed post treatment are most 
likely attributable to the intervention.   
Two sources of heterogeneity in our study sample may be considered 
limitations: stroke etiology and previous treatment. As we included not only first-
time infarctions, but also hemorrhages, SAH, and recurrent stroke, we cannot 
relate the observed treatment effects to any type of brain lesion. However, in our 
data, no influence of stroke type on treatment effects was found and, in the 
literature, prevalence rates of fatigue do not differ markedly between stroke 
types. 
20, 210
 Although more patients with SAH were allocated to the CO than to the 
COGRAT group (7 vs 2) and prognosis and complications after SAH differ from 
ischemic infarctions, the patients with SAH in this study did not differ from the 
other patients on any of the demographic characteristics or outcome measures at 
any point in time. The fact that the effect of Time ceased to be significant for SOL-
f when excluding patients with SAH is most likely due to a loss of power, since all 
other effects remained unaltered. The etiological heterogeneity can also be 
considered as a strength for it indicates the effectiveness of COGRAT in a large 
variety of patients, irrespective of etiology. The strict eligibility criteria with regard 
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to ambulation and cognition, however, limit the generalizability of the results to 
other patients.  
Patients also differed with regard to the amount and type of prior 
rehabilitation they had received. We were unable to post-hoc determine the 
nature and amount of fatigue relieving strategies offered in these treatments. 
Nevertheless, all patients still had severe fatigue complaints at study entry, and no 
significant changes were detected during the three-month qualification period. 
Future studies should also incorporate (severely) fatigued patients with 
more pronounced cognitive and/or physical sequelae of stroke. To this aim, the 
cognitive treatment might be modified by using a more directive approach and by 
involving the primary caregivers.  
 In conclusion, this is the first controlled study showing that cognitive 
therapy can alleviate persistent fatigue complaints after stroke. However, the 
best results are obtained when cognitive therapy is augmented with graded 
activity training. As fatigue is known to have a negative impact on functional 
independence and quality of life after stroke, lasting treatment effects on 
persistent PSF potentially have a major impact on rehabilitation outcome.  
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Chapter 7. Summary and General Discussion 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“There are three methods of gaining wisdom. The first is reflection, which is 
the highest. The second is limitation, which is the easiest. The third is 
experience, which is the bitterest. “ 
Confucius (551-479 BC) 
126 
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Post-stroke fatigue (PSF) is a common, chronic and debilitating complaint after 
stroke, experienced by 27% to 77% of the stroke survivors, even in patients 
showing good recovery. Prevalence rates of PSF show no marked decline even 
after years, and fatigue has been found to (negatively) influence quality of life, 
rehabilitation outcomes, functional independency, suicide rate and mortality. 
Although fatigue has captured growing attention in the past few years, often 
researchers and clinicians still neglect the subject. In addition, a uniform definition 
of PSF is still not embraced by everyone in the field and, until recently, there were 
little directives to guide therapy. This renders PSF a difficult and unattractive 
symptom to treat. Knowledge of the prevalence, etiology and associations with 
other impairments could therefore aid in adequate assessment and subsequent 
treatment of PSF. For this reason, the first part of this dissertation is devoted to 
these issues. To meet another general aim of this thesis, the second part of this 
dissertation deals with the management of PSF. Herein a comprehensive 
treatment of PSF and its subsequent evaluation are presented.  
 The current chapter starts with a Summary of the main findings of both 
parts of this thesis following the research questions posed at the end of chapter 1. 
Thereafter, in the General Discussion, the findings of the presented studies will be 
discussed and their most important limitations will be dealt with. In addition, first 
guidelines for clinicians and researchers faced with PSF will be given.     
 
7.1. Summary 
Section 1. The trouble with fatigue  
 In chapter 1 an overview of the current literature on PSF is presented. 
Even though it is evident that PSF is a frequently encountered problem after 
stroke, no standard or uniform definition of PSF exists. On the contrary, until now, 
17 different definitions have been reported. Even more fatigue assessment tools 
are in use, partly due to the absence of valid biological markers. Fatigue can have 
mental, emotional and/or physical dimensions. In general, it is assessed with self-
report measures that seem to assess different aspects of fatigue. This complicates 
the comparability of research results. Studies focusing on the experience of PSF 
show that it is a qualitatively different feeling when compared with pre-stroke 
fatigue; in particular that PSF is more persistent and severe.  
 To shed light on the etiology of PSF, many studies have investigated the 
associations of PSF with various pre-clinical, clinical, demographical and 
psychosocial variables. Of several pre-stroke variables, only pre-stroke fatigue has 
been found to be significantly related to PSF. No global stroke characteristics have 
consistently been related to PSF. Neither severity of stroke, nor stroke type or 
global stroke location correlates with PSF. However, there is some evidence for a 
higher prevalence of PSF after lesions of the basal ganglia. These brain areas are 
part of a central fatigue network proposed by Chaudhuri & Behan (2000 
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&2004).
68, 69
 Moreover, recent research on a possible hormonal origin points 
towards a role of cytokines and hypothalamic-pituitary-adrenal axis dysregulation 
in PSF. Amongst the investigated clinical variables, weak associations of PSF have 
been found with pain, whereas contradictory findings have been reported with 
regard to sleep disturbances and physical disability. The results of a majority of 
the investigations seem to depend, at least partly, on the applied assessment 
tools.   
 With regard to psychosocial variables, depressive symptoms have 
consistently been associated with PSF, although evidence for a dissociation 
between the two also exists. Studies on the relationship between PSF and other 
psychosocial variables are scarce. In studies using extensive neuropsychological 
test batteries, strong associations between cognitive dysfunctioning and fatigue 
have been found. These findings support the so-called “cognitive coping 
hypothesis” proposed by van Zomeren et al (1984).
103
 This hypothesis assumes 
that fatigue is primarily due to the additional cognitive effort invested by brain-
injured patients to compensate for their information processing deficits in order 
to meet the demands of daily life.  
 Chapter 1 concludes that PSF comprises cognitive, emotional and physical 
components. However, many aspects regarding its etiology, assessment and 
effective treatment are still unclear. Therefore, the following research questions 
were addressed in this dissertation.  
 
1: Is there a problem of underdiagnosis of PSF in the Netherlands? Do patients 
receive sufficient information about PSF in Dutch healthcare and is PSF related to 
personal or clinical characteristics?  
The notion that PSF is still a crudely assessed and undertreated symptom 
in the Netherlands can be deduced from the findings reported in chapter 2. 
Herein 538 stroke survivors filled in a web-based questionnaire. Questions were 
asked about the amount of information received about PSF, self-management and 
other treatment options, the need for treatment and the nature of the fatigue. 
The mean age of the respondents was 52 ± 11 years. On average, they reported to 
be in the chronic phase after stroke (mean post onset time: 2.7 ± 3.4 yrs). 
Respondents were generally well educated and 57% were still employed. Almost 
half (48%) of the participants reported to suffer from severe fatigue and 68% 
indicated that they experienced a great impact of fatigue on daily life. No 
associations of PSF with personal or clinical characteristics of the respondents 
were found. 
Although in this study some bias towards participants who had received 
insufficient information was expected, the results were nevertheless surprising. It 
was found that only 17% of the respondents had received sufficient information 
about PSF and only 7% had been informed about treatment options, whereas 56% 
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expressed a substantial need for treatment. As expected, this need for treatment 
was related to fatigue severity (r=.35) and to the impact of fatigue on daily life 
(r=.30). These findings are all the more striking, since the data suggested relatively 
well-preserved cognitive skills in the respondents. Most patients (81%) 
experienced no problems to complete the questionnaire within 10 minutes. 
Furthermore, employment status was not related to fatigue severity or 
information status, indicating that the respondents were capable to search for 
and understand information about PSF, but that this information was not 
available. 
   
2. Do patients with PSF have specific psychological or social characteristics? If so, 
could knowledge of these characteristics aid in the development of effective 
treatments? 
In chapter 3 a cross-sectional study is reported on the psychosocial make-
up of 88 chronic stroke patients suffering from severe PSF. In this study fatigue 
was assessed with the Checklist Individual Strength (CIS-20R) subscale fatigue 
(CIS-f) and the fatigue severity scale (FSS). Anxiety and depression were assessed 
with the Hamilton Anxiety and Depression Scale (HADS), psychological distress 
with the Symptom Checklist-90 (SCL-90), coping styles with the Coping Inventory 
for Stressful Situations (CISS), social support with the Social Support List (SSL) and 
self-efficacy with the Self Efficacy Scale (SES). The latter psychosocial variables 
were correlated with PSF and the average scores were subsequently compared to 
those of healthy controls and patient groups suffering from other chronic 
diseases.  
Different associations were found for the FSS and the CIS-f. The FSS was 
associated with the subscale Obsessive Compulsive of the SCL-90 (r=.36), 
indicating a relationship with cognitive complaints. In contrast, the CIS-f was 
found to be related to the subscales Somatic Complaints (r=.53) and Depression 
(r=.35) of the SCL-90. This latter association disappeared when entered in a 
multiple regression analysis, wherein only Somatic Complaints were related to the 
CIS-f scores. No other associations were found. Furthermore, PSF was not related 
to personality problems. When compared to healthy controls, it appeared that 
patients with PSF showed higher degrees of psychological distress (SCL-90 and 
HADS) and scored relatively low on the use of problem-focused coping styles. 
However, hardly any differences were found when the scores of patients with PSF 
were compared to the normative data of other chronic patients groups.  
Overall, these results challenge previous findings that emotion-oriented 
coping is the main determinant of PSF and that personality plays a significant role 
in PSF. Moreover, the results show that psychological factors cannot exhaustively 
explain the presence of fatigue after stroke.  
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3. How does the one-dimensional FSS psychometrically compare to the multi-
dimensional CIS20-R? To what extent do both commonly used fatigue scales assess 
the same construct?  
  In chapter 4 the psychometric properties and underlying constructs of the 
CIS20-R fatigue severity subscale (CIS-f) and the FSS were assessed. The FSS is the 
most frequently used questionnaire in PSF research, while the CIS-20R (and 
especially its CIS-f subscale) is the list of choice in fatigue studies conducted in the 
Benelux countries. Both lists were administered to 196 patients with stroke and 
112 age-matched controls. 
  The results showed that both scales had a high internal consistency 
(Cronbach’s α:  FSS = .893; CIS-f = .938), but that the convergent validity of both 
scales was moderate (r=.52). Furthermore, the first two items of the FSS 
decreased its internal consistency significantly and were unable to discriminate 
between stroke patients and healthy controls. Principal Axis Factoring analyses on 
all items revealed that 6 of the 8 items of the CIS-f loaded high on a factor that 
was named “subjective feelings of weakness and tiredness”, whereas the two 
remaining items loaded on “physical condition”. Eight of the 9 items of the FSS 
loaded on another factor referred to as “impact of fatigue on daily life”.  
  These results indicated that the CIS-f and the FSS assess different 
constructs. In accordance with previous psychometric studies on the FSS, it was 
concluded that the first two items of the original FSS should be skipped in stroke 
patients, retaining a FSS7, to assess fatigue impact. The FSS does not assess 
fatigue severity. With regard to the CIS-f, it was concluded that it not only 
addresses a physical fatigue dimension, but also the severity of a more general 
subjective experience of tiredness. 
 
Section 2. The management of fatigue 
 
4. What components should be part of a comprehensive treatment protocol for 
PSF, taking into account the emotional, cognitive and physical aspects of fatigue?  
Based on the positive findings of a pilot study evaluating the PSF-
treatment module “Dealing with Fatigue” at the Sint Maartenskliniek in 
Nijmegen,
10
 this treatment protocol was taken as a starting point and was 
adapted based on experiences (feedback) from patients and therapists. Notable 
changes were a more structural incorporation of cognitive behavioral therapy 
(CBT), a restriction of the treatment group size, and the addition of a graded 
activity protocol based on the recommendations for Stroke Survivors of the 
American Heart Association. Based on the experiences from the pilot study, the 
new treatment was given to small groups of four patients. The complete 
treatment protocol, called COGRAT (COGnitive and GRaded Activity Training), is 
presented in chapter 5. 
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In this protocol, the cognitive coping hypothesis was used as a starting 
point. The primary aim of the COGRAT treatment was to teach patients how to 
use energy more parsimoniously and how to deal with their limited cognitive 
resources. In order to accomplish this, patients were requested to register their 
activities hour by hour for two weeks. Every registration was accompanied by an 
estimation of its level of fatigue in order to obtain insight into the subject’s 
activity and fatigability patterns. Based on this information, three compensation 
strategies were proposed: alternation, planning and relaxation. First, patients 
were taught how to pace and alternate their activities with periods of rest or 
relaxation in order to avoid fatigue. Second, they were taught to plan their 
activities more effectively, taking into account the additional time needed to 
accomplish tasks, the time needed to switch from task to task and, above all, the 
time needed to recover from fatigue. Finally, patients were coached on how to 
relax, since many activities that used to be relaxing prior to their stroke had 
become fatiguing afterwards. 
 Because adopting these new behaviors was challenging for many 
patients, basic CBT components were structurally incorporated into the 
treatment. The goal of CBT was to replace ‘disabling thoughts’ (that might hinder 
the implementation of compensation strategies) by ‘enabling thoughts’. 
Furthermore, CBT was used to better cope with feelings of fatigue and the related 
psychological distress. By performing CBT-homework assignments, patients 
learned to generate rational and adaptive thoughts with the objective of better 
coping with the negative emotions related to their fatigue. Besides these fatigue-
specific treatment strategies, more general rehabilitation principles of psycho-
education, goal-setting and homework assignments constituted a substantial part 
of the cognitive treatment.  
The cognitive treatment was given once a week for two hours, whereas 
the graded activity training was given in parallel twice a week for two hours. The 
treatment lasted 12 weeks. During the graded activity training, patients followed 
an exercise scheme based on specific percentages of their maximum heart rate 
and maximal muscle strength. They were trained to improve their performance by 
walking on a treadmill with increasing inclination and by structured weight-lifting 
exercises.  
 
5. Is a comprehensive COGRAT treatment approach effective to reduce PSF in the 
chronic phase after stroke?  
Chapter 6 reports the evaluation of the COGRAT treatment compared to 
cognitive training alone (CO), by means of a randomized controlled clinical trial 
(RCT). This RCT was carried out in eight rehabilitation centers in the Netherlands. 
Patients were selected based on the following inclusion criteria: severe fatigue 
(CIS-f >40), able to walk 10 meters independently, no severe cognitive deficits, no 
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co-morbid depression, and no severe cardiac or pulmonary disease. According to 
these criteria, 88 out of 231 patients were found to be eligible and 83 finally 
participated in the study. Primary outcome measures of fatigue (CIS-f and Self 
Observation List-fatigue / SOL-f) and secondary outcome measures of depression, 
anxiety, functional health, pain, sleep disturbances and physical endurance were 
administered at four time points: (1) at the start of the study, (2) after a three-
months qualification period without any treatment, (3) after the completion of 
treatment, and (4) at 6-month follow-up. Randomization to either the CO or 
COGRAT treatment took place after the second assessment. The three-month 
qualification period without treatment was used to wash out any possible 
previous intervention effects and to assess whether patients could be considered 
‘stable’ in terms of fatigue.  
The results of this study showed that CO treatment alone was already 
effective in reducing experienced fatigue, but that more patients showed clinically 
significant levels of fatigue reduction after COGRAT treatment (24% vs. 58%, 
respectively). Since all patients were in the chronic phase after stroke (mean: 3.9 
years post-onset, ± 3.9) and suffered from severe fatigue at the start of the study, 
without any decline during the qualification period, it was concluded that 
persistent fatigue can be substantially alleviated with cognitive treatment. This 
cognitive treatment should preferably be given in combination with graded 
activity training. Benefits of both treatments on secondary outcome measures 
were found for depressive symptoms, functional health and sleep disturbances. 
No significant improvement was found for anxiety or pain. Physical endurance 
improved only after the COGRAT treatment.  
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7.2. General Discussion 
 In the summary several of the research questions have been briefly 
answered. In this paragraph, these answers will be discussed in depth. First the 
issues regarding the neglected status of fatigue and the possible characteristics of 
patients that could aid in assessment and treatment will be addressed. Herein, the 
cognitive coping hypothesis and the importance of a differential diagnosis of 
fatigue versus depression are extensively discussed, since they entail significant 
clinical implications. Next, in order to broaden the discussion regarding the 
assessment and treatment of PSF, some unpublished outcomes of the COGRAT 
study will be presented. This is followed by a discussion on the limitations of the 
studies reported in this thesis. Last, recommendations for clinical practice and 
research will be given.  
 
7.2.1 The trouble with PSF in clinical healthcare: professional neglect and lack of clear 
patient characteristics  
  
The results of the internet based study strongly suggest that patients with 
PSF, irrespective of personal or clinical characteristics, are underdiagnosed and ill-
informed in Dutch healthcare. These findings are congruent with the results of 
several qualitative studies, where patients reported having received only scant 
information on PSF and how to deal with it.
29-31
 It must be noted that these 
studies did not take patient characteristics into account. Remarkably, in a recent 
review on therapeutic patient education programs for stroke survivors, fatigue 
was not mentioned at all, neither as a symptom of interest nor as a theme within 
these programs.
211
 This underscores the notion of a severe lack of information 
and education affecting large groups of stroke patients. What is more, these 
findings do not seem to be limited to patients with stroke. A study of patients with 
Parkinson’s disease showed that in 50% of the consultations with neurologists, 
non-motor signs such as fatigue were not identified,
212
 again indicating that 
fatigue is often overlooked and undertreated in healthcare.  
  This professional neglect of fatigue as a cardinal symptom can in part be 
explained by the absence of a uniformly embraced definition of either fatigue in 
general or PSF specifically. This void has hindered research as phrased by 
Harrington (2012, p. 94):
48
 “Optimal would be a definition that allowed objective 
measures of the state, although we might be content at this point if we can simply 
agree on a definition allowing consistent self-report measures in human 
populations; unfortunately there is at this moment no agreement”. This has even 
led some authors to suggest that it is impossible to treat a condition that cannot 
be defined.
213
 Furthermore, research into valid biological markers that could aid in 
objective and agile assessment of PSF has so far not yielded clear or unambiguous 
results.
33, 39, 48
 
134 
 
 Another plausible reason for the neglected status of PSF in healthcare is 
the absence of a simple explanatory (etiological) model
20
 that could subsequently 
aid in the development of treatments. The studies in this dissertation (chapters 2, 
3 and 6) may not seem to be directly useful in contributing to this matter. 
Specifically, no associations between stroke-related, clinical or personal variables 
and PSF were found, except for cognitive and somatic complaints. With regard to 
clinical and stroke-related variables, the findings in this thesis are in line with 
many previous studies. 
14, 16, 18, 19, 46, 47, 49, 56, 58, 62, 80
 Somatic complaints have 
consistently been found to be related to fatigue, not only in stroke patients but 
also in patients with other chronic diseases.
51
 This might reflect both a physical 
dimension of fatigue as well as an emotional component, i.e. dealing with somatic 
consequences of the disease. Concerning associations with lesion site, it cannot 
be excluded that the lack of associations found in the literature and the studies in 
this thesis is due to limited sample size and the inability to obtain detailed 
information about lesion location. Since the corpus striatum is hypothesised to be 
part of a central fatigue network it would be recommendable to specifically 
identify lesions of this brain area in future studies.
68, 69
   
 
Cognitive coping hypothesis 
The cognitive coping hypothesis, instead of coupling fatigue to specific 
locations in the brain, tries to unravel the brain mechanisms leading to PSF. This 
hypothesis states that fatigue may arise as a result of the extra mental effort 
required from patients in tasks or demands of everyday life to compensate for 
their information processing deficits. The coping hypothesis was used as a 
cornerstone for the COGRAT-treatment. Fatigue is present with approximately the 
same frequency as information processing deficits across patients with different 
neurological disorders and it also seems to share similar mechanisms
102
. The 
association that was found between fatigue impact and cognitive complaints 
might also be seen in this light and is congruent with findings in other neurological 
patients. Studies of patients with traumatic brain injury (TBI) and Multiple 
Sclerosis (MS) have shown a solid relationship between attentional deficits, 
reaction time variability, mental effort and subjective fatigue.
36-38, 40, 174, 175
 
Furthermore, several imaging studies using working memory tasks have reported 
that patients with TBI show increased activation in comparison to healthy controls 
in several regions of the right hemisphere,
153, 154
 more dispersed activations,
153, 214
 
and altered functional networks.
176, 214, 215
 In MS patients also, altered activation 
patterns have been found, reflecting compensatory reorganization.
177, 216
 
Furthermore, studies in patients with Chronic Fatigue Syndrome (CFS) have 
provided evidence for a link between these altered activation patterns, the 
utilization of more extensive brain networks, and the experience of subjective 
fatigue.
217, 218
 Thus, cerebral reorganization and extra cerebral activation 
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undeniably reflect increased mental effort. This effort, exerted to compensate for 
less efficient, less accurate or slower information processing, might significantly 
contribute to PSF.
11, 176, 216
  
In line with this reasoning, Claros-Salinas et al (2010)
102
 studied the diurnal 
variations of fatigue (with a VAS-f scale), tonic attention (with reaction times 
(RTs)), divided attention and selective attention (with a GoNoGo task) in stroke 
patients, patients with MS, and in healthy controls. Measurements were 
performed three times a day on two consecutive days.
102
 The authors reported a 
higher diurnal increase in fatigue for stroke patients than for healthy controls. 
Moreover, performance on the tasks was not only worse in patients compared to 
controls (RTs and mistakes), but it also showed a diurnal decline across all tasks. 
This study has several implications. First, since the stroke group (and to a lesser 
extent the healthy controls) reported an increase in fatigue during the day, this 
effect seems to be non-specific. Second, patients performed more or less stably 
across various difficulty levels. The authors suggest that patients must have 
engaged compensatory strategies when performing the more difficult attentional 
tasks. This implies that there could be a clear gap between performance and 
competence in these patients. On the one hand they seem to be competent 
enough to accomplish the same attentional tasks as healthy controls, on the other 
hand their performance seems to imply a much greater energetic cost. Hence, 
diurnal increase in fatigue is more conspicuous. This is particularly evident in tasks 
where a speed-accuracy trade-off is possible or in short tasks where additional 
attentional resources can be recruited. Third, no differences were found between 
patients with MS and stroke with regard to task performance and fatigue. Hence, 
fatigue might be produced by similar mechanisms in both groups.
102
  
What is more, the cognitive coping hypothesis can be linked to the central 
fatigue hypothesis. After stroke, the basal ganglia can be directly affected. This in 
turn can lead to difficulties in executing tasks that require self-motivation, and a 
much higher perceived effort for task execution. Chaudhuri and Behan primarily 
present their hypothesis in association with dysfunctions of the basal ganglia.
68, 69
  
However, the overwhelming prevalence rates of PSF in patients with different 
lesions suggests that disruptions of other brain areas of the striato-thalamical-
frontal cortical system (or possibly the subcortical attentional network)
22
  might 
also lead to fatigue complaints. In addition, one cannot exclude that prolonged 
stress reactions such as in the case of depression or anxiety might negatively 
influence these brain networks through the dysregulation of the HPA-axis. This 
might in part explain the high concomitant occurrence of PSF, depressive 
symptoms and anxiety.  
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Personal factors and the necessity of a differential diagnosis with depression 
 Approximately half of the stroke population does not develop complaints 
of fatigue. Moreover, stroke-related and clinical characteristics do not seem to 
entirely explain PSF, while the role of subtle attentional deficits and compensatory 
mechanisms needs to be further clarified. Thus, psychological and social variables 
are generally believed to influence PSF.
18, 20, 23, 42, 46, 47, 80, 86, 95
 If clearly identified, 
these could aid in the development of a suitable treatment. However, in our 
studies no associations of fatigue with psychosocial factors were found and it was 
concluded that patients suffering from PSF do not differ from other chronic 
patient populations in this respect. This result can be explained in different ways.  
Patients with other chronic medical and psychiatric diseases also frequently suffer 
from fatigue
219
, suggesting that physical disease in itself might contribute to 
fatigue. Additionally, anxiety,
100
 depression
94
 and medical complications
7
 are 
common after stroke, possibly aggravating PSF. Conversely, inadequate coping 
styles and insufficient social support might also bring about psychological distress 
and fatigue. These precipitating factors apply to every chronic illness, but 
especially to patients with stroke who are confronted with the permanent 
consequences of their condition in everyday life when they return home from 
hospital or rehabilitation centre. This might be the reason why a minority of 
patients (10%) in the internet study reported the onset of their fatigue more than 
6 months after stroke, a stage in which these consequences become evident. 
Furthermore, psychological factors may be present to different degrees in 
individual patients, thus, it is not surprising that cross-sectional studies have 
found equivocal results. To be more specific, either too little or too much of one 
these psychological factors may increase the susceptibility to fatigue. For 
example, overachievement
12
 as well as boredom
41
 have been suggested as 
precipitating factors for fatigue. Thus, in clinical practice, it remains valuable to 
look at such personal characteristics. 
 One important point remains to be made. As a proper differential 
diagnosis of PSF versus post-stroke depression is not always made,
9, 12
 this might 
be another cause for the neglected status of PSF in healthcare. Several reasons 
can be invoked for this gap. First, there are several assessment issues. In the 
majority of studies on PSF only subjective questionnaires were used to determine 
the severity of depression. As a result, clinical depression was almost never 
assessed according to DSM IV
26
 criteria. Thus, there is a positive association of PSF 
with depressive mood, but not necessarily with a clinically assessed depression. 
Furthermore, the questionnaires used to assess these depressive symptoms often 
include fatigue items (e.g. Beck Depression Inventory, Geriatric Depression Scale, 
Hospital Anxiety and Depression Scale: HADS)
57
. On the other hand, some fatigue 
questionnaires contain items on motivation that can be influenced by mood (e.g. 
Short Form-vitality subscale, FSS).
57, 220
 Therefore, the associations found between 
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depressive complaints and PSF might be explained by the overlap inherent in the 
assessment tools used to measure both concepts. Last, the sequelae of stroke 
such as cognitive impairment, indifference, unawareness of illness (anosognosia), 
difficulty with emotional expression (e.g. aprosody), and emotional lability can be 
mistakenly interpreted as depressive symptoms,
221
 especially when using generic 
questionnaires,
222
 leading to artifact associations with fatigue.
9
  
Another necessity for the differential diagnosis of depression and fatigue 
stems from the clear distinction between the two syndromes. Dissociations 
between patients suffering from PSF and depressed mood have consistently been 
found.
14, 15, 46, 49, 57, 58, 98, 99
 Moreover, in studies excluding clinically depressed 
patients, prevalence rates of PSF were still high (16%-59%).
45, 66, 118, 223-225
 The 
presented studies corroborate this notion: 88 patients were identified that 
suffered from severe fatigue but did not meet the DSM-IV criteria for depression. 
Furthermore, it is known that selective serotonin reuptake inhibitors (SSRIs) have 
small benefits on mood, but barely affect PSF, as reported in a double blind 
placebo controlled RCT.
104
  
Last but not least, the relationship between PSF and mood is probably 
bidirectional
9
 and complex. Fatigue may precipitate feelings of depression 
because of its interference with mood, work and leisure activities on the one 
hand, whereas depressed individuals may experience fatigue as a symptom of 
their depression,
9, 27
 or when they have to put in extra effort to accomplish daily 
activities. In concordance with our findings, some studies examining the role of 
physical disease or somatic complaints have shown that the association between 
fatigue and depressive symptoms diminishes considerably or even disappears 
when somatic variables are taken into account.
15, 16
 
 Thus, although fatigue and depression frequently co-occur after stroke, 
there is no clear evidence for a causal relationship between them. Therefore, 
anecdotal reports of patients being prescribed SSRIs to treat fatigue lack empirical 
evidence. Moreover, a recent systematic review of 14 trials involving 1515 
patients with stroke did not reveal clear-cut effects of pharmacological 
interventions on the prevention of depression.
226
 Since several adverse side 
effects of antidepressants have been reported
221
 and SSRIs do not improve PSF,
104
 
caution against their use to treat PSF is warranted. 
 
 In sum, it seems that PSF is still neglected by many professionals in stroke 
rehabilitation. No clinical or demographical characteristics of patients suffering 
from PSF have been found to affect the support or help that they receive. 
Furthermore, no clear-cut psychological or social profile of PSF patients has as yet 
been identified. However, on an individual basis, depressive symptoms and 
anxiety can aggravate primary fatigue or may be direct causes of secondary 
fatigue, and should be treated accordingly. A careful differential diagnosis of PSF 
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versus depression is, however, essential to select the most appropriate treatment. 
The cognitive coping and the central fatigue hypotheses both offer plausible 
explanations for underlying mechanisms of PSF, corresponding with the subjective 
experience of patients. As such, they can be used to design theory-driven 
therapies.  
 
7.2.2. The experience and assessment of PSF: FSS, CIS20-R and beyond 
 As previously mentioned, in the absence of valid biological markers, the 
assessment of PSF is restricted to the self-report of experienced fatigue. Mental 
effort is difficult to measure without sophisticated tools, such as fMRI. This is 
probably the reason why objective assessment tools for fatigue in clinical practice 
have not yet been developed. On the other hand, the subjective experience of 
fatigue is the main reason why patients seek professional help. Therefore, it is 
sensible to assess, understand and treat subjective complaints of fatigue in clinical 
practice. With regard to the assessment of PSF, several considerations are 
relevant. 
 First, the experience of fatigue can differ greatly between patients. As 
found in the internet study, 57% of the participants experienced both physical and 
mental fatigue, whereas about 20% experienced either physical or mental fatigue. 
These findings are congruent with those of Barbour and Mead (2012)
41
, who 
reported that some patients described their fatigue solely as “a tiredness in the 
muscles”, “a general feeling of tiredness”, or “mental tiredness”, whereas others 
reported that their fatigue was best described by more than one of these 
characterizations. Furthermore, in two studies with stroke patients completing 
modified versions of fatigue scales developed for MS, it was suggested that both 
physical and cognitive fatigue were components of PSF.
224, 227
 Hence, a definition 
of PSF and its derived assessment tools need to incorporate aspects of both 
physical and mental fatigue. Neither previous studies nor the studies reported in 
this thesis investigated the emotional aspects of fatigue as a separate entity. 
Therefore, this remains a subject for further research. 
 Different fatigue scales assess different components of fatigue.
28, 51
 In the 
presented studies, emphasis was placed on the well-known and commonly used 
FSS and CIS20-R. These scales assess different constructs, with moderate mutual 
correlations. This was congruent with the study on psychosocial characteristics, 
where both instruments correlated with qualitatively distinct variables. 
Furthermore, in the internet study, the correlations between the FSS7 and visual 
numerical scales assessing fatigue severity was only moderate (r=.39). This 
underscores the conclusion that the FSS assesses “the impact of fatigue” on daily 
functioning, as the developers stated in the original paper.
54
 However, in the 
current literature the FSS is often used as a tool for measuring fatigue severity. To 
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complicate matters even further, different cut-off scores for PSF have been 
applied: 4,
35, 46, 57, 58, 65, 66, 80, 83, 117, 118, 123
 5
16, 51, 82
 or even 5.2.
91
  
 A further issue related to the FSS concerns its limited sensitivity to 
change. Only in a few studies clinical change was detected with the FSS in non-
stroke patients, including small samples of patients with MS and Lyme disease 
described in the original paper.
54, 228
 In contrast, in later clinical trials using the FSS 
in addition to other fatigue measures, significant changes were found with the 
other assessment tools, but not with the FSS.
224, 228
 This is in agreement with the 
findings of the intervention study reported in chapter 6. Although the FSS-data of 
the RCT were not reported in this chapter, every patient was assessed at all time- 
points with this questionnaire. No significant changes on the FSS (or on the FSS7) 
were found between the different time points (prior to treatment T0: M=5.2 ± 
.99; after qualification period T1: M=5.3 ± .95; after intervention T2: M=5.0 ± 1.0; 
at follow-up T3: M=5.0 ± 1.2; p>.05). However, considering the low 
responsiveness of the FSS,
224, 228, 229
 it is questionable whether the conclusion that 
fatigue impact did not improve after the intervention would be justified, 
particularly given the finding that many other measures of fatigue and activity 
improved.  
 In contrast, the CIS-20R
52, 53
 and its CIS-f subscale have a well-established 
quality of responsiveness in different diseases, such as cancer, chronic fatigue 
syndrome and arthritis.
52, 229
 Moreover, the CIS-20R consists of several subscales 
that assess different domains, such as the CIS-fatigue and the CIS-concentration 
subscales. A closer look at item-level, however, reveals a less solid subscale 
structure, which also bears an inherent risk. For instance, the fatigue severity 
subscale contains specific ‘physical’ items. As patients suffering from severe and 
predominantly mental fatigue may score low on these items, these scores might 
not reach the detection threshold and, subsequently, the severity of their fatigue 
may be underestimated. The CIS-concentration seems to consist of items referring 
to both attentional problems as well as mental fatigability. This needs to be 
further investigated.  
  Both the FSS and the CIS20-R include questions about the experience of 
fatigue during the last week(s) and, thus, do not capture diurnal variations. For 
this diurnal variation aspect, the Self-Observation-fatigue (SOL-f) scale was used in 
the treatment study. Patients were asked to complete this scale at four fixed 
times per day during seven consecutive days. This scale is time consuming and 
cognitively demanding, which are major drawbacks. However, to gain qualitative 
insight into individual patterns of fatigability, it is still useful to apply the SOL-f to 
skilful and compliant patients. So far, however, it has not been validated for 
stroke patients, nor does it have published and reliable norm scores. 
  None of the previously mentioned questionnaires has specifically been 
developed for stroke patients, and the above discussed problems might be related 
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to this issue. Three recently developed stroke specific tools seem to be promising 
in this regard. These are the Dutch Multidimensional Fatigue Scale (DMFS),
230
 the 
Fatigue Scale for Motor and Cognitive Functions (FSMC),
231
 and the Neurological 
Fatigue Index for Stroke (NFI-Stroke).
227
 The latter two were originally developed 
for MS patients and were adapted for stroke patients by analysing the validity of 
the individual items and, subsequently, eliminating the invalid ones. Both the NFI-
Stroke as well as the FSMC have a cognitive as well as a physical subscale. A study 
on the FSMC in stroke patients showed that the cognitive tasks (such as verbal 
short-term memory, working memory, mental speed and flexibility) were 
predominantly related to cognitive fatigue.
224
 The items of the DMFS have been 
generated from in-depth interviews with a group of stroke patients. The scale is, 
thus, specifically tailored to the stroke population.
230
 The psychometric properties 
and usability of the DMFS are currently being investigated.
230
 In addition, as 
outcome tools, the sensitivity to change of all the three above-mentioned scales 
needs to be investigated.  
 
7.2.3. The treatment of PSF, is it possible to reduce fatigue after stroke? 
 In chapter 6 the evaluation of the COGRAT treatment has been reported. 
Since fatigue diminished significantly as measured by two different assessment 
tools, it was concluded that it is possible to reduce PSF by a comprehensive 
treatment. In post-hoc analyses (not described in chapter 6) significant, moderate 
to large time effects (but no interaction effects) were found for the other 
subscales of the CIS-20R, which further substantiates the efficacy of COGRAT with 
regard to fatigue (ANOVA on intention-to- treat basis: CIS-concentration 
F(2,78)=12.2, p<.001, η
2
=.24; CIS-motivation F(2,78) =20.2,p<.001, η
2
=.34; CIS-activity 
F(2,76)=10.8, p<.001, η
2
=.22). In contrast, no positive effects were found on 
cognitive tests of attention (Sustained Attention Test and Attention Network Task) 
or memory (Rivermead Behavioural Memory Task and California Verbal Learning 
Task). This latter finding is not surprising, since COGRAT did not focus on the 
improvement of cognitive functions and the participants were all in the chronic 
phase of stroke. In this stage (spontaneous) improvements in cognitive functions 
may no longer be expected. Yet, in line with the cognitive coping hypothesis, it 
can be expected that patients have become less fatigable, because they learned 
how to handle the challenges of daily life with less mental effort.   
 Additional analyses were performed to tease out the effects of 
medication on PSF. Medication included pharmacological agents for cardiac 
diseases (51.8%), antihypertensive medication (66.3%), non-steroid anti-
inflammatory drugs (NSAIDs) (27.7%), antiepileptic medication (4.8%), 
antidepressants (14.5%), sleep medication (9.6%), and cholesterol reducing agents 
(60.2%). These pharmaceuticals were frequently prescribed with a mean number 
of 2.7 (± 1.5) drugs per patient.  This quantity did not differ between patients with 
a stroke post-onset time of more than  5 years and those with an onset time of 
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less than 5 years (all p>.05). This suggests a relatively stable distribution of 
medical co-morbidities over time. Besides, neither the amount of medication 
used, nor the use of specific drugs predicted treatment outcome.  
Furthermore, none of the other variables assessed predicted treatment 
outcome. Neither demographic variables nor etiology of stroke, stroke post-onset 
time, cognitive performance or psychological variables predicted levels of fatigue 
reduction. This finding has considerable clinical implications. It means that 
COGRAT can be offered with success to a wide range of chronic stroke patients 
suffering from severe PSF. Nevertheless, several questions remain unanswered. 
Of all the patients who received the COGRAT intervention, 58% improved 
substantially, 29% improved slightly (but this improvement did not reach clinically 
significant levels), and 13% showed no decline on the CIS-f scale. Thus, not all 
patients benefited equally from the treatment, which is not a new finding. 
Successful treatments in other populations with fatigue complaints have also 
yielded mixed results. 
232, 233
 Further research is needed to understand which 
variables determine therapeutic success and to find ways to help treatment-
resilient patients.  
 Another related question concerns the content of the cognitive 
treatment protocol. Several treatment elements such as psycho-education on PSF, 
sleep hygiene, goal-setting, CBT, and the three behavioral compensation 
strategies were incorporated. Some therapy ingredients might have been more 
effective than others, whereas on the other hand the combination of therapeutic 
elements might have resulted in the observed benefits. It is also possible that for 
patients suffering from predominantly mental fatigue, the compensation 
strategies were most helpful, whereas physical fatigue was better treated with 
GRaded Activity Training (GRAT) and emotional fatigue by CBT. Due to the study 
design, it was impossible to disentangle the influence of each treatment 
component. Future research should, therefore, be focused on the specific 
treatment elements or various combinations of treatment elements as used in the 
CO(GRAT) protocol.   
  More patients improved to clinically significant levels after the COGRAT 
intervention compared to the CO intervention alone, which may imply that the 
addition of graded activity training is responsible for this differential effect. 
Although physical endurance has not been found to be associated with PSF,
34
 
patients indicated that exercise alleviated their fatigue.
41
 In addition, graded 
exercise has been found to effectively alleviate fatigue in other medical conditions 
associated with fatigue.
71, 126, 181, 234
 It is well known that cardiovascular condition 
in stroke patients is generally poor
117, 235
 and that physical deconditioning, caused 
by a lack of physical exercise, may exacerbate fatigue.
34
 In this perspective, graded 
activity training can be a safe treatment to counteract this deconditioning, 
thereby reducing fatigue. Because physical exercise has been found to have a 
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small but helpful effect in the treatment of depression,
236
 it has been suggested 
that it might also have positive effects on the neuroendocrine system and 
eventually on the regulation of the HPA-axis.
237
 Exercise might, therefore, prove 
to be effective in patients who have been submitted to prolonged psychological 
distress. Finally, the inclusion of graded activity into general rehabilitation practice 
seems to have a preventive effect on the recurrence of stroke and on the 
occurrence of secondary diseases.
184, 185
 A wider implementation of programs 
promoting physical activity after stroke is, thus, recommended.  
 
7.2.4 Study limitations  
  Despite promising results, the studies reported in this thesis have several 
limitations. Except for the intervention study (chapter 6), all studies used a cross-
sectional design. Therefore, no directions could be established for the observed 
associations, which would have required the use of a longitudinal study design. 
Second, in the internet study (chapter 2), it is likely that a bias occurred in favor of 
individuals suffering from fatigue, actively searching for information. This might 
have led to overestimation of the observed lack of information and attention with 
regard to their fatigue. As for the studies on the psychosocial profile of PSF 
patients (chapter 3) and the evaluation of the (CO)GRAT treatment (chapter 6), 
patients were specifically selected for participation in a rehabilitation intervention 
aimed at reducing fatigue, while those with a clinical depression were excluded. 
Therefore, the results of these studies can only be generalized to patients with 
relatively good outcome and a clear motivation for treatment. On the other hand, 
this careful patient selection allowed the investigation of the relationship 
between psychosocial variables and PSF without confounding by depression or 
severe cognitive impairment. In all reported studies, stroke patients were 
included regardless of etiology and stroke post- onset time, which suggests that 
the results are applicable to multiple types of stroke patients in various phases. 
This can be considered a major strength, since a more homogeneous inclusion 
would have substantially reduced the generalizability of the results as well as the 
feasibility of the study, often-serious problems in clinical trials. Our strategy of 
patient selection is (post-hoc) corroborated by the results that indicate that stroke 
location and post-stroke interval were not associated with the outcome of the 
(CO)GRAT intervention.   
  Another limitation is related to the use of self-report measures of fatigue, 
psychological variables, somatic complaints and sleep disturbances. These self-
report measures may be biased in several respects; retrospective bias, response 
bias, social desirability and neurological influences may have limited the validity of 
the findings. As for depression, although clinical interviews were used to exclude 
clinically depressed patients, the severity of depressive symptoms was assessed 
merely by two self-report measures (and not by psychiatric examination). With 
regard to the assessment of fatigue, unfortunately, there was no golden standard 
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to validate our results with. The CIS-f scale was used as one of the primary 
outcome measures in the RCT (chapter 6). This scale emphasizes several physical 
aspects of fatigue. Therefore, it cannot be excluded that the additional benefit 
found for GRAT (in terms of number of patients with a clinically relevant 
improvement on this scale) might have been due to a reduction of these ‘physical’ 
aspects of fatigue. In future studies a more differentiated fatigue scale including 
subscales of mental, physical and emotional fatigue should be used to shed more 
light on the specificity of treatment effects.  
   From a design point-of-view, it would have been preferable to also 
include a sham treatment as a control condition in the intervention study (chapter 
6) as well as a treatment condition including GRAT alone. In the absence of a 
sham condition (‘placebo’) it is not possible to control for the influence of 
aspecific (e.g. Hawthorne) effects. The addition of a GRAT arm would have given 
information about whether and to what extent GRAT alone would also have been 
effective. However, using a similar RCT design, this would have implicated that at 
least an additional 80 patients had to be included in the intervention study, which 
was not feasible within the constraints of this PhD project. Nevertheless, we 
conducted the first controlled intervention study for post-stroke fatigue, showing 
that COGRAT is effective, thereby paving the way for future (replication) studies.  
  A possible source of allocation bias in the RCT was that patients who were 
allocated to either the CO or COGRAT intervention had significantly different 
levels of fatigue at baseline, despite randomization. The larger decrement in 
fatigue found in the COGRAT group might, therefore, be (partly) due to a 
‘regression-to-the-mean’ effect. Controlling for this discrepancy was not possible 
since the interaction between group and the covariates was significant for all 
outcome measurements, indicating nonparallel regression. However, both groups 
showed stable scores on all primary and secondary outcomes during the three-
month qualification period prior to randomization, which makes this explanation 
highly unlikely.    
  It may be argued that for some the patients included in the RCT the 
relation of their fatigue with stroke is doubtful, since their strokes had occurred 
more than 5 to 10 years before.
213
 Yet, it has repeatedly been found that PSF 
shows relatively stable levels of severity, even years after stroke.
15, 45-47, 58, 64, 83, 90
 
In addition, with the coping hypothesis in mind, it can be understood that patients 
who never learned how to cope with limited energy levels may experience severe 
chronic fatigue for many years, even life-long. A different argument underscoring 
that all patients suffered from PSF, regardless of the time since stroke onset, was 
that patients with co-morbid diseases were excluded. In addition, as shown in 
chapter 3, the selected stroke patients had a psychosocial profile comparable to 
patient groups with other chronic diseases, which makes it unlikely that co-
morbidities were responsible for the causation of chronic fatigue. 
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7.2.5 Clinical recommendations  
 A main aim of this dissertation was to provide clinicians and with specific 
guidelines for dealing with patients with PSF. Therefore, recommendations for a 
stepped care approach will be given here.  
 
Recognition and assessment 
  Adequate recognition and assessment of PSF is direly needed in 
healthcare. A first step in this recognition is the acknowledgement that PSF is a 
highly prevalent condition requiring medical attention.
7
 Second, PSF is not the 
same as depression or sleepiness and it generally does not respond to 
antidepressants
104
 or wakefulness promoting agents.
107
 Third, patients’ 
experiences of PSF may vary considerably; some experience it as ‘physical’, 
whereas others suffer mainly from ‘mental’ fatigue. In addition, ‘emotional’ 
components of fatigue are important as well. It is, thus, important to interview 
patients about all these dimensions of fatigue. Because some individuals develop 
PSF more than 6 months after stroke while others show improvement towards 
subclinical levels of fatigue within the first year, it is recommended to reassess 
fatigue approximately every three months in the first year after stroke. Caregivers 
can aid in the detection, especially when the patient’s cognitive skills are 
inadequate. For patients who are unable to communicate about their fatigue, 
caregivers or hospital staff may also look at secondary behavioral aspects of 
fatigue such as falling asleep, squinting, agitation, anger outburst or excessive 
crying. 
 
Psycho-education and cognitive treatment 
  After appropriate recognition and assessment, the next step is to further 
provide patients with information about PSF. Informing patients that PSF is a 
distinct consequence of stroke is a first element of psycho-education.
211
 Patients 
hereby receive validation from a (medical) professional, which facilitates the 
acceptance of the condition.
30, 31
 Since slow information processing, attentional 
and memory problems are common in stroke patients, it is recommended to 
provide the necessary information not only verbally, but also through leaflets or 
information booklets. Patients and their caregivers can read these materials at 
their own pace. An example is the booklet “Fatigue” (Zorgwijzer Vermoeidheid)
238
 
that has been issued in 2010 by the Dutch Brain Foundation (Hersenstichting 
Nederland). This information, together with information on where to find more 
advice and help, should be made available to patients shortly after their stroke, 
since many of them will experience PSF at a certain point in time. The provision of 
information on the possible treatment of PSF is an important aspect of managing 
patient expectations and hope. 
  It has repeatedly been proposed that, in order to help stroke patients to 
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really understand all relevant aspects of PSF, it is important to design tailored 
educational programs.
42, 46
 Education and treatment programs can be entirely 
focused on PSF. In designing educational programs for patients with PSF, it is 
recommended to use professionally coached small group interventions whenever 
possible. Groups foster mutual support and social learning. They reduce isolation 
and stimulate recognition of problems by sharing experiences. They also promote 
reduction of fatigue by reinforcing positive change.
239
 Groups should preferably 
consist of four to five patients. The pilot study of COGRAT conducted by Knoop et 
al
10
 indicated that in larger groups overstimulation in combination with 
attentional problems hamper optimal participation. It is further important to 
judge whether patients are able to participate in a group at all, and to form 
groups that are reasonably homogeneous with respect to age, cognitive and 
learning abilities. Patients with severe executive problems, verbal disinhibition, 
and lack of awareness or anger outbursts are better off with individual psycho 
education.   
  Alternatively, educational programs can also be part of an integrated 
rehabilitation program in which other sequelae of stroke are treated as well. 
Teaching patients how to pause effectively and to intersperse activity with rest 
moments is an example that can be helpful to manage various symptoms, such as 
physical disabilities, speech problems, memory deficits, and impulsivity. 
Depending on stroke severity, the individual need for treatment and the timing of 
treatment, specific (fatigue) programs can be provided either as primary or as an 
adjunct treatment. When patients are still in the sub-acute phase of 
rehabilitation, treatment of fatigue may already be provided by occupational 
therapists as an adjunct therapy by focusing on how to plan and efficiently 
perform daily activities. Another option for patients in the sub-acute phase is the 
treatment module “Stop running, Start planning” (“Niet rennen, maar 
plannen”)
240
. This includes PSF-related information and several compensation 
strategies adapted from the COGRAT protocol.  
  In the chronic phase, patients with PSF can either enter a COGRAT 
treatment or an adjusted treatment when needed, for instance when they exhibit 
co-morbid cognitive deficits. So far, cognitive behavioral techniques have been 
recommended in rehabilitation
156, 241
 and have been found to be effective in other 
patient groups suffering from fatigue.
233, 242
 Thus, for patients with severe 
cognitive impairments, psycho-education and compensation strategies can easily 
be modified by using a more behavioral and directive approach and by including 
support from the primary care system. Tips and tricks derived from the 
compensation strategies can be offered and carried out. In the COGRAT protocol, 
achievable weekly homework assignments are given. These assignments concern 
both the pursuit of individual goals as well as the application of compensation 
strategies. Working on these assignments at home helps to incorporate the new 
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strategies in daily life and, thus, helps to achieve the patients’ goals. It thereby 
increases the effectiveness and generalizability of the treatment. Thus, principles 
derived from the cognitive coping hypothesis, goal setting and behavioral therapy 
can also be applied to the more severely affected patients. 
 
Caring for outpatients 
As yet, COGRAT has been implemented in several rehabilitation centers in 
the Netherlands, but it is not available for all stroke patients. The patients who 
participated in the study and the majority of the patients who now receive 
COGRAT are outpatients in the chronic phase after stroke who are referred to a 
rehabilitation centre specifically for PSF or for general cognitive rehabilitation. 
Many victims of stroke, especially those with minor cognitive or physical sequelae, 
are discharged home from the hospital and become ‘outpatients’ from the very 
beginning. They are not automatically and closely monitored and thus not always 
referred for further rehabilitation. Even with minor levels of impairment, many of 
these patients will face great difficulties in returning to their previous levels of 
activity and participation. The future development of web-based educational and 
treatment programs, holds a promise in terms of accessibility and cost-
effectiveness for these outpatients. As the study on psychosocial characteristics 
(chapter 3) showed, even patients with severe PSF do not necessarily have a 
particularly difficult psychological make-up. Hence, extensive psychotherapeutical 
support for stroke patients is often superfluous, and thus online support may 
suffice. 
 Although web-based programs have not yet been developed for stroke 
patients, attempts have been made in other neurological patient groups. 
Recently, a study on the effects of online information and self-management for 
patients with MS, post-polio syndrome and Parkinson’s disease has shown a small, 
but significant decrease in fatigue impact in the participating patients.
243
 
Unfortunately, general well-being did not improve, nor did self-efficacy. However, 
further studies that develop and evaluate similar web-based programs for large 
groups of patients are expected in the near future. As the present programs have 
been designed for patients with progressive neurological disorders, specific 
adaptations for patients with acquired brain injury (e.g. stroke) will have to be 
made.  
 
   
147 
 
 
-  Chapter 7. Summary and Discussion  -    
In conclusion, I would like to convey a message of genuine hope to patients with 
stroke. Even though PSF is a chronic and debilitating symptom affecting almost all 
areas of life, it can be treated with success in many of them. Furthermore, interest 
in PSF has recently been growing and the number of studies on PSF is increasing. 
With this development, a better understanding of the etiology and the 
multifaceted nature of PSF can be expected. Such knowledge will lead to more 
effective treatments and to more patients that will receive the actual help they 
need.     
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 Ernstige vermoeidheid na een Cerebrovasculair Accident (CVA), oftewel 
Post-Stroke Fatigue (PSF) is een veel voorkomende, chronische en invaliderende 
klacht, die door 27% tot 77% van de CVA patiënten wordt ervaren. Dit is zelfs het 
geval bij patiënten die verder goed herstellen. Het voorkomen  van PSF vertoont 
zelfs jaren na het CVA, geen duidelijke afname .  Daarnaast is er een (negatieve) 
invloed van PSF gevonden op de kwaliteit van leven, de uitkomsten van de  
revalidatie, de mate van onafhankelijk  functioneren, suïcidaliteit en zelfs 
mortaliteit. Hoewel er in de afgelopen jaren meer aandacht voor vermoeidheid na 
een CVA is gekomen, wordt het onderwerp door veel onderzoekers en clinici nog 
steeds onderschat.  Dit tekort aan onderkenning wordt versterkt door het 
ontbreken van een algemeen geaccepteerde en uniforme definitie van PSF en 
door het gemis aan   richtlijnen voor behandeling. Deze knelpunten  zorgen ervoor 
dat PSF een moeilijke en ook weinig aantrekkelijke klacht is om te behandelen. 
Kennis van de prevalentie, etiologie en associaties met andere stoornissen kan 
daarom helpen bij een adequate diagnose en een eventuele  behandeling van PSF. 
Deze onderwerpen worden in het eerste deel van dit proefschrift behandeld. Het 
tweede gedeelte vervolgens gaat in op de behandeling van PSF en de evaluatie 
hiervan.  
Deel 1. Het probleem  vermoeidheid na een CVA 
 In hoofdstuk 1 wordt een overzicht gegeven van de huidige 
wetenschappelijke literatuur over Post-Stroke Fatigue (PSF), oftewel 
vermoeidheid na een CVA. Ook al is het duidelijk dat PSF een vaak voorkomende 
klacht na een CVA is,  wordt er nog steeds geen uniforme definitie van 
gehanteerd. Er zijn op dit moment  17 verschillende definities in omloop. Door het 
ontbreken van valide biologische markers is het aantal vragenlijsten dat PSF 
pretendeert te meten zelfs nog groter. Vermoeidheid kan cognitieve, emotionele 
en/of fysieke aspecten en uitingsvormen hebben. Over het algemeen wordt 
vermoeidheid gemeten met vragenlijsten die door patiënten zelf worden 
ingevuld. Deze lijsten lijken verschillende aspecten van vermoeidheid te meten. 
Deze verscheidenheid bemoeilijkt in ernstige mate de vergelijkbaarheid van 
onderzoeksresultaten van studies waarin verschillende vragenlijsten  gebruikt zijn. 
Studies gericht op de persoonlijke ervaring van PSF laten zien dat deze vorm van 
vermoeidheid kwalitatief anders is dan de vermoeidheid die ervaren werd voor 
het CVA. De vermoeidheid na het CVA wordt met name als langer durend en 
ernstiger   geduid.  
Om duidelijkheid te krijgen over de etiologie van PSF, is in  veel  studies de 
associatie met verschillende preklinische, klinische, demografische en 
psychosociale variabelen onderzocht. Van alle premorbide variabelen , is alleen de 
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preklinische vermoeidheid significant gerelateerd aan PSF.  Globale CVA-
kenmerken laten geen consequente relaties zien met PSF. Noch de ernst van het 
CVA, noch het type beroerte, noch de globale lokalisatie  zijn significant met PSF  
gecorreleerd .  Niettemin is er enig bewijs voor een hogere prevalentie van PSF na 
laesies van de basale ganglia. Deze hersengebieden zijn onderdeel van een 
centraal vermoeidheid netwerk (Chaudhuri & Behan 2000,  2004). Ook  zouden 
volgens recent onderzoeken hormonale dysfuncties  zoals een verhoogd cytokine-
niveau of een ontregeling van de hypothalamus-hypofyse-bijnier-as een rol 
kunnen spelen in de ontwikkeling of het in stand houden van PSF. Met betrekking 
tot klinische variabelen zijn er zwakke associaties gevonden tussen PSF en pijn , 
terwijl er tegenstrijdige resultaten beschreven zijn omtrent de relatie van PSF met 
fysieke handicaps en slaapstoornissen . De resultaten van de meeste onderzoeken 
lijken deels te zijn  beïnvloedt  door de gebruikte meetinstrumenten.  
 Wat de psychosociale variabelen betreft zijn depressieve symptomen vrij 
consistent geassocieerd met PSF, hoewel er ook bewijs voor een dissociatie 
tussen beide bestaat. Studies over de relatie tussen PSF en andere psychosociale 
variabelen zijn schaars. In studies waar uitgebreide neuropsychologische 
testbatterijen zijn gebruikt, zijn er sterke associaties tussen cognitief 
disfunctioneren en vermoeidheid gevonden. Deze bevindingen ondersteunen de 
zogenaamde "cognitieve coping-hypothese" van Van Zomeren et al. (1984). Deze 
hypothese gaat ervan uit dat vermoeidheid vooral veroorzaakt wordt door de 
extra cognitieve inspanning die patiënten met hersenletsel moeten leveren om te 
compenseren voor hun informatieverwerkingstekorten om zodoende aan de 
eisen van het dagelijks leven te voldoen. 
In Hoofdstuk 1 van dit proefschrift wordt geconcludeerd  dat PSF bestaat 
uit cognitieve, emotionele en fysieke componenten.  Andere aspecten van PSF, 
zoals  etiologie, meetbaarheid en effectieve behandelmethoden  zijn echter nog 
steeds onduidelijk. Daarom werden de volgende onderzoeksvragen in dit 
proefschrift gesteld . 
 
1: Wordt PSF te weinig  gediagnostiseerd in Nederland? Krijgen patiënten 
voldoende informatie over PSF in de Nederlandse gezondheidszorg en is er een 
relatie tussen PSF en persoonlijke of klinische variabelen?  
Het idee dat in Nederland PSF nog steeds onvoldoende wordt 
gediagnostiseerd en behandeld kan worden afgeleid uit de bevindingen van  
hoofdstuk 2. In de studie die in dit hoofdstuk wordt beschreven  vulden 538 CVA 
patiënten een vragenlijst op het internet in.  Deze vragenlijst bevatte vragen over 
de hoeveelheid informatie die zij hadden ontvangen omtrent PSF, de hoeveelheid 
handvatten om zelf met  vermoeidheid om te gaan na het CVA, of ze een 
behandeling gericht op  vermoeidheid hadden gekregen,  of ze behoefte hadden 
aan een dergelijke behandeling, en de aard van hun ervaren vermoeidheid. De 
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gemiddelde leeftijd van de respondenten was 52 ± 11 jaar. Gemiddeld bevonden 
zij zich in de chronische fase na het CVA (gemiddeld post-CVA aanvangstijd: 2.7 ± 
3.4 jaar). De respondenten waren over het algemeen goed opgeleid en 57% was 
nog werkzaam. Bijna de helft (48%) van de deelnemers gaf aan met ernstige 
vermoeidheidsklachten te kampen en 68% gaf aan een grote impact van 
vermoeidheid op dagelijkse leven te ervaren. Er werden geen associaties tussen 
PSF en persoonlijk of klinische variabelen gevonden.  
Hoewel in deze studie een bias werd verwacht met betrekking tot  de 
(geringe) hoeveelheid informatie die patiënten omtrent PSF hadden ontvangen, 
waren de resultaten toch verrassend. Zo  bleek dat slechts 17% van de 
respondenten voldoende informatie over PSF had ontvangen en dat alleen  7% 
was ingelicht over  behandelmogelijkheden, terwijl 56% aangaf een aanzienlijke 
behoefte aan behandeling te hebben. Zoals verwacht was deze behoefte aan 
behandeling gerelateerd aan de ernst van de  vermoeidheid (r = 0,35) als ook aan 
de impact van vermoeidheid op het dagelijks leven (r = 0,30). Deze bevindingen 
zijn des te opmerkelijker, omdat de resultaten  impliceren dat de cognitieve 
vaardigheden van de respondenten relatief  intact waren  na het CVA. De meeste 
patiënten (81%) ondervonden geen problemen om de vragenlijst binnen 10 
minuten te voltooien. Bovendien was het wel of niet  werkzaam zijn niet 
gerelateerd aan vermoeidheid of aan de hoeveelheid informatie die de 
respondenten  over PSF hadden ontvangen. Dit resultaat onderstreept  dat de 
respondenten wel in staat waren om naar informatie te zoeken en deze te 
begrijpen, maar dat deze informatie niet beschikbaar was.  
   
2. Hebben patiënten met PSF hebben specifieke psychologische of sociale 
kenmerken? Zo ja, kan kennis van deze kenmerken helpen bij de ontwikkeling van 
doeltreffende behandelingen? 
hoofdstuk 3 worden de psychosociale kenmerken van 88 CVA chronische 
CVA patiënten met ernstige PSF onderzocht. In deze studie is  vermoeidheid 
gemeten met zowel de Checklist Individual Strength (CIS-20R) subschaal 
vermoeidheid (CIS-f) als met  de Fatigue Severity Scale (FSS). Angst en depressie 
werden vastgesteld aan de hand van  de Hamilton Anxiety and Depression Scale, 
psychische distress met de Symptom Checklist-90 (SCL-90), copingsstijl met de 
Coping Inventory for Stressfull Situations (CISS), sociale steun met de Social 
Support List (SSL) en self-efficacy met de Self Efficacy Scale (SES). Deze  
psychosociale variabelen werden gecorreleerd met PSF en de gemiddelde scores 
werden vervolgens vergeleken met die van gezonde controles en 
patiëntengroepen met andere chronische ziekten. 
De FSS en de CIS-f waren  niet gecorreleerd met dezelfde psychosociale 
kenmerken. De FSS was matig gecorreleerd met de subschaal Obsessief 
Compulsief van de SCL-90 (r = 0,36), hetgeen  wijst op een relatie met cognitieve 
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klachten.  De CIS-f was gecorreleerd et de subschalen Somatische klachten (r = 
0,53) en Depressie (r = 0,35) van de SCL-90. Deze laatste relatie verdween na een 
multiple regressieanalyse, waaruit bleek  dat alleen de lichamelijke klachten 
gerelateerd waren aan de CIS-f scores. Geen andere correlaties met vermoeidheid 
werden gevonden. Bovendien was PSF niet gerelateerd aan 
persoonlijkheidsproblematiek. In de vergelijking met gezonde controles kwam 
naar voren dat patiënten met PSF meer last hadden van psychische klachten (SCL-
90 en de HADS) en dat zij relatief laag scoorden op het gebruik van 
probleemgerichte coping stijlen. Er werden echter nauwelijks verschillen 
gevonden  wanneer de scores van patiënten met PSF vergeleken werden met de 
normatieve gegevens van andere patiëntengroepen met chronische 
aandoeningen. 
In hun geheel  genomen, weerleggen  deze bevindingen de resultaten van 
eerdere studies die concludeerden  dat emotie georiënteerde coping de 
belangrijkste determinant van PSF is, en dat persoonlijkheid een significante rol in 
PSF speelt. Bovendien tonen de resultaten aan dat psychologische factoren  
vermoeidheid na een CVA niet volledig kunnen verklaren.  
 
3. Wat zijn de uitkomsten van psychometrisch onderzoek naar twee 
vermoeidheidsvragenlijsten: de ééndimensionale Fatigue Severity Scale (FSS) in 
vergelijking met de meerdimensionale Checklist Individual Strenght (CIS20-R)? In 
hoeverre meten beide veelgebruikte vermoeidheidsschalen hetzelfde construct? 
  In hoofdstuk 4 werden de psychometrische eigenschappen en de 
onderliggende constructen van de CIS20-R vermoeidheids-subschaal (CIS-f) en de 
FSS onderzocht. De FSS is de meest gebruikte vragenlijst in onderzoek naar PSF, 
terwijl de CIS-20R (en vooral de CIS-f subschaal) de geprefereerde lijst is in studies 
die uitgevoerd zijn in de Benelux. Beide lijsten werden afgenomen bij 196 CVA-
patiënten en 112 leeftijds-gematchte controles. 
  De resultaten lieten zien dat beide schalen  een hoge interne consistentie 
hadden (Cronbach's α: FSS = 0,893; CIS-f = 0,938), maar dat de convergente 
validiteit van beide schalen matig was (r = .52). Bovendien reduceerden  de eerste 
twee items van de FSS de interne consistentie aanzienlijk en kon met deze items 
geen onderscheid gemaakt worden tussen CVA-patiënten en de gezonde 
controles. Met behulp van Principal Axis Factoring analyses op alle items bleek dat 
6 van de 8 items van de CIS-f hoog laadden op de factor: "subjectieve gevoelens 
van zwakte en vermoeidheid", terwijl de twee resterende items laadden op 
"fysieke conditie". Acht van de 9 items van de FSS laadden op een andere factor 
die "impact van vermoeidheid op dagelijkse leven" genoemd werd. 
  Deze resultaten laten zien dat de CIS-f en de FSS verschillende aspecten 
van vermoeidheid  meten. In overeenstemming met eerdere psychometrische 
studies over de FSS, werd geconcludeerd dat de eerste twee items van de 
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oorspronkelijke FSS moeten worden overgeslagen bij de afname in de  CVA-
populatie . Zodoende houdt men een FSS7 over waarmee  de impact van 
vermoeidheid op het dagelijks functioneren in kaart gebracht kan worden. In 
tegenstelling tot wat de naam van de FSS (Fatigue Severity Scale) suggereert , 
meet de FSS  niet de ernst van  vermoeidheid. Met betrekking tot de CIS-f werd 
geconcludeerd dat met deze subschaal niet alleen de  fysieke dimensie van 
vermoeidheid gemeten wordt, maar ook de ernst van een meer algemene 
subjectieve ervaring van vermoeidheid.   
Deel 2. De  behandeling van vermoeidheid na een CVA 
 
4. Welke onderdelen moeten deel uitmaken van een  behandelprotocol voor PSF, 
rekening houdend met de emotionele, cognitieve en fysieke aspecten van 
vermoeidheid? 
Op basis van de positieve resultaten van een pilot-studie ter evaluatie van 
de PSF-behandelmodule "Omgaan met beperkte belastbaarheid " in de Sint 
Maartenskliniek in Nijmegen, is het protocol van deze behandeling als 
uitgangspunt genomen voor de huidige studie. Dit behandelprotocol is vervolgens 
aangepast naar aanleiding van de ervaringen (feedback) van patiënten en 
therapeuten. De belangrijkste aanpassingen waren de structurele integratie van 
cognitieve gedragstherapie (CGT) in het protocol, een verkleining van de 
behandel-groepsgrootte naar vier patiënten en de toevoeging van een Graded 
Activity protocol. Dit laatste was gebaseerd op de aanbevelingen  voor Stroke 
Survivors van de American Heart Association. Het volledige behandelprotocol, 
genaamd COGRAT (Cognitieve en Graded Activity Training) wordt gepresenteerd 
in hoofdstuk 5. 
In het COGRAT  behandelprotocol werd de cognitieve coping hypothese 
als uitgangspunt genomen. Het primaire doel van de COGRAT behandeling was 
om patiënten in het algemeen te leren hun energie spaarzamer te gebruiken en ze 
doelmatigere laten  omgaan met hun beperkte cognitieve belastbaarheid . Om dit 
te bereiken werden de patiënten gevraagd om hun activiteiten en hun 
vermoeidheid per uur registreren gedurende twee weken. Uit deze registraties 
kon vervolgens het persoonlijk activiteiten- en vermoeidheidspatroon worden 
afgeleid. Op basis van deze informatie werden drie compensatiestrategieën 
aangeboden: afwisseling, planning en ontspanning. Eerst werd de patiënten 
geleerd hoe ze hun activiteiten en de intensiteit hiervan met periodes van rust of 
ontspanning konden afwisselen om zo vermoeidheid te voorkomen. Ten tweede, 
leerden ze hoe ze activiteiten beter konden  plannen, rekening houdend met de 
extra tijd die nodig is om de taken te volbrengen en de tijd die nodig is om te 
herstellen van  vermoeidheid. Ten slotte werden de patiënten gecoacht in het 
zoeken naar nieuwe manieren om te ontspannen. Dit was van belang omdat veel 
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activiteiten die voor het CVA ontspannend waren, na het CVA veel energie 
opslorpten.   
Om deze gedragsveranderingen en de daarmee gepaarde gaande 
gedachten beter te leren hanteren, , werden principes uit de Cognitieve 
Gedragstherapie (CGT) systematisch  toegepast. Het doel van de CGT was om 
'blokkerende gedachten' (die de uitvoering van de compensatiestrategieën 
konden  belemmeren) te vervangen door 'helpende gedachten'. Verder werd CGT 
gebruikt om beter om te gaan met gevoelens van vermoeidheid en de 
bijbehorende psychische klachten. Door het uitvoeren van CGT-
huiswerkopdrachten werd patiënten geleerd om rationele en adaptieve 
gedachten te formuleren om zo beter te kunnen omgaan met de negatieve 
emoties die samengaan  met  vermoeidheid. Naast deze vermoeidheids-specifieke 
behandelstrategieën waren ook meer algemene revalidatie behandelprincipes 
zoals psycho-educatie, het stellen van persoonlijke doelen en het uitvoeren van 
huiswerkopdrachten een substantieel onderdeel van de cognitieve behandeling.  
De cognitieve behandeling werd één keer per week gedurende twee uur 
gegeven. Graded activity training liep hier synchroon  mee en werd twee keer per 
week gedurende twee uur gegeven. De behandeling duurde 12 weken. Tijdens de 
graded activity training volgden de patiënten een trainingsschema gebaseerd op  
specifieke percentages van de eigen maximale hartslag en maximale spierkracht. 
De training bestond uit het lopen op een loopband met toenemende inclinatie, 
geprotocolleerde spierversterkende oefeningen (met gewichten), 
rompspieroefeningen en  wandeloefeningen die als huiswerk werden opgegeven.  
 
5. Is de uitgebreide COGRAT behandeling effectief in het reduceren  van PSF in de 
chronische fase na een CVA? 
Hoofdstuk 6 beschrijft de evaluatie van de COGRAT behandeling in 
vergelijking met alleen een cognitieve behandeling (CO)  door middel van  een 
gerandomiseerde gecontroleerde trial  (RCT). Deze RCT werd uitgevoerd in acht 
revalidatiecentra in Nederland. Patiënten werden geselecteerd op basis van de 
volgende criteria: ernstige vermoeidheid (CIS-f> 40), in staat om 10 meter 
zelfstandig te lopen, geen ernstige cognitieve stoornissen, geen co-morbide 
depressie, en geen ernstige hart-of longziekte. Volgens deze criteria, kwamen 88 
van 231 patiënten in aanmerking en 83 namen ten slotte deel aan de studie. De 
primaire uitkomstmaten hadden betrekking op vermoeidheid (CIS-f en 
Zelfobservatie List-moeheid / SOL-f) terwijl de  secundaire uitkomstmaten gericht 
waren op  depressie, angst, functionele gezondheid, pijn, slaapstoornissen en 
uithoudingsvermogen.  Gemeten werd op vier tijdstippen: (1) bij de start van de 
studie, (2) na een drie maanden durende kwalificatie-periode zonder behandeling 
(3) na voltooiing van de behandeling en (4) na 6 maanden als follow-up. 
Randomisatie en toewijzing  aan  de CO óf de COGRAT behandeling vond plaats na 
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het tweede meetmoment. De kwalificatie periode van drie maanden werd 
gebruikt om eventuele effecten van eerdere behandelingen op de studie te 
voorkomen, en om te zien of patiënten stabiele niveaus  van vermoeidheid 
vertoonden.   
De resultaten van deze studie toonden aan dat  de CO behandeling op 
zichzelf al effectief was om vermoeidheid significant te doen afnemen. Echter , de 
gecombineerde COGRAT behandeling zorgde bij meer patiënten  voor een klinisch 
significante daling van de ervaren ernst van de vermoeidheid dan alleen de CO 
behandeling (58% vs 24%). Aangezien alle patiënten zich in de chronische fase na 
het CVA bevonden (gemiddeld: 3,9 jaar post-onset, ± 3.9 jaar) en leden aan 
ernstige vermoeidheid bij de start van de studie, zonder enige daling in de 
kwalificatie periode, werd geconcludeerd dat PSF aanzienlijk verlicht kan worden 
met de cognitieve behandeling. Deze dient bij voorkeur in combinatie met graded 
activity training te worden gegeven. Verbeteringen  van beide behandelingen op 
secundaire uitkomstmaten werden gevonden voor depressieve symptomen, 
functionele gezondheid (functional health) en slaapstoornissen. Geen significante 
veranderingen  werden gevonden ten aanzien van  angst of pijn. Het fysieke 
uithoudingsvermogen verbeterde alleen na de COGRAT behandeling. 
 
In Hoofdstuk 7 van dit proefschrift werden allereerst redenen 
aangedragen voor het onvoldoende herkennen van PSF in Nederland en 
daarbuiten. Er wordt gesteld dat het ontbreken van een algemeen geaccepteerd 
definitie van PSF en van een duidelijk oorzakelijk model voor deze aandoening, de 
achterliggende oorzaak voor dit gebrek aan erkenning en herkenning vormen. De 
central fatigue hypothese van Chaudhuri en Behan en de cognitieve 
copinghypothese van van Zomeren bieden een goede aanzet om beide problemen 
op te lossen.. PSF wordt dan enerzijds duidelijker gekarakteriseerd en afgebakend 
(central fatigue hypothese) en anderzijds wordt het werkingsmechanisme 
ontrafeld door PSF afhankelijk te maken van de manier waarop mensen met een 
hersenbeschadiging cognitieve taken uitvoeren (cognitieve copinghypothese). 
Studies uit verschillende onderzoeksdomeinen (cardiovasculaire inspannings-
fysiologie, imaging-onderzoek en  neuropsychologisch onderzoek) ondersteunen 
deze laatste hypothese. Hoewel er in het huidige onderzoek geen duidelijk eigen 
psychosociaal- en persoonlijkheidsprofiel van patiënten met PSF is gevonden, 
spelen psychosociale factoren en stress op individueel niveau waarschijnlijk ook 
een rol bij de instandhouding van de klachten. Daarnaast blijft van belang om het 
onderscheid tussen PSF en depressie na een CVA te maken en de behandeling hier 
op aan te passen.  
De gepresenteerde COGRAT behandeling is tot nu toe de eerste therapie 
die effectief is gebleken en de vermoeidheidsklachten bij PSF significant 
reduceert. Toch kon niet bij alle patiënten een significante reductie van 
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vermoeidheid gerealiseerd worden. Toekomstige studies zouden hierbij in kunnen 
gaan op de individuele verschillen van patiënten en daarnaast de effectiviteit van 
de verschillende onderdelen van de COGRAT-therapie, zoals de cognitief 
gedragstherapeutische interventies, het stellen van doelen, de compensatie 
strategieën en de graded activity afzonderlijk kunnen onderzoeken. Hierbij is het 
wellicht van belang om in de meetinstrumenten van vermoeidheid een 
onderscheid te maken tussen de fysieke, de cognitieve als ook de emotionele 
aspecten van vermoeidheid. Vermoeidheid wordt immers door verschillende 
patiënten verschillend ervaren.  
Vervolgens werden adviezen voor de praktijk gegeven met betrekking tot 
het geven van psycho-educatie over vermoeidheid en behandelmogelijkheden. 
Steeds meer informatie en behandelprogramma’s zijn voorhanden, zoals de 
zorgwijzer vermoeidheid van de Hersenstichting Nederland en het 
ziekenhuisprogramma voor cognitieve revalidatie “Niet rennen maar plannen”. 
Ook is het COGRAT-protocol momenteel geïmplementeerd in meerdere 
revalidatiecentra.  
 
Tot slot van deze dissertatie wil ik graag een hoopvolle boodschap overbrengen 
aan CVA-patiënten. Ook al PSF is een chronische en invaliderende klacht die bijna 
alle terreinen van het leven beïnvloedt, de resultaten van dit proefschrift laten zien 
dat deze aandoening bij veel slachtoffers met een CVA met succes kan worden 
behandeld. Bovendien groeit de belangstelling voor PSF en neemt het aantal 
studies toe. Deze ontwikkelingen leiden waarschijnlijk tot een beter inzicht in het 
ontstaan van PSF en het veelzijdige karakter ervan. Deze kennis kan leiden tot 
meer effectieve behandelingen en daardoor zullen meer patiënten de doelgerichte  
hulp die ze vragen en nodig hebben, ontvangen. 
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